FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1694,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,5928674414.359817,8072770331.214497,1.3616484507331816,0.44535427761600443,0.3665240257755601,0.7429210442740862,Upregulated
Feature1693,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak6,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,10478885.399553813,20071945.439842284,1.915465688812375,0.93769518341067,0.3598564836461385,0.7429210442740862,Upregulated
Feature1692,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,4367561.2588447295,3515755.3807076034,0.8049699070820958,-0.31299324422523245,0.8126107731052383,0.9118080082836999,Downregulated
Feature1691,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,1416120.3414187366,1427557.2122399067,1.0080761998021384,0.011604695307743483,0.9630724393632534,0.9839835417860984,Upregulated
Feature1690,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak13",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,3582037.9611541303,2981359.0668662065,0.8323080601595899,-0.2648104864666462,0.8278618853083984,0.9146541535125908,Downregulated
Feature1689,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,7799529.293226403,5117704.00974594,0.6561554957156802,-0.6078903496863988,0.22565232169256463,0.7429210442740862,Downregulated
Feature1688,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak2,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2012780839.94488,2281515969.85741,1.1335143521735278,0.18080265810868476,0.47432468409459116,0.7573100988277449,Upregulated
Feature1687,NA,C30 H32 O10,552.19968,NA,NA,Feature1687,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2223024.11775243,2820211.64048111,1.2686374466024515,0.3432798322040642,0.32494500801065573,0.7429210442740862,Upregulated
Feature1686,Phenacetin,C10 H13 N O2,179.09467,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak5,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,5499918.52560126,7103785.100684741,1.2916164244284223,0.36917769175265147,0.2458176096966539,0.7429210442740862,Upregulated
Feature1685,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,108398404.66564234,90163235.79756217,0.8317764092162886,-0.2657323269376037,0.1424932160851013,0.7397744129866796,Downregulated
Feature1684,NA,C30 H32 O10,552.19968,NA,NA,Feature1684,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,1249986.4692792085,1304921.9665853628,1.0439488735728735,0.06205105898729528,0.8730383160520088,0.9391342199196943,Upregulated
Feature1683,NA,C9 H16 O7,236.0896,NA,NA,Feature1683,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1789024804.09572,1640695756.9611266,0.9170894406857775,-0.12486565295207955,0.3339382050002098,0.7429210442740862,Downregulated
Feature1682,Citric acid,C6 H8 O7,192.02697,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,Citric acid,6,8,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,1516320001.2386968,1368284421.71401,0.9023718084548412,-0.14820609855769837,0.22794106652910007,0.7429210442740862,Downregulated
Feature1681,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,1187803057.92444,983905353.699306,0.8283404787815385,-0.2717042038733599,0.09208787032787415,0.6854522562238613,Downregulated
Feature1680,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1006518641.137699,1022553155.1363784,1.0159306676929054,0.022801948577930345,0.9010572437240184,0.9498388119903466,Upregulated
Feature1679,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak12",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1585905.8363629987,1390555.5566048534,0.8768210096217645,-0.18964572757205336,0.8053416775634914,0.9118080082836999,Downregulated
Feature1678,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,782421971.9559387,1300303989.3197188,1.6618960559979572,0.732830150949521,0.18096392487119362,0.7429210442740862,Upregulated
Feature1677,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak5,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1426525063.6315167,1685057518.8714533,1.1812323259023494,0.24029274328182443,0.3165807520514168,0.7429210442740862,Upregulated
Feature1676,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,169885067.59644634,193513600.1296747,1.1390853997206911,0.18787591309950744,0.8202090130788535,0.9125694928365151,Upregulated
Feature1675,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,594207430.5203856,727037137.1634094,1.2235409720923487,0.29106241301905017,0.4815457830940946,0.7593501989503708,Upregulated
Feature1674,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak3,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1752706.7486465783,940132.8477419387,0.5363891298232858,-0.8986480942388293,0.2964613801990647,0.7429210442740862,Downregulated
Feature1673,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,1332025415.7769334,1341089761.73424,1.0068049346881416,0.009784192760381099,0.954751161293751,0.9819966406992192,Upregulated
Feature1672,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak3,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,452435803.42121434,583625220.240993,1.289962500376307,0.3673291266504759,0.3848428245315251,0.7429210442740862,Upregulated
Feature1671,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,130487134.0848672,150571239.10183132,1.1539163623894266,0.20653865904505955,0.6776330129731392,0.8450956500772007,Upregulated
Feature1670,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak11",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1004642.8426608624,921658.0547113087,0.9173987168118741,-0.12437920539907825,0.6893195756350345,0.8507102856872568,Downregulated
Feature1669,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak4,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1086162715.2313764,1215169590.4174993,1.1187730653768957,0.16191742625339728,0.4812487429908304,0.7593501989503708,Upregulated
Feature1668,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,316740531.5004467,290787909.7806373,0.9180634647644621,-0.1233342058058456,0.05704137459337251,0.6384005117332444,Downregulated
Feature1667,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak3",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,1267930189.5387566,1454341546.02621,1.1470202050755378,0.19789080504644688,0.38823752279158985,0.7429210442740862,Upregulated
Feature1666,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,1068305488.4302399,1272127177.3172166,1.1907897049059168,0.2519186537750964,0.284360565807795,0.7429210442740862,Upregulated
Feature1665,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak3,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,713331278.6814806,1086191782.2299414,1.5227031460581049,0.6066347130312888,0.48928890285468996,0.7626394464118028,Upregulated
Feature1664,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,57125761.334278,59697029.496977866,1.0450106589854233,0.06351765770040274,0.5171850055396147,0.7682508165605624,Upregulated
Feature1663,NA,C32 H36 O10,580.23111,NA,NA,Feature1663,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,1500324.01302831,1969122.9129541733,1.3124651047740163,0.3922790655683054,0.3158531503577126,0.7429210442740862,Upregulated
Feature1662,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,895333583.38082,994218528.4575304,1.1104448072899447,0.15113768804212124,0.4514488714943987,0.7437859477801351,Upregulated
Feature1661,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,656369983.5988823,555081577.314299,0.8456839757826552,-0.24180945252122638,0.23387437066179576,0.7429210442740862,Downregulated
Feature1660,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak2,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,11128767.092833877,11710713.5037128,1.052292082853783,0.07353520652899742,0.7439588391951919,0.8727605772830022,Upregulated
Feature1659,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,85619725.88008006,80233761.02276483,0.9370943459354347,-0.09373379026746435,0.3234586049122943,0.7429210442740862,Downregulated
Feature1658,NA,C6 H11 N O7,209.05352,NA,NA,Feature1658,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,769431539.7167867,665615730.906783,0.8650746642797923,-0.20910343827960393,0.0923207139535573,0.6854522562238613,Downregulated
Feature1657,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1046766.2323553789,1555879.9745575981,1.486368136901625,0.5717914802813181,0.4947008184129435,0.7638837682405117,Upregulated
Feature1656,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,54569453.74481186,59636252.1728997,1.0928504516791056,0.12809599260880042,0.4847860231460471,0.7603958548235219,Upregulated
Feature1655,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,808757439.1317866,748250482.733063,0.9251852861301916,-0.112185772920828,0.22091526667109954,0.7429210442740862,Downregulated
Feature1654,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,691600977.4142157,796572804.0591704,1.1517809113535775,0.20386631733268762,0.15882152421748197,0.7429210442740862,Upregulated
Feature1653,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,1137766.9033402193,1273025.39061908,1.1188806660501138,0.1620561742246205,0.7342550198626254,0.8680261231817094,Upregulated
Feature1652,L-Pyroglutamic acid,C5 H7 N O3,129.04257,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak2,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,552110872.183229,462022477.64062136,0.8368291604431402,-0.25699496976795566,0.2806366922079758,0.7429210442740862,Downregulated
Feature1651,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak10",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1107105.953566929,981579.973819647,0.8866179164308021,-0.17361557866807348,0.5868227150707203,0.801558357602538,Downregulated
Feature1650,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14748,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak2",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,570807608.204198,536728939.488705,0.9402974518459785,-0.08881088658591305,0.5145443356314869,0.7682508165605624,Downregulated
Feature1649,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak3,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,331131759.53069633,474560762.5948807,1.4331478299377332,0.5191874320132112,0.11342170613677273,0.7055599272098991,Upregulated
Feature1648,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak8,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,641506640.38748765,714228645.3461003,1.113361266088667,0.1549217977345276,0.3229161810596404,0.7429210442740862,Upregulated
Feature1647,NA,C16 H29 N O12,427.16894,NA,NA,Feature1647,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,687984502.8410476,722052623.4572064,1.0495187325811464,0.06972791714053593,0.6502274278854785,0.8331143341897993,Upregulated
Feature1646,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,635435088.2563257,528896255.8435273,0.8323371900894744,-0.2647599945010052,0.17641559375551114,0.7429210442740862,Downregulated
Feature1645,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,2352770.51825216,2927904.64469687,1.2444497336153162,0.31550795749572763,0.22769625856444126,0.7429210442740862,Upregulated
Feature1644,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,354562757.68827665,295078941.268605,0.8322333208160332,-0.2649400429698529,0.16106517437425294,0.7429210442740862,Downregulated
Feature1643,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,789295.480819123,855314.3914042084,1.0836428336274921,0.11588932582184702,0.7276631841952432,0.8678071861534502,Upregulated
Feature1642,NA,C11 H15 N O7,273.08486,NA,NA,Feature1642,11,15,7,1,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,228574865.83266133,201721700.205658,0.8825191670607282,-0.1803004828795497,0.09306612687809215,0.6854522562238613,Downregulated
Feature1641,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,7176409.0620310465,12443200.26598412,1.733903426968596,0.7940235471679286,0.4071552482224124,0.7429210442740862,Upregulated
Feature1640,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,556335440.7511483,690060812.1780196,1.2403682412292827,0.31076849232761555,0.4892735001565386,0.7626394464118028,Upregulated
Feature1639,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,761412.10086397,731148.5199789184,0.9602533492037864,-0.05851300424217311,0.8353373360800747,0.9174806109836959,Downregulated
Feature1638,NA,C12 H21 N O9,323.12168,NA,NA,Feature1638,12,21,9,1,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,574459158.1760417,472613486.2819047,0.8227103346780893,-0.2815435284969441,0.1465686160114049,0.7419901680471508,Downregulated
Feature1637,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,10204992.370394753,13223637.255809199,1.2958007978694528,0.3738439512359104,0.013130609237598283,0.49964037324760396,Upregulated
Feature1636,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,319769998.370729,266339171.65060967,0.8329085686826263,-0.26376996033839867,0.1571589162374329,0.7429210442740862,Downregulated
Feature1635,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,6542694.701841807,4493117.723263533,0.6867380992114295,-0.5421680904707142,0.09091031828914069,0.6854522562238613,Downregulated
Feature1634,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06332,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Υ-Aminobutyric acid (GABA),4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,245946907.96754232,228043035.163359,0.9272043183948215,-0.10904080926743254,0.4022941693969462,0.7429210442740862,Downregulated
Feature1633,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,292424832.92699504,241937224.81929967,0.8273484245426591,-0.27343306960306174,0.19533475741280795,0.7429210442740862,Downregulated
Feature1632,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak7,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,225894825.685053,209572017.82551968,0.9277415593295134,-0.10820512466528626,0.3965371046231909,0.7429210442740862,Downregulated
Feature1631,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,734226.0237097887,2913344.5471633216,3.967912404470772,1.98838017717879,0.2886239325721378,0.7429210442740862,Upregulated
Feature1630,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,831249.2262662787,4617280.9781829445,5.554628903442571,2.473690530507861,0.4320833962266268,0.7437859477801351,Upregulated
Feature1629,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak9",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1777879.00106052,2217983.196558307,1.247544515253997,0.31909129515402174,0.401685957722186,0.7429210442740862,Upregulated
Feature1628,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,12048530.487466266,12039047.157729534,0.9992129056944664,-0.0011359841733121693,0.9925737268536532,0.9961018325178248,Downregulated
Feature1627,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3613435.904969217,4009999.9892647765,1.1097470924419062,0.15023092878002522,0.6498847019313618,0.8331143341897993,Upregulated
Feature1626,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,387986442.892381,334912370.8858963,0.8632063749165424,-0.2122225754894667,0.05710444719011191,0.6384005117332444,Downregulated
Feature1625,NA,C9 H17 N O6,235.10555,NA,NA,Feature1625,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,26615235.532553665,23716028.789830364,0.8910696567318662,-0.16638988031902283,0.252079995476347,0.7429210442740862,Downregulated
Feature1624,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1624,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,186692.92418370134,239846.34008222233,1.2847103934491877,0.3614431757428139,0.3205240356155684,0.7429210442740862,Upregulated
Feature1623,Homovanillic acid,C9 H10 O4,182.05795,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Other,Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Homovanillic acid,9,10,4,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,8902098.647656726,13446375.225962933,1.5104725029644988,0.5949999211080024,0.06686973611758595,0.6384005117332444,Upregulated
Feature1622,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,30718140.624015868,56831137.493715666,1.8500839028415768,0.8875906996435575,0.14804762502947874,0.7419901680471508,Upregulated
Feature1621,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4230091.981193717,6756114.969305797,1.5971555699834321,0.6755048444413996,0.23919261639825748,0.7429210442740862,Upregulated
Feature1620,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,5316145.62187049,5054366.66028941,0.9507577519125646,-0.07285029810725514,0.22195106402585732,0.7429210442740862,Downregulated
Feature1619,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,470013.372213485,603427.4516999503,1.2838516675773795,0.36047852737266506,0.2660038545904293,0.7429210442740862,Upregulated
Feature1618,NA,C29 H30 O10,538.18407,NA,NA,Feature1618,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,750798.246205621,948484.8701356333,1.2633019255560058,0.33719948033390096,0.3366375210453025,0.7429210442740862,Upregulated
Feature1617,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,209545264.08690166,179187490.089733,0.8551254587907134,-0.2257919959449312,0.21819166119969646,0.7429210442740862,Downregulated
Feature1616,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak3,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,325559995.554799,323096698.810504,0.9924336626799088,-0.010957423585159871,0.9056684106282717,0.9535129195800449,Downregulated
Feature1615,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak1,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,44303261.3871966,69434702.54271436,1.5672593928441712,0.6482439761089978,0.11216461935234535,0.7055599272098991,Upregulated
Feature1614,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,283259574.4882043,267360489.5932707,0.9438709709154219,-0.08333844117247846,0.3708694007836531,0.7429210442740862,Downregulated
Feature1613,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,355165680.48982066,277371150.566532,0.7809627050226259,-0.35667444096777273,0.07521457582226457,0.6384005117332444,Downregulated
Feature1612,Diethylpyrocarbonate,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Diethylpyrocarbonate,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,44990385.58668537,40873698.86217317,0.9084985231660138,-0.1384439256374373,0.028304210337210752,0.5904389566427806,Downregulated
Feature1611,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak7",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,272928152.8340937,373107430.72671366,1.367053661750741,0.45106987500117973,0.413264106763272,0.7429210442740862,Upregulated
Feature1610,Ectoine,C6 H10 N2 O2,142.07426,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak2,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,268886881.58963734,261366448.74587765,0.9720312393103765,-0.04092541472509345,0.7911102608258069,0.9069252842381308,Downregulated
Feature1609,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak3,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,266060493.43562132,258880665.25250667,0.973014301783771,-0.039467084371330716,0.8029550079244081,0.9118080082836999,Downregulated
Feature1608,NA,C9 H19 N O7,253.11617,NA,NA,Feature1608,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,304093107.00351065,228725007.71673432,0.7521545291524604,-0.41089900274621166,0.0733151789644546,0.6384005117332444,Downregulated
Feature1607,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak8,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,378119177.00863636,357197257.7463087,0.944668452343929,-0.08212001538128376,0.6748161248284734,0.8435495508777358,Downregulated
Feature1606,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,12808219.035848,13388475.522321833,1.045303448110139,0.0639218126736503,0.6471092261742283,0.8331143341897993,Upregulated
Feature1605,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak2,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,394010513.88275737,385026907.45519567,0.9771995768868369,-0.033274855947966996,0.8748251470090185,0.9391342199196943,Downregulated
Feature1604,NA,C6 H14 O4,150.08923,NA,NA,Feature1604,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,1282120.0421128734,1741628.6211892401,1.3583974698025298,0.4419056767930898,0.22512735135336892,0.7429210442740862,Upregulated
Feature1603,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1603,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,201151.27249958634,251213.89852000866,1.2488804838185912,0.3206354195780554,0.3334946219097297,0.7429210442740862,Upregulated
Feature1602,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,1,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Lignin,111499237.28287533,117330355.17426866,1.052297379188341,0.0735424677984655,0.49652584440308145,0.7638837682405117,Upregulated
Feature1601,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1601,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,1114016.9695573,1392677.4380379233,1.2501402367249042,0.3220899408708876,0.31334592005437817,0.7429210442740862,Upregulated
Feature1600,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,231055344.91051534,199169237.186542,0.8619979653086043,-0.2142436309588947,0.3995523330223581,0.7429210442740862,Downregulated
Feature1599,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,5692561.255716033,6577674.496089307,1.1554859404428035,0.20849970569317156,0.03294531315068195,0.6051275072806717,Upregulated
Feature1598,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,240620663.812276,308634603.66527665,1.2826604281420435,0.3591392815127677,0.11530986468916594,0.7055599272098991,Upregulated
Feature1597,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,602575.0432490953,685767.8537128167,1.1380621573956071,0.18657935528728145,0.6316967650387255,0.8263276602128193,Upregulated
Feature1596,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak4,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,158235150.45927033,195328194.43045533,1.2344172193316347,0.30383009183584264,0.20553801178205192,0.7429210442740862,Upregulated
Feature1595,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,571347.255124425,733080.3585006733,1.2830732132265636,0.3596034941573901,0.11438751629605298,0.7055599272098991,Upregulated
Feature1594,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,215820459.44167367,214288247.57619366,0.9929005254207881,-0.01027890751719059,0.8729781498589391,0.9391342199196943,Downregulated
Feature1593,NA,C6 H15 N O7,213.0849,NA,NA,Feature1593,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,28597479.417800535,30544327.436983965,1.0680776088948458,0.09501648026495779,0.5325786754071591,0.7697066387459335,Upregulated
Feature1592,NA,C6 H15 N O7,213.08492,NA,NA,Feature1592,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,26600131.002324466,27895501.12805227,1.0486978851951747,0.06859911804186389,0.6404728110827724,0.8313876949993997,Upregulated
Feature1591,NA,C10 H20 O7,252.12091,NA,NA,Feature1591,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,32504815.99345463,38669810.94693193,1.189664047159003,0.250554224015561,0.3065596183092002,0.7429210442740862,Upregulated
Feature1590,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,10528943.061727364,7907533.770427209,0.751028258398608,-0.4130609028807756,0.3876760544233877,0.7429210442740862,Downregulated
Feature1589,NA,C12 H18 O9,306.09515,NA,NA,Feature1589,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,213561281.70269233,207589716.62147465,0.9720381661244619,-0.04091513393953887,0.9005953438655702,0.9498388119903466,Downregulated
Feature1588,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,227745354.42250735,207877855.67710534,0.9127644171018113,-0.13168554369828156,0.11012788553353335,0.7055599272098991,Downregulated
Feature1587,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1561309.0580327634,2174009.028304983,1.3924270900241984,0.4776017874472759,0.6704563796074474,0.8400540732655443,Upregulated
Feature1586,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,1080098.550459237,1031465.5105789014,0.9549735162040002,-0.06646737071379284,0.8478993551873971,0.9272701792688512,Downregulated
Feature1585,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,4117076.4516436267,4507829.49512655,1.0949103199982906,0.1308127089203843,0.5108202927070761,0.7678958865079032,Upregulated
Feature1584,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,583902.4348225764,793576.24653097,1.3590904904722734,0.44264151630352233,0.3272428996767888,0.7429210442740862,Upregulated
Feature1583,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak6",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,254294666.43864334,278403660.388848,1.0948073126654496,0.1306769761974453,0.5321787365094289,0.7697066387459335,Upregulated
Feature1582,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,138219330.1161319,89663296.52130944,0.6487030174865869,-0.6243699452605372,0.14979588244546058,0.7429210442740862,Downregulated
Feature1581,Cytarabine,C9 H13 N3 O5,243.08555,Metabolic pathways;ABC transporters;Other,Other,Cytarabine,9,13,5,3,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,144022479.38370132,174707099.47474217,1.213054380276926,0.2786442267958494,0.6145931323907333,0.8152864262097903,Upregulated
Feature1580,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak2,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,1450153.1840626334,822970.290029628,0.5675057635801344,-0.8172930504199268,0.07809832460573793,0.6384005117332444,Downregulated
Feature1579,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,541607.0838303952,721934.0615280243,1.3329479674126614,0.41462046488236304,0.25115250639429165,0.7429210442740862,Upregulated
Feature1578,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,7027575.569087977,6771335.602518303,0.9635379279737966,-0.05358663809885748,0.5169217008567775,0.7682508165605624,Downregulated
Feature1577,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,406039.73343447235,406527.421980252,1.0012010857697462,0.0017317606951939288,0.9962098761823439,0.9987495928719955,Upregulated
Feature1576,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,8460965.197765537,9629065.301116144,1.1380575473421273,0.18657351121741134,0.8922618863473263,0.9484653686568222,Upregulated
Feature1575,NA,C9 H17 N O6,235.10557,NA,NA,Feature1575,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,5493495.641235604,4036909.6799033396,0.7348526227273665,-0.44447315348235034,0.612482487750047,0.8152864262097903,Downregulated
Feature1574,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,191773.96188366934,81739767.87971163,426.2297502582505,8.735487484566177,0.19112779442038053,0.7429210442740862,Upregulated
Feature1573,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak2,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,111432874.795541,126119143.2741136,1.1317947554123433,0.17861235729022348,0.4761315674049583,0.7584892140248123,Upregulated
Feature1572,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1572,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,144524.49223110458,162543.15081956767,1.1246754671841366,0.16950876194987952,0.6823556555497281,0.8468208648360729,Upregulated
Feature1571,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,138603818.04286835,228067645.92901868,1.645464382939872,0.7184947988037155,0.06489259135471666,0.6384005117332444,Upregulated
Feature1570,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak7,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,155801874.28800988,209407764.45291167,1.3440644755390287,0.42660234668014313,0.44269900327842704,0.7437859477801351,Upregulated
Feature1569,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Adenine,5,5,0,5,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,270525261.2107137,252394847.85705268,0.9329807010534993,-0.10008085602080374,0.4977815173509149,0.7643022379378415,Downregulated
Feature1568,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,470732.312874458,557108.5738078277,1.183493375260189,0.24305163044428776,0.7712979734335731,0.8949169636962143,Upregulated
Feature1567,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak2",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,186167939.594406,162321067.58928767,0.8719066663300231,-0.19775438560707795,0.1319471733668396,0.7353513019132542,Downregulated
Feature1566,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,89563599.49815647,59172595.93849336,0.6606768404803933,-0.5979833218532663,0.037507960804925584,0.6051284343194661,Downregulated
Feature1565,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,698446.6996904823,654458.7388093304,0.9370203039105987,-0.09384778549407734,0.6754653584755959,0.8435495508777358,Downregulated
Feature1564,NA,C22 H33 N O6,407.23081,NA,NA,Feature1564,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,676481.6349219293,936971.4964931447,1.3850656812010538,0.4699543919396233,0.28808964792652136,0.7429210442740862,Upregulated
Feature1563,NA,C8 H19 N O6,225.12125,NA,NA,Feature1563,8,19,6,1,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,7624228.716973393,6368580.658687296,0.8353081859295856,-0.2596195185204262,0.21366250100679265,0.7429210442740862,Downregulated
Feature1562,NA,C15 H27 N O12,413.15342,NA,NA,Feature1562,15,27,12,1,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,227485086.11968866,209219662.11952367,0.9197071583384818,-0.12075352552890178,0.35709772911779464,0.7429210442740862,Downregulated
Feature1561,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,450408.32069840067,358828.86246022367,0.7966745860818593,-0.3279375412043736,0.48472434919559354,0.7603958548235219,Downregulated
Feature1560,NA,C21 H31 N O12,489.18471,NA,NA,Feature1560,21,31,12,1,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Lignin,217747566.119569,210381474.77267367,0.9661714182244844,-0.0496489200264021,0.3824450572339345,0.7429210442740862,Downregulated
Feature1559,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,30530589.277096566,73329972.46257353,2.401852509200803,1.264147562043682,0.44966603923864595,0.7437859477801351,Upregulated
Feature1558,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,243495094.8393323,276955036.14837337,1.1374152581230403,0.18575906290269006,0.4623470866497286,0.749905170284088,Upregulated
Feature1557,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,5070200.89902148,7315738.360402414,1.4428892476064035,0.5289605665920548,0.3500324309785013,0.7429210442740862,Upregulated
Feature1556,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10572,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,239066432.30900332,266763832.23117465,1.1158564991942126,0.15815150636750333,0.5749872146892939,0.7938291293265395,Upregulated
Feature1555,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,187386333.35372666,175438579.07571265,0.9362399911232566,-0.0950497043696734,0.552213725859876,0.7801918695634946,Downregulated
Feature1554,NA,C10 H15 N O8,277.07983,NA,NA,Feature1554,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,183724079.909322,214242752.77677166,1.1661114475713381,0.22170567633856444,0.10345016472485448,0.7055599272098991,Upregulated
Feature1553,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1553,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,138894163.18414265,118986374.46218866,0.8566693641721956,-0.22318959849454484,0.02625327165958442,0.5904389566427806,Downregulated
Feature1552,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,8499324.299868757,10108748.4432414,1.189359069802466,0.2501843332657549,0.5147486786520579,0.7682508165605624,Upregulated
Feature1551,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,436981.57118371467,913863.4388809353,2.0913088769520014,1.0644061572587162,0.09569441815992669,0.6957353835318275,Upregulated
Feature1550,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1550,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,852690.561840671,987152.3098043483,1.1576911414070536,0.2112504103271015,0.41586972509696324,0.7429771053580235,Upregulated
Feature1549,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,9309896.145588437,9751073.626738736,1.0473880131691216,0.0667959990726907,0.8059139893962282,0.9118080082836999,Upregulated
Feature1548,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,82214393.36366877,66493896.3027052,0.8087865589249656,-0.3061690733306907,0.282798386299809,0.7429210442740862,Downregulated
Feature1547,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,119241776.191707,115391922.6852382,0.9677138866140393,-0.04734753021526766,0.7233956253844995,0.8661346898978831,Downregulated
Feature1546,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,387449.291161081,476592.4240169417,1.2300769026798908,0.2987485136512699,0.4186574405289658,0.7429771053580235,Upregulated
Feature1545,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,91515993.17573813,56166476.776421934,0.6137340024116382,-0.704314580253824,0.40522455799030954,0.7429210442740862,Downregulated
Feature1544,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,3662592.5598911564,4064069.7401237534,1.1096155724852257,0.15005993988082322,0.8201921012467558,0.9125694928365151,Upregulated
Feature1543,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1031910.6884731706,941147.563436631,0.9120436234933916,-0.1328252640363334,0.8719952321272777,0.9391342199196943,Downregulated
Feature1542,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak3,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,136396694.644171,182630846.39868,1.3389682710063007,0.42112177410194185,0.05019164699349515,0.6384005117332444,Upregulated
Feature1541,NA,C10 H17 N O9,295.09039,NA,NA,Feature1541,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,138771278.48479533,151357616.790341,1.0906984387761816,0.1252522739618111,0.5023709325759703,0.7643022379378415,Upregulated
Feature1540,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,35440155.949352734,38800111.764074564,1.0948064624637521,0.1306758558338573,0.6757359743453881,0.8435495508777358,Upregulated
Feature1539,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak3,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,59811894.6975575,136993434.31386432,2.29040452583186,1.1956024262134073,0.056809785664045015,0.6384005117332444,Upregulated
Feature1538,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak2,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,23688180.77457177,18456415.3578791,0.7791402612771031,-0.36004502843116454,0.25212578416190495,0.7429210442740862,Downregulated
Feature1537,triacetic acid,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,triacetic acid,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,79897314.55989887,86070787.60896564,1.0772675913210892,0.10737665723639818,0.521673706441231,0.7682508165605624,Upregulated
Feature1536,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,11214605.121018624,13896713.016376033,1.2391620450666205,0.30936486086636866,0.3548445798124411,0.7429210442740862,Upregulated
Feature1535,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,157291212.99000734,125908763.033222,0.8004818618902821,-0.32105938178656257,0.0012394265706364431,0.19965892031945995,Downregulated
Feature1534,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,227029021.12702733,202733353.50200066,0.8929843087706714,-0.16329326988535184,0.14227576930560232,0.7397744129866796,Downregulated
Feature1533,NA,C12 H25 N O12,375.13771,NA,NA,Feature1533,12,25,12,1,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,15890472.964530466,17521095.507801235,1.102616363081862,0.14093091662862806,0.32306647145777195,0.7429210442740862,Upregulated
Feature1532,NA,C7 H15 N O5,193.09509,NA,NA,Feature1532,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,67487727.35803877,56778324.66538247,0.841313330409834,-0.24928489126629946,0.5014301020179146,0.7643022379378415,Downregulated
Feature1531,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,104079022.872539,108565839.17500603,1.0431097081682044,0.06089090005008552,0.6119206122453282,0.8152864262097903,Upregulated
Feature1530,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,9896126.92704453,7624726.481554353,0.7704758172328203,-0.3761784190114111,0.39314344840763726,0.7429210442740862,Downregulated
Feature1529,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,161684662.232707,129596281.70548134,0.8015372634354024,-0.3191585021135311,0.07454072992401445,0.6384005117332444,Downregulated
Feature1528,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07427,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak2",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,70662050.71277964,67536379.273011,0.9557659110054196,-0.0652707825242259,0.3858358213499195,0.7429210442740862,Downregulated
Feature1527,NA,C6 H14 O4,150.08924,NA,NA,Feature1527,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,645095.6805554427,850390.7392264074,1.3182397043709868,0.3986127291198514,0.39170516682544293,0.7429210442740862,Upregulated
Feature1526,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,1586862.18846643,2335407.74974838,1.4717142841530284,0.5574976164731267,0.18633978602680845,0.7429210442740862,Upregulated
Feature1525,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Lactamide,3,7,2,1,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,160599752.844718,138065391.916733,0.8596862041887872,-0.21811794004151042,0.23174441518450808,0.7429210442740862,Downregulated
Feature1524,cis-acetylacrylic acid,C5 H6 O3,114.03168,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak2,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,44191857.34721963,95587643.07023443,2.1630148359502797,1.1130435606667395,0.3577488771465315,0.7429210442740862,Upregulated
Feature1523,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,269706.6148320023,335193.86520351033,1.2428092110840492,0.31360483915046816,0.3205960962738224,0.7429210442740862,Upregulated
Feature1522,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,7681748.392673217,7847930.477566967,1.0216333673532256,0.030877550483041586,0.8176223224175772,0.9125694928365151,Upregulated
Feature1521,NA,C8 H9 N,119.07346,NA,NA,Feature1521,8,9,0,1,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,142063574.00676432,121533640.858365,0.855487704769262,-0.22518097470906248,0.13325254776986878,0.7376791370005154,Downregulated
Feature1520,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4779450.295033393,6221391.89063461,1.3016961170408285,0.3803926884359441,0.4574528494704721,0.7483691664015606,Upregulated
Feature1519,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,71452423.9883356,74258439.8472506,1.0392711079945038,0.05557204994904677,0.6607843433189864,0.8390728999405301,Upregulated
Feature1518,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,28791235.352258768,28974133.08252657,1.006352548893094,0.00913580359123536,0.9701179655560868,0.9855864682789036,Upregulated
Feature1517,NA,C17 H31 N O12,441.1847,NA,NA,Feature1517,17,31,12,1,0,0,1.8235294117647056,0.7058823529411765,-0.23529411764705888,67.00588235294117,3,-9,-2.5,-0.4,-10,Carbohydrate,102485326.08003421,111424170.65694994,1.087220726310956,0.12064486440136088,0.5825619888845023,0.7984304281313486,Upregulated
Feature1516,fructosylglycine,C8 H15 N O7,237.08487,NA,NA,fructosylglycine-peak2,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,98761968.9632457,100772716.25337458,1.0203595302041535,0.029077584598288433,0.5842418980169423,0.7997783212758481,Upregulated
Feature1515,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,42430260.974053234,34942648.0901988,0.823531302613641,-0.2801046067242173,0.06405129886216618,0.6384005117332444,Downregulated
Feature1514,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,115780475.15817167,120453595.481989,1.0403619031398275,0.05708547552237919,0.3935834785193453,0.7429210442740862,Upregulated
Feature1513,3-Butynoic acid,C4 H4 O2,84.0211,Metabolic pathways;Other,NA,3-Butynoic acid-peak6,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,124690960.731737,134384613.44485033,1.0777414229245412,0.10801108104717014,0.6058000811123027,0.8132671428028913,Upregulated
Feature1512,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,133075780.64713943,149211916.6602284,1.1212552421982416,0.16511473018420392,0.781746709632059,0.9027817218351678,Upregulated
Feature1511,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Hordenine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,177240606.19818667,144177564.10485134,0.8134567309233588,-0.29786248622678546,0.0016515930400567082,0.1998427578468617,Downregulated
Feature1510,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak3,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,122272772.445867,165833508.76614496,1.3562586784360624,0.43963236911222275,0.47280853548545054,0.7563150699833363,Upregulated
Feature1509,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak5,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1898330.3659177234,1805768.400161719,0.9512403281231523,-0.07211821501199558,0.9025439365920327,0.9508143212605121,Downregulated
Feature1508,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,29042595.9207956,48319433.952579565,1.6637436296795018,0.7344331422018485,0.06697077522015993,0.6384005117332444,Upregulated
Feature1507,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,64752150.1900951,54608899.84107277,0.8433526868336504,-0.24579200804043602,0.6793515243938538,0.8451333690948524,Downregulated
Feature1506,Thymidine,C10 H14 N2 O5,242.09029,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,5,2,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,168955691.66223398,159848208.32405698,0.9460954333732413,-0.07994237822536616,0.424440672835801,0.7437646832554922,Downregulated
Feature1505,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,60288567.85821807,60068925.08205247,0.996356808861638,-0.005265611437558468,0.9806976413381414,0.9910397843019159,Downregulated
Feature1504,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,166060635.08331332,81823956.64735587,0.49273541924191994,-1.021114914432621,0.027890131072823104,0.5904389566427806,Downregulated
Feature1503,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,15453507.2846101,17242248.755968668,1.1157498707843458,0.15801363951040956,0.5455734998144729,0.7733903838374202,Upregulated
Feature1502,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,600028.1738537643,545050.7451990487,0.9083752546124368,-0.13863968929850273,0.6400283364814665,0.8313876949993997,Downregulated
Feature1501,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,49011891.38806747,57815709.5913881,1.1796261673236308,0.23832973077552677,0.4446885416266405,0.7437859477801351,Upregulated
Feature1500,pseudouridine,C9 H12 N2 O6,244.06948,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak2,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,17987383.542185333,20624182.416487835,1.1465915744843316,0.1973515828110047,0.469955004741881,0.7531729215068557,Upregulated
Feature1499,NA,C18 H31 N O11,437.18971,NA,NA,Feature1499,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,153325707.16377667,141971502.081639,0.925947153336723,-0.11099823811315547,0.03916275184698518,0.614208185361607,Downregulated
Feature1498,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,58589626.34218753,52813387.67688387,0.9014119217697677,-0.14974156411034437,0.37209110396923795,0.7429210442740862,Downregulated
Feature1497,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,346416.94865527266,436067.12622126867,1.2587927002821357,0.33204071760876314,0.3709605198970391,0.7429210442740862,Upregulated
Feature1496,2908,C5 H11 N,85.08916,Other,NA,2908-peak2,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,102576687.865501,88639113.71827637,0.8641253247960234,-0.2106875320936321,0.2984647068242944,0.7429210442740862,Downregulated
Feature1495,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak2,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,111067935.987499,108902258.07707833,0.980501322085751,-0.028408519171344803,0.40728039498288504,0.7429210442740862,Downregulated
Feature1494,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,7769730.2176764235,6896307.158400167,0.887586436747934,-0.17204047307799025,0.07757290579573058,0.6384005117332444,Downregulated
Feature1493,NA,C17 H31 N O13,457.17959,NA,NA,Feature1493,17,31,13,1,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,152306120.93696567,156260010.09182265,1.025960146122383,0.036974689903707954,0.7663413274891504,0.8909967115762668,Upregulated
Feature1492,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak5,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,40593346.6204388,50782000.108757235,1.2509931882085434,0.323073933896611,0.09722866497160355,0.7038690532559676,Upregulated
Feature1491,NA,C75 H89 N10 O16 P3 S,1510.53954,NA,NA,Feature1491,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,117945878.196633,119250346.183635,1.0110598861693774,0.01586845215766352,0.8924756774728304,0.9484653686568222,Upregulated
Feature1490,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,12240038.277188867,52305315.388846874,4.273296717243574,2.095349494326269,0.48034213189022035,0.7593501989503708,Upregulated
Feature1489,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,142252105.60756502,155580591.97988567,1.0936962325822461,0.1292120940707809,0.45464714038593707,0.7462909455559859,Upregulated
Feature1488,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,651524.9468751734,670007.9217358014,1.028368790710587,0.040357732543752106,0.9494817258172026,0.9777641602032469,Upregulated
Feature1487,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak1,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,105735325.731944,103348661.18764444,0.9774279359544403,-0.032937755918720474,0.3628450938471181,0.7429210442740862,Downregulated
Feature1486,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak3,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,82636803.7250192,94380423.9782085,1.1421112594367415,0.19170319852836518,0.819207253829189,0.9125694928365151,Upregulated
Feature1485,Isoferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Isoferulic acid,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,921681.5939679324,1392093.84023913,1.5103847677439508,0.5949161202817543,0.253672327581539,0.7429210442740862,Upregulated
Feature1484,NA,C11 H19 N5 O2,253.15388,NA,NA,Feature1484,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,126540295.53926367,116144522.351895,0.9178461442415156,-0.12367575556479316,0.03138329264160469,0.6051275072806717,Downregulated
Feature1483,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak3,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,89005228.97449563,104908388.60444917,1.178676689147225,0.23716804153210522,0.3990016122694726,0.7429210442740862,Upregulated
Feature1482,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak3,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,83191051.99310783,67127125.162249,0.8069031891532075,-0.3095325030532421,0.7334549832366307,0.8680261231817094,Downregulated
Feature1481,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak4,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1134773.8273043386,1055299.0325261336,0.929964198269361,-0.10475291842310634,0.7355443633077623,0.8680261231817094,Downregulated
Feature1480,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,76816999.05357827,79642205.1515947,1.0367783971363669,0.052107562890606016,0.7049405915611537,0.8548098511843912,Upregulated
Feature1479,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,16043974.249820033,19261559.018855534,1.2005478641971514,0.26369292298800057,0.41217741448113665,0.7429210442740862,Upregulated
Feature1478,NA,C2 H5 N2 O5 P S,199.96575,NA,NA,Feature1478,2,5,5,2,1,1,2.5,2.5,4,-53.7,2,-3,1,1,-7,Other,126411427.46501867,125055382.11415434,0.9892727629292882,-0.015559738240179716,0.8931451996783847,0.9485817982791119,Downregulated
Feature1477,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature1477,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1109688.2735209963,29711318.109656353,26.77447245196485,4.742786244151143,0.23705774182685158,0.7429210442740862,Upregulated
Feature1476,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1674086.8474714633,1780625.9840119432,1.0636401490767318,0.08901014054503671,0.8249455721355857,0.9143744565996981,Upregulated
Feature1475,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,113458948.94980933,105403857.53667773,0.9290043536654397,-0.10624273724948596,0.5635854424581587,0.786982267927221,Downregulated
Feature1474,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak4,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,127709867.857676,109867005.11665983,0.8602859509579884,-0.217111817096793,0.32597956427848224,0.7429210442740862,Downregulated
Feature1473,NA,C43 H79 N O9,753.57577,NA,NA,Feature1473,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,12147536.741204103,43859126.61526643,3.6105366503233123,1.852213287311664,0.1652165884767776,0.7429210442740862,Upregulated
Feature1472,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature1472,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,170167.37198310767,204440.63976781335,1.2014091619638336,0.2647275710324453,0.433231891869174,0.7437859477801351,Upregulated
Feature1471,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature1471,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,1516666.18894234,1193427.12375015,0.7868752745008422,-0.3457931187725506,0.10642297385880259,0.7055599272098991,Downregulated
Feature1470,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak6,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,70786319.65331987,44428497.5717436,0.6276424284993875,-0.671985213396085,0.420974851049405,0.7429771053580235,Downregulated
Feature1469,arg-leu,C12 H25 N5 O3,287.19576,NA,NA,arg-leu-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,22071804.025473967,10204325.607594376,0.4623240400203422,-1.1130237128101481,0.14450010322108872,0.7409363968247682,Downregulated
Feature1468,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11167,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,109304320.10749166,107966540.15800667,0.9877609599678275,-0.017766145784127746,0.8039224824892947,0.9118080082836999,Downregulated
Feature1467,NA,C16 H29 N O13,443.16396,NA,NA,Feature1467,16,29,13,1,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,100505783.5884106,119636459.7639229,1.1903440328753208,0.2513786010886722,0.4013773873384503,0.7429210442740862,Upregulated
Feature1466,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,6909713.55027468,7464107.19556234,1.0802339548888567,0.11134380220819232,0.524355649865047,0.7690549531354023,Upregulated
Feature1465,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,727292.2311135017,905761.6632044386,1.245388888339555,0.3165963123116556,0.3998670595404452,0.7429210442740862,Upregulated
Feature1464,NA,C12 H18 N6,246.15928,NA,NA,Feature1464,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,731735.12829554,741828.355755602,1.0137935532541298,0.019763894924946762,0.9232696704677112,0.9618811942019083,Upregulated
Feature1463,NA,C11 H23 N O7,281.14745,NA,NA,Feature1463,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,59837591.667414464,54909957.694256134,0.917649861302126,-0.1239843113159281,0.526655029236343,0.7697066387459335,Downregulated
Feature1462,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,NA,4-Guanidinobutyric acid,5,11,2,3,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,62254438.24192476,54016576.3687487,0.8676743039401753,-0.20477449031436884,0.18955791424091242,0.7429210442740862,Downregulated
Feature1461,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,751202.7160784883,690447.0880594696,0.9191221933592281,-0.121671420495449,0.7200835712096543,0.865798265531041,Downregulated
Feature1460,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak4,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,104832954.57315266,86125781.08383256,0.8215525493344157,-0.2835752370102572,0.007685864239749508,0.3497215117308036,Downregulated
Feature1459,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,102147317.2628619,95911788.35313837,0.9389555293588645,-0.09087126405060966,0.6160630102459768,0.8153208901224099,Downregulated
Feature1458,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,376103.4865140967,424997.885020228,1.130002513295762,0.17632598141506473,0.54970627759441415,0.777297524411467,Upregulated
Feature1457,NA,C18 H31 N O14,485.17458,NA,NA,Feature1457,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,130317239.008864,116139218.90795,0.8912038022847489,-0.16617270699661532,0.00464681071555393,0.319665224680575,Downregulated
Feature1456,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,2184267.9109846763,3010530.14931822,1.3782787972932595,0.4628677449285001,0.2862886746021394,0.7429210442740862,Upregulated
Feature1455,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1255528.674778031,1617774.7480471167,1.28852074870622,0.3657157687183376,0.19126911407845235,0.7429210442740862,Upregulated
Feature1454,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04228,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak5",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,133728826.73693167,99707241.25029464,0.7455927318231579,-0.4235402984866322,0.1689992391292069,0.7429210442740862,Downregulated
Feature1453,NA,C6 H14 O4,150.08923,NA,NA,Feature1453,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,553790.7004440266,721395.2484702274,1.3026496253761868,0.3814490933409673,0.34989075330687397,0.7429210442740862,Upregulated
Feature1452,NA,C9 H15 N O7,249.08484,NA,NA,Feature1452,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,64955999.57873333,64244610.984051,0.9890481464484269,-0.01588734240479931,0.8970951724357298,0.949799513816329,Downregulated
Feature1451,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,52589281.9869738,49728122.51434,0.9455942472585478,-0.08070683631439832,0.4344615210486134,0.7437859477801351,Downregulated
Feature1450,Furan,C4 H4 O,68.02623,Other,NA,Furan-peak3,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,67899164.01722163,44094353.672972605,0.6494093750813886,-0.6227998829061108,0.4589555153562387,0.7495930230749429,Downregulated
Feature1449,NA,C23 H35 N O6,421.24649,NA,NA,Feature1449,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,3157459.8351768735,4148900.9535652935,1.313999597823192,0.3939648340935947,0.2974025674081887,0.7429210442740862,Upregulated
Feature1448,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,112371672.0335255,120553183.34939733,1.0728075961478167,0.10139135757313318,0.657505492303599,0.8368251720227624,Upregulated
Feature1447,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature1447,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,119447264.64053367,97413783.50704136,0.8155380016461642,-0.2941759910843402,0.005403456072458623,0.32409559267895377,Downregulated
Feature1446,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak4,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,32724394.666070666,32014518.041675534,0.9783074177035536,-0.03164021426396247,0.8821305763203362,0.9410752829536629,Downregulated
Feature1445,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,75852632.92168693,71274896.7363784,0.9396496072847629,-0.08980521476998697,0.3208314755036201,0.7429210442740862,Downregulated
Feature1444,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak3,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,17397734.003213167,22237698.6411857,1.2781951165064742,0.35410808051823284,0.4301600106542296,0.7437859477801351,Upregulated
Feature1443,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,103408303.57512014,102236394.06174621,0.9886671623761567,-0.016443179573140326,0.8987402986667141,0.9498388119903466,Downregulated
Feature1442,3-Butynoic acid,C4 H4 O2,84.02112,Metabolic pathways;Other,NA,3-Butynoic acid-peak5,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,113894462.46240063,107215106.22201076,0.9413548640032005,-0.08718941441155192,0.8597313747331816,0.9347785293953849,Downregulated
Feature1441,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1528486.1677850217,3424875.5672361767,2.2406977828260453,1.1639480765054466,0.07703111969035062,0.6384005117332444,Upregulated
Feature1440,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,30428651.165845245,46770431.569914736,1.5370524087644208,0.6201663573354392,0.6490871634727684,0.8331143341897993,Upregulated
Feature1439,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature1439,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,123484892.72212633,97980421.9100618,0.7934608011568157,-0.3337691426190265,0.5120387685857798,0.7678958865079032,Downregulated
Feature1438,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak2",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,1900089.785388992,4796836.9679150535,2.52453173781629,1.336015814724075,0.18482004070890756,0.7429210442740862,Upregulated
Feature1437,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,49699898.3822559,36332419.93864343,0.7310361011042834,-0.4519854416534497,0.022117589505015186,0.5785251858234263,Downregulated
Feature1436,Veronal,C8 H12 N2 O3,184.08481,NA,NA,Veronal-peak2,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,81221006.24250942,79328788.9620119,0.9767028584348273,-0.034008375953792545,0.5544367707916719,0.7816618873872457,Downregulated
Feature1435,NA,C22 H46 O6,406.32947,NA,NA,Feature1435,22,46,6,0,0,0,2.090909090909091,0.2727272727272727,-1.545454545454546,104.34545454545454,0,-6,-0.375,-0.15789473684210523,-6,Lipid,47938495.234863155,1730780.2093382534,0.03610418309666816,-4.79169018969286,0.42613189492089826,0.7437859477801351,Downregulated
Feature1434,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,11366388.356186815,11016625.011458725,0.9692282778163469,-0.045091597990924555,0.965346959675184,0.9851191263191337,Downregulated
Feature1433,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature1433,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,106599024.21331117,100638237.98195413,0.9440821689002599,-0.08301566378969644,0.448971652053154,0.7437859477801351,Downregulated
Feature1432,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1030560.3747998477,1092260.84983346,1.0598708009179914,0.0838884098495307,0.8784279814829357,0.9403980032751831,Upregulated
Feature1431,NA,C15 H18 O11,374.08496,NA,NA,Feature1431,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,150419.921624349,2248346.756775363,14.947134212649498,3.9017970004800047,0.2790632360175077,0.7429210442740862,Upregulated
Feature1430,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,282667.63466775365,297056.44576275966,1.0509036385149597,0.0716303889860462,0.9204199836875865,0.9606848135346713,Upregulated
Feature1429,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1124926.82117971,1228929.3269791184,1.0924526856692252,0.12757079768602886,0.8248752651641156,0.9143744565996981,Upregulated
Feature1428,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak3,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,84167949.6813357,78860033.5237394,0.936936610934538,-0.09397665018743692,0.6518060469895284,0.8331143341897993,Downregulated
Feature1427,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10574,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,65355199.6656091,75134284.0793438,1.1496297840687433,0.20116934405789924,0.7234832268037218,0.8661346898978831,Upregulated
Feature1426,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04716,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Inosine-5'-monophosphate (IMP),10,13,8,4,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Tannin,111288669.97479767,30221280.600072004,0.2715575683213384,-1.8806700230908795,0.0798011165122291,0.6437290065319814,Downregulated
Feature1425,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.111,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak3,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,49682442.664077334,45044976.827752665,0.9066578536067477,-0.14136987272308027,0.32881847150938154,0.7429210442740862,Downregulated
Feature1424,NA,C10 H21 N O9,299.12162,NA,NA,Feature1424,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,52677313.12837377,55072938.119560696,1.0454773573084266,0.06416181673133323,0.7024827941649925,0.8535652471997965,Upregulated
Feature1423,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature1423,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,15139493.980570832,28833855.736861866,1.904545539888295,0.9294467848219754,0.2571227640883498,0.7429210442740862,Upregulated
Feature1422,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak4,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,1367886.5567249544,1874151.2941415233,1.3701072540903443,0.4542888339797091,0.4159861339605665,0.7429771053580235,Upregulated
Feature1421,NA,C16 H27 N O14,457.14329,NA,NA,Feature1421,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,67916503.01658353,74096951.3896489,1.0910006861153652,0.1256520089529258,0.5414862826512454,0.7721846506499914,Upregulated
Feature1420,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak2,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,78666406.26897317,75293020.01116683,0.9571178293530762,-0.0632315512009262,0.5005021197316593,0.7643022379378415,Downregulated
Feature1419,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10 H15 N3 O3,225.11134,Other,NA,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",10,15,3,3,0,0,1.5,0.3,0,60.3,5,2,-0.25,0.09090909090909093,-1,Lipid,88869414.56427106,93171471.9289989,1.0484087510401743,0.06820130096665532,0.5366520199644287,0.7721846506499914,Upregulated
Feature1418,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak4",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,101551174.13694249,88255544.5137251,0.8690745849448462,-0.20244809884584108,0.44342055477956566,0.7437859477801351,Downregulated
Feature1417,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak3,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,38613825.67846437,33598333.069163665,0.870111481543826,-0.20072783925162144,0.29787885278321385,0.7429210442740862,Downregulated
Feature1416,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak2,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,38753944.00021413,44239184.886913866,1.1415401974743378,0.19098166260756622,0.40350805748128726,0.7429210442740862,Upregulated
Feature1415,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8240856.912766904,12078851.502309676,1.4657276094184906,0.5516170181687131,0.21200723265011145,0.7429210442740862,Upregulated
Feature1414,NA,C14 H25 N O12,399.13775,NA,NA,Feature1414,14,25,12,1,0,0,1.7857142857142858,0.8571428571428571,0.1428571428571428,56.22857142857143,3,-9,-10,-0.5714285714285714,-10,Carbohydrate,85578570.25464423,88083550.03529206,1.0292711104333025,0.04162303875401617,0.7973063799382035,0.9095198704480248,Upregulated
Feature1413,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,14382825.331000667,13850098.543171799,0.96296090819648406,-0.05445086244250887,0.5879695041861475,0.801558357602538,Downregulated
Feature1412,NA,C23 H41 N,331.32396,NA,NA,Feature1412,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,71604146.8279154,131494887.84999263,1.836414421164898,0.8768916665363599,0.23115651812020352,0.7429210442740862,Upregulated
Feature1411,NA,C21 H31 N O13,505.17965,NA,NA,Feature1411,21,31,13,1,0,0,1.4761904761904765,0.6190476190476191,-0.0952380952380949,63.014285714285705,7,-6,-1,-0.03703703703703703,-7,Lignin,87779654.48873894,85637145.97788262,0.975592197037741,-0.03564987564212779,0.689454416651208,0.8507102856872568,Downregulated
Feature1410,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak3,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,24744531.925992668,24488492.160634935,0.9896526729168484,-0.015005807049198397,0.8215280263138639,0.9125694928365151,Downregulated
Feature1409,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,587011.5281552183,390229.137416819,0.6647725277954577,-0.5890673319611089,0.30693957775487224,0.7429210442740862,Downregulated
Feature1408,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1309352.8706610133,2195150.6909622764,1.6765157354824274,0.7454660240776726,0.35394871167553454,0.7429210442740862,Upregulated
Feature1407,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,NA,4-guanidinobutanal,5,11,1,3,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,100299879.8591608,87194164.9177232,0.8693346895346196,-0.20201638048114123,0.15529250680147327,0.7429210442740862,Downregulated
Feature1406,NA,C9 H15 N O7,249.08488,NA,NA,Feature1406,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,50211988.38515577,52764616.23669133,1.0508370198757195,0.07153893109840334,0.7204570439974474,0.865798265531041,Upregulated
Feature1405,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,11821771.188093333,16794590.424355403,1.4206492544256482,0.5065504100617927,0.29481828969834317,0.7429210442740862,Upregulated
Feature1404,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,1857079.67001472,2453694.625674655,1.32126513756688,0.40192000047650384,0.6783729144430102,0.8450956500772007,Upregulated
Feature1403,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak2",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,79944655.5597035,77920631.37978888,0.9746821827457489,-0.03699622281777176,0.5439583334863712,0.7729780816985922,Downregulated
Feature1402,NP-016455,C11 H18 N2 O4,242.12665,NA,NA,NP-016455-peak3,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,93464008.86277036,92185393.72785057,0.9863197058367448,-0.01987273706282565,0.6387923540126934,0.8313876949993997,Downregulated
Feature1401,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak3,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,55412642.33357316,75919046.58029631,1.3700672514997325,0.4542467114513923,0.15877472324944084,0.7429210442740862,Upregulated
Feature1400,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,71664654.66099754,69102626.94364753,0.9642497723672929,-0.05252119461368976,0.537663465141081,0.7721846506499914,Downregulated
Feature1399,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,769751.11278467,968235.8426875693,1.2578557232413166,0.3309664537743392,0.33507651355436424,0.7429210442740862,Upregulated
Feature1398,2908,C5 H11 N,85.08916,Other,NA,2908-peak1,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,57890990.70685727,47973882.7614676,0.8286934145658872,-0.2710896374295761,0.19529119118826477,0.7429210442740862,Downregulated
Feature1397,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak4,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,46916858.29442514,39864776.77851754,0.8496898178549701,-0.2349918182403686,0.14306187491098743,0.7397744129866796,Downregulated
Feature1396,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature1396,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,6154988.584055764,9762064.399940154,1.5860410245485046,0.6654300882847817,0.23065093759515384,0.7429210442740862,Upregulated
Feature1395,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak3,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,8786859.725671163,11832786.005050004,1.3466456020095603,0.4293702253395563,0.32189391786303745,0.7429210442740862,Upregulated
Feature1394,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,404134.0867600787,500364.2354614084,1.2381144077026556,0.3081446326451257,0.3827153518962316,0.7429210442740862,Upregulated
Feature1393,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak6,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1856488.9368664501,12791282.301145187,6.890039604941287,2.7845122757725522,0.43762791784914934,0.7437859477801351,Upregulated
Feature1392,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,89168058.56355298,68751924.30455863,0.7710375824270852,-0.37512691223116984,0.1378688173311319,0.7397744129866796,Downregulated
Feature1391,3-Buten-1-amine,C4 H9 N,71.07352,NA,NA,3-Buten-1-amine-peak2,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,84164291.52018936,69707169.88559906,0.8282273708545111,-0.271901213909136,0.140271459684395,0.7397744129866796,Downregulated
Feature1390,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak4,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,78582637.6018989,85425367.8941945,1.0870768722088586,0.12045396357881352,0.8134721041163825,0.9118080082836999,Upregulated
Feature1389,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1306938.5257920318,1377230.722840805,1.053783858736718,0.075578986609151,0.908572328040353,0.9551748813293666,Upregulated
Feature1388,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak4,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,28283119.9356631,18772841.361200698,0.6637471892741725,-0.5912942482418303,0.034806589814935784,0.6051275072806717,Downregulated
Feature1387,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,92017802.30956429,79469241.2393135,0.8636289853126985,-0.21151643065484407,0.05689066144113909,0.6384005117332444,Downregulated
Feature1386,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,403415.9741164023,413271.2873380477,1.0244296553780037,0.0348209220537989,0.9416687367054837,0.9726033422167238,Upregulated
Feature1385,Ne-Acetyllysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,41777140.9310341,31696723.58639403,0.7587097364733295,-0.3983800430334385,0.13105642534645964,0.7353513019132542,Downregulated
Feature1384,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak2,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,69430566.33673203,84150865.93269123,1.212014684203598,0.2774071779357623,0.1431555914551727,0.7397744129866796,Upregulated
Feature1383,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,2,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Tannin,103120152.14076723,45221982.42708413,0.4385368086477658,-1.1892301543270463,0.13697910061558147,0.7397744129866796,Downregulated
Feature1382,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak7,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1244407.5320091066,1069637.8350867017,0.859555899151271,-0.21833662992983066,0.27727384778327,0.7429210442740862,Downregulated
Feature1381,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1551888.9361251667,1891263.45105278,1.2186847956883953,0.28532503120809194,0.5119658694703351,0.7678958865079032,Upregulated
Feature1380,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,781546.4281185863,818210.8518145327,1.046912662353545,0.06614109189139948,0.8821886359683688,0.9410752829536629,Upregulated
Feature1379,NA,C5 H13 O6 P,200.04503,NA,NA,Feature1379,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,1455294.2836895846,2043994.3447241534,1.4045230353973814,0.49008028610976534,0.5218934103496308,0.7682508165605624,Upregulated
Feature1378,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,79004065.93098937,71571722.1653144,0.9059245409955587,-0.142537208926338,0.5195920046466439,0.7682508165605624,Downregulated
Feature1377,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,3288672.7352299835,1420131.985823816,0.431825268172968,-1.2114804300326059,0.019345985316759847,0.5702677803232292,Downregulated
Feature1376,Acetonedicarboxylic Acid,C5 H6 O5,146.02149,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Acetonedicarboxylic Acid,5,6,5,0,0,0,1.2,1,0.7999999999999998,37.5,3,-2,-Inf,0.2,-2,Tannin,77009587.61272463,66644287.729848064,0.8654024751437072,-0.20855684785942175,0.13817377917835327,0.7397744129866796,Downregulated
Feature1375,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak6",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,16727901.729484066,16009636.250199066,0.957061830533174,-0.0633159625249881,0.48187807784630965,0.7593501989503708,Downregulated
Feature1374,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,563675.6365352977,836884.3568095809,1.4846913766817997,0.5701630686660872,0.27891574388382134,0.7429210442740862,Upregulated
Feature1373,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733-peak2,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,392019.480088463,5848842.609930774,14.919775437207678,3.8991539161329944,0.4189041055676252,0.7429771053580235,Upregulated
Feature1372,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak6,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,72314562.21309873,63933615.90896656,0.8841043069660721,-0.17771150551352452,0.25293569098709623,0.7429210442740862,Downregulated
Feature1371,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak2,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,43623191.86274453,44185822.698952705,1.0128975164856902,0.01848821171322191,0.9608908270288625,0.9835341758228962,Upregulated
Feature1370,NA,C16 H28 N2 O13,456.15926,NA,NA,Feature1370,16,28,13,2,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,76673587.64419967,64642537.765451334,0.8430874275170496,-0.2462458495975824,0.06797417690828451,0.6384005117332444,Downregulated
Feature1369,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,3222519.6552185565,5002141.766767236,1.552245541362876,0.6343567877359392,0.5597252999319164,0.7855630970046946,Upregulated
Feature1368,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,58772559.69621567,41400653.541273266,0.7044214809643391,-0.5054891908173303,0.5277048098616454,0.7697066387459335,Downregulated
Feature1367,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak2,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,682794.8590092073,438344.5756240957,0.6419857587389725,-0.6393868006932791,0.18468881778399818,0.7429210442740862,Downregulated
Feature1366,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,67820514.859196,65489827.180788636,0.9656344738277766,-0.05045091265050495,0.9340593556948007,0.9677654731174266,Downregulated
Feature1365,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak1,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,10002180.823663991,5240352.948591607,0.523921036919623,-0.9325787034085614,0.52889270816947,0.7697066387459335,Downregulated
Feature1364,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,229368.930757146,267367.71269578434,1.165666648107939,0.2211552723451411,0.5213491884497896,0.7682508165605624,Upregulated
Feature1363,Zalcitabine,C9 H13 N3 O3,211.0957,Other,NA,Zalcitabine-peak2,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,54385078.1145047,50125355.38408657,0.9216747887821449,-0.11767030667988107,0.08078568954751368,0.6455233872334348,Downregulated
Feature1362,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak3,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,4510153.10753234,3849854.074055167,0.8535972021937753,-0.22837264738924734,0.7859873397276869,0.9029702269064507,Downregulated
Feature1361,ile-his,C12 H20 N4 O3,268.15355,NA,NA,ile-his-peak4,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,8160607.215715219,5518777.722838216,0.6762704755855027,-0.5643277245010115,0.042694403787975954,0.6234855173864765,Downregulated
Feature1360,glu-thr,C9 H16 N2 O6,248.10093,NA,NA,glu-thr,9,16,6,2,0,0,1.7777777777777777,0.6666666666666666,0.22222222222222232,53.96666666666666,3,-3,-5,-0.5,-5,Amino Sugar,17537613.766150933,59106814.428881794,3.37028829674439,1.7528720057969576,0.4227346493385183,0.7429771053580235,Upregulated
Feature1359,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature1359,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,2344986.1896034502,2611858.3436827166,1.1138054267707205,0.15549722697734636,0.7842042922194781,0.9029702269064507,Upregulated
Feature1358,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak2,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,1020796.3534472547,3678631.1416348433,3.603687580987152,1.8494739431998422,0.4200957145888139,0.7429771053580235,Upregulated
Feature1357,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,18575254.497613765,18241085.2315764,0.9820099764404148,-0.026190413638634977,0.722381716973052,0.8661346898978831,Downregulated
Feature1356,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,45392214.019517735,48802098.9914842,1.0751204814662771,0.10449834193031682,0.8353598851592796,0.9174806109836959,Upregulated
Feature1355,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16304,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,18211122.1244742,15967536.221354866,0.8768013366895088,-0.18967809718899617,0.27836799491561126,0.7429210442740862,Downregulated
Feature1354,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",C12 H18 O8,290.10021,NA,NA,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",12,18,8,0,0,0,1.5,0.6666666666666666,-0.16666666666666696,65.05000000000001,4,-4,-1,0,-4,Amino Sugar,73584833.88562097,72828257.67055343,0.9897183132023707,-0.014910121182219141,0.8715556986369417,0.9391342199196943,Downregulated
Feature1353,NA,C12 H18 O9,306.09516,NA,NA,Feature1353,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,59544265.95443323,70616078.22004074,1.1859425435537372,0.24603411600699115,0.13809945769691268,0.7397744129866796,Upregulated
Feature1352,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Other,Other,Asparagine,4,8,3,2,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,81195998.61353737,49087833.40013549,0.6045597595735628,-0.7260431407244633,0.2887858056734312,0.7429210442740862,Downregulated
Feature1351,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,6721660.593125354,7924469.689784417,1.1789452293811515,0.23749669615004532,0.04095739255430743,0.6160378041011744,Upregulated
Feature1350,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,480656.416828036,892793.9741597964,1.8574473218344871,0.8933212957674693,0.16944817177327912,0.7429210442740862,Upregulated
Feature1349,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal-peak1,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,10299990.1639855,30609241.133210044,2.971773821710723,1.5713243181936758,0.4488217810737684,0.7437859477801351,Upregulated
Feature1348,NA,C10 H15 N O5,229.09503,NA,NA,Feature1348,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,25414376.845831867,20947935.743171968,0.8242553366641989,-0.27883677219212394,0.06208844050895052,0.6384005117332444,Downregulated
Feature1347,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,36989249.070482,32872729.556546368,0.8887103788970758,-0.17021475795320956,0.27885083753538725,0.7429210442740862,Downregulated
Feature1346,2-Methylhippuric Acid,C10 H11 N O3,193.07391,Phenylalanine metabolism;Other,NA,2-Methylhippuric Acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,23562195.619609367,23461814.936841734,0.9957397568381067,-0.006159361206638726,0.9290289728952823,0.9637324434075984,Downregulated
Feature1345,NA,C14 H27 N O11,385.1585,NA,NA,Feature1345,14,27,11,1,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,69609560.00848196,74465839.59047273,1.069764549314764,0.09729330044447687,0.40787664454289124,0.7429210442740862,Upregulated
Feature1344,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3309489.8739319434,2869541.9606115567,0.8670647350258568,-0.20578838585278592,0.06995371973855014,0.6384005117332444,Downregulated
Feature1343,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,24200544.0305102,26006852.503248665,1.0746391680476775,0.10385232692683793,0.3883194329359503,0.7429210442740862,Upregulated
Feature1342,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak2,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,575443.8434719193,757301.152976759,1.3160296379358416,0.3961919799710124,0.5270025844822732,0.7697066387459335,Upregulated
Feature1341,L-(+)-Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-(+)-Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,1553284.0892393,1688837.0823823533,1.0872686420224895,0.12070844508418978,0.6662586560266553,0.8393995881059486,Upregulated
Feature1340,NA,C37 H71 N O5,609.53331,NA,NA,Feature1340,37,71,5,1,0,0,1.9189189189189189,0.13513513513513514,-1.5675675675675675,104.97567567567567,3,-2,-0.0967741935483871,-0.01492537313432835,-3,Lipid,14451720.24544387,15183999.08671264,1.0506707041675287,0.07131057804960453,0.9684974996121063,0.9855864682789036,Upregulated
Feature1339,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,748976.7344346476,906085.388639463,1.2097643985208781,0.27472611015998905,0.43258609091534866,0.7437859477801351,Upregulated
Feature1338,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak6,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,10636221.876838967,4168925.28742744,0.3919554646096217,-1.3512383554369776,1.325447220877316e-4,0.10448726305784786,Downregulated
Feature1337,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak2,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,26236087.6473592,24445141.128825366,0.9317372871059874,-0.10200486534887511,0.14138022392280525,0.7397744129866796,Downregulated
Feature1336,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak4,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,7365426.111747166,8920928.168751214,1.2111896899655497,0.2764248298064277,0.5395552761150519,0.7721846506499914,Upregulated
Feature1335,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,699088.1194718223,1038445.3482713463,1.4854284021532458,0.5708790687560945,0.3239698130724845,0.7429210442740862,Upregulated
Feature1334,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,21242394.339269932,20252386.790172067,0.9533947288009958,-0.06885444593633547,0.22949886978756878,0.7429210442740862,Downregulated
Feature1333,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,17436751.2369296,16210407.735399267,0.9296690372611935,-0.10521088757335267,0.1931951961306269,0.7429210442740862,Downregulated
Feature1332,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,1697254.0696677798,2030246.4492578132,1.1961947745720904,0.25845232049804,0.4869035345484225,0.7616016505309582,Upregulated
Feature1331,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak2,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,8451913.727523226,6962554.827248793,0.8237844175545224,-0.2796612579861613,0.24748320105947957,0.7429210442740862,Downregulated
Feature1330,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,30080505.563723333,24065214.508561864,0.8000269296532095,-0.3218795316083051,0.17139187895400462,0.7429210442740862,Downregulated
Feature1329,NA,C6 H15 N O6,197.08997,NA,NA,Feature1329,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,47639782.59616557,48445209.37752483,1.0169066006909966,0.02418717879448939,0.9227811870797411,0.9618811942019083,Upregulated
Feature1328,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak3",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,7921317.63069854,31800430.496139802,4.014537982027049,2.005233962987341,0.10650543827190477,0.7055599272098991,Upregulated
Feature1327,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak3,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,57045374.60574953,48513006.034051165,0.8504283891434311,-0.23373833692612828,0.4680128714933284,0.7518356990216489,Downregulated
Feature1326,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,51737119.63430764,47392963.930082634,0.9160340634552,-0.12652684780513526,0.2864869807545659,0.7429210442740862,Downregulated
Feature1325,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,3607536.5092834868,2927795.783530947,0.8115775893041351,-0.3011990674544267,0.2721650805661675,0.7429210442740862,Downregulated
Feature1324,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak1,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,40085260.1550249,39234034.54697344,0.9787646230869039,-0.030966137952534823,0.7164480985802231,0.8644323924465085,Downregulated
Feature1323,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,65243450.5525251,53713293.61372127,0.8232748752379163,-0.2805538963993129,0.2895609366998154,0.7429210442740862,Downregulated
Feature1322,NA,C14 H25 N O9,351.15307,Biosynthesis of secondary metabolites;Other,NA,Feature1322,14,25,9,1,0,0,1.7857142857142858,0.6428571428571429,-0.2857142857142856,68.44285714285714,3,-6,-1.75,-0.29411764705882354,-7,Amino Sugar,67031695.719707295,59258141.38869883,0.8840316622226962,-0.1778300531963954,0.45061867402063477,0.7437859477801351,Downregulated
Feature1321,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11612,NA,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,2,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Lignin,56801842.30081977,50586994.955161266,0.8905872222815419,-0.16717118205477902,0.056234639742883716,0.6384005117332444,Downregulated
Feature1320,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,9354037.948937003,3343014.6635806533,0.3573873317416416,-1.484439598609323,0.015589725554603483,0.538959083459149,Downregulated
Feature1319,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak4,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,12071009.006123634,11838335.700135266,0.9807246183090136,-0.028080001840723227,0.9126868616775907,0.957332225189993,Downregulated
Feature1318,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,182379.50852089535,197524.172354997,1.083039284165888,0.11508557354959771,0.564502711507172,0.7870515171137031,Upregulated
Feature1317,Nojirimycin,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,5557592.91492344,5197972.400465987,0.935292037404937,-0.09651118963898274,0.4151144266530722,0.7429771053580235,Downregulated
Feature1316,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature1316,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,15344435.661499867,20430900.7971972,1.3314859697616372,0.4130372265493139,0.22960838372253464,0.7429210442740862,Upregulated
Feature1315,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,1145042.1284453936,1804021.8238533703,1.5755069434018671,0.6558161124572407,0.40303637168707923,0.7429210442740862,Upregulated
Feature1314,NA,C30 H46 O11,582.30426,NA,NA,Feature1314,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,740528.4470302997,935649.8702077643,1.263489436442245,0.33741360250501107,0.36933704504927145,0.7429210442740862,Upregulated
Feature1313,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak2,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,50172144.641137004,49380010.37885223,0.9842116722745138,-0.022959468652288897,0.6814652014192972,0.8463358146659014,Downregulated
Feature1312,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,34530622.35374943,37967940.01513143,1.0995440402483438,0.1369053898913307,0.24605697907541949,0.7429210442740862,Upregulated
Feature1311,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature1311,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,25588093.90281103,23189619.2343299,0.9062659892686402,-0.141993551150958,0.35726263527024776,0.7429210442740862,Downregulated
Feature1310,Guanosine monophosphate,C10 H14 N5 O8 P,363.05806,Metabolic pathways;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Guanosine monophosphate,10,14,8,5,0,1,1.4,0.8,1.2000000000000002,26.09999999999999,7,-1,1.75,-Inf,-7,Tannin,66436988.56459,20159210.01141193,0.3034335307328561,-1.7205475763785307,0.08320859443600136,0.6481296779476766,Downregulated
Feature1309,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3120995.0807709266,4377973.263176323,1.4027491712979268,0.48825706050735224,0.6918763102696576,0.8507102856872568,Upregulated
Feature1308,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,19609120.942046132,20469442.55648263,1.0438735431832533,0.06194695168515294,0.8276831964819464,0.9146541535125908,Upregulated
Feature1307,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,655156.398666356,810898.86010096,1.2377179887911272,0.3076826372342296,0.37821223673278215,0.7429210442740862,Upregulated
Feature1306,NA,C18 H34 N2 O12,470.2114,NA,NA,Feature1306,18,34,12,2,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,68702111.4424112,57378200.293222904,0.8351737535944519,-0.259851720807757,0.11338851010271708,0.7055599272098991,Downregulated
Feature1305,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,1190362.6520684343,1767277.5290478033,1.4846547192797863,0.5701274477243781,0.28066836614052554,0.7429210442740862,Upregulated
Feature1304,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak2,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,122636.84270640834,136296.50048946167,1.111382986397933,0.15235606007873806,0.5170545100952414,0.7682508165605624,Upregulated
Feature1303,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,1537783.15952019,6055956.365640943,3.9381081319231552,1.9775027250656596,0.4271073525321493,0.7437859477801351,Upregulated
Feature1302,(+)-castanospermine,C8 H15 N O4,189.10013,NA,NA,(+)-castanospermine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,637184.7122502427,432080.594498258,0.6781088531963495,-0.5604112147981188,0.3077171170542867,0.7429210442740862,Downregulated
Feature1301,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Other,Other,Agmatine,5,14,0,4,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,12492187.884065367,5881102.83954567,0.4707824517310867,-1.086867549516038,0.08379008233207862,0.6481296779476766,Downregulated
Feature1300,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak5,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,23455446.7994228,27197633.8454133,1.159544479284129,0.21355816177939846,0.5189748271822956,0.7682508165605624,Upregulated
Feature1299,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,13080531.154434234,15819913.648629034,1.2094244080651237,0.2743206002251213,0.43925356996484666,0.7437859477801351,Upregulated
Feature1298,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,206782.35852818732,242543.13084533132,1.172939183843719,0.23012821247840495,0.3514208266635962,0.7429210442740862,Upregulated
Feature1297,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4838543.73519495,3875376.8938620132,0.8009386927047938,-0.32023627811575267,0.5763101144533631,0.7946197840672303,Downregulated
Feature1296,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,255377.55001479466,340912.17599885666,1.3349340064508677,0.416768422872094,0.4504255510523134,0.7437859477801351,Upregulated
Feature1295,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,44473488.58541206,48703035.531331465,1.0951026573459937,0.13106611759082867,0.2575621564700426,0.7429210442740862,Upregulated
Feature1294,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak3,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,12344355.102297032,10223606.714932917,0.8282009574587265,-0.2719472243213748,0.2021790260035808,0.7429210442740862,Downregulated
Feature1293,NA,C15 H22 N4 O6,354.15406,NA,NA,Feature1293,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,12285268.595907766,13533245.183579933,1.1015831748349294,0.13957842957500158,0.4455860092959321,0.7437859477801351,Upregulated
Feature1292,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,4870979.351821437,2364558.4870165326,0.48543800255124014,-1.042641040485405,0.15982459035158356,0.7429210442740862,Downregulated
Feature1291,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,351237.4016229617,459774.68574044365,1.309014027594909,0.3884805575071232,0.43163192169127323,0.7437859477801351,Upregulated
Feature1290,NA,C15 H22 N4 O6,354.15401,NA,NA,Feature1290,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,53333968.1968837,47988414.4957418,0.8997720611860597,-0.15236852438527618,0.40239142185210275,0.7429210442740862,Downregulated
Feature1289,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,254879.762307682,209550.1279815403,0.8221528695894603,-0.28252142398094515,0.627534357034925,0.8227888551216431,Downregulated
Feature1288,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-D-galactosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,10753852.47352492,10328264.580101654,0.960424611136239,-0.05825572140101052,0.8493193151478305,0.9276253512962122,Downregulated
Feature1287,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,1779204.7583904667,1668096.5692536202,0.9375517693436483,-0.09302974005731054,0.8431624121206451,0.9244771042927981,Downregulated
Feature1286,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature1286,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1087082.17285546,1140653.5365263538,1.0492799578620415,0.06939965401916372,0.63575695898957,0.8309971362101323,Upregulated
Feature1285,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak2,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,514794.44897582167,467810.1057261347,0.9087318378370981,-0.1380734696644216,0.7959845660071612,0.9086238913855331,Downregulated
Feature1284,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12666,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak2,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,15076009.675709132,47111353.9215301,3.1249219743760954,1.643820167827207,0.05120331702845017,0.6384005117332444,Upregulated
Feature1283,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak1,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,61919983.98173937,55749809.88765667,0.9003524597825747,-0.151438212958269,0.662738807627172,0.8390728999405301,Downregulated
Feature1282,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature1282,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,226164.210754724,275275.84001829766,1.2171503134810107,0.283507346459694,0.43644643609657985,0.7437859477801351,Upregulated
Feature1281,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak1",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,9381388.458043126,7516124.13135071,0.8011739589470647,-0.31981256578428513,0.30344658738870567,0.7429210442740862,Downregulated
Feature1280,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,599996.760959412,724392.8680309303,1.2073279643586832,0.2718176299316471,0.4573956398988223,0.7483691664015606,Upregulated
Feature1279,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,5708522.550163693,6922759.595105817,1.212706008301098,0.2782298457813572,0.14653413005461577,0.7419901680471508,Upregulated
Feature1278,N-Methyltyramine,C9 H13 N O,151.09973,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,N-Methyltyramine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,58067287.65426336,38210666.11341607,0.6580411735592854,-0.603750238842644,8.139885812934057e-4,0.19965892031945995,Downregulated
Feature1277,NP-013538,C12 H16 O8,288.08462,NA,NA,NP-013538-peak2,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,34228882.1238676,43133350.22560297,1.2601448703323657,0.33358960015038547,0.23457191681002063,0.7429210442740862,Upregulated
Feature1276,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11608,NA,Other,N1-Acetyl-5-methoxykynuramine-peak2,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,54390452.244318366,42807316.75209427,0.7870373380939469,-0.34549601416707726,0.3432478797631764,0.7429210442740862,Downregulated
Feature1275,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak5,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,930532.4697116113,950185.9039732903,1.0211206324350723,0.030153312381614186,0.9286457337329638,0.9637324434075984,Upregulated
Feature1274,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,2260644.1960889,1368558.30205304,0.6053842105806646,-0.7240770470989301,0.1364504996147094,0.7397744129866796,Downregulated
Feature1273,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,386214.3527366583,32598970.725208707,84.40641963256202,6.3992808239128625,0.4223924800049138,0.7429771053580235,Upregulated
Feature1272,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4483746.58280565,6520361.606454623,1.454221706342419,0.5402472350466792,0.24909247375587662,0.7429210442740862,Upregulated
Feature1271,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,178400.40303597832,206864.12200262898,1.1595496337578919,0.2135645749160576,0.7225365365332629,0.8661346898978831,Upregulated
Feature1270,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak2,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,4934316.859953053,4366332.08139415,0.8848908988458623,-0.17642850341692273,0.3337809745039554,0.7429210442740862,Downregulated
Feature1269,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,1686283.4742625633,5641415.08097297,3.3454725537413244,1.742210008411624,0.3849142049602374,0.7429210442740862,Upregulated
Feature1268,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,10454744.723946193,6637922.834035059,0.6349196474239253,-0.6553540724484533,0.0022572606719262777,0.2549199718828743,Downregulated
Feature1267,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak2,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,28324525.4776634,22501277.07085047,0.7944096747038139,-0.3320449020787008,0.22969861573999364,0.7429210442740862,Downregulated
Feature1266,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,289858.030093897,396343.992388399,1.3673728213084413,0.4514066548825115,0.3018270538126217,0.7429210442740862,Upregulated
Feature1265,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13723,NA,NA,L-gamma-Glutamyl-L-leucine-peak3,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,21937837.883679166,21091020.7623784,0.9613992442741696,-0.056792425468487784,0.5891028070927744,0.801558357602538,Downregulated
Feature1264,NA,C18 H33 N O15,503.18514,NA,NA,Feature1264,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,55422783.40876703,59931002.375760935,1.0813423413570524,0.11282333712350325,0.44040887768994147,0.7437859477801351,Upregulated
Feature1263,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,10347474.308855299,9737146.314259857,0.9410167180533004,-0.08770774086198843,0.0597555898892444,0.6384005117332444,Downregulated
Feature1262,NA,C11 H23 N O7,281.14745,NA,NA,Feature1262,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,28266316.130448565,39971389.26504677,1.4140997037102214,0.49988384361071414,0.11098592635216832,0.7055599272098991,Upregulated
Feature1261,NA,C5 H16 N5 O7 P,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,Feature1261,5,16,7,5,0,1,3.2,1.4,1.6,14.699999999999996,1,-6,1.5,1.8888888888888888,-12,Other,8294892.519045037,10514249.50635227,1.267557051789592,0.34205068330875177,0.5107112569908864,0.7678958865079032,Upregulated
Feature1260,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,45037846.020857364,40292578.0246029,0.8946382117373709,-0.1606237149187806,0.2144000911048776,0.7429210442740862,Downregulated
Feature1259,Pipecolic acid,C6 H11 N O2,129.07898,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak2,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,51483016.46591394,47870971.05856937,0.929840058813647,-0.10494551436617001,0.1109112767852991,0.7055599272098991,Downregulated
Feature1258,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak4,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,41265910.5107946,34400470.9664737,0.8336292727013742,-0.2625221564748505,0.0738449009860993,0.6384005117332444,Downregulated
Feature1257,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,23807983.577724032,29355077.710527733,1.2329930258349913,0.30216463946360034,0.1631199502024397,0.7429210442740862,Upregulated
Feature1256,NA,C7 H11 N O6,205.0586,NA,NA,Feature1256,7,11,6,1,0,0,1.5714285714285714,0.8571428571428571,0.5714285714285716,44.014285714285705,3,-3,-Inf,-0.3333333333333333,-4,Carbohydrate,44002151.565532364,40343402.19207837,0.9168506710858212,-0.1252413159494776,0.1991289568161898,0.7429210442740862,Downregulated
Feature1255,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,2897444.8909948,4809767.666729563,1.6600031571534712,0.7311859854308295,0.44885717636895517,0.7437859477801351,Upregulated
Feature1254,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature1254,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,474013.87893485196,626280.205280979,1.3212275697249245,0.4018789794064057,0.25106019921379435,0.7429210442740862,Upregulated
Feature1253,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak3,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,507151.752481201,592220.915013533,1.167739068466465,0.22371793972766918,0.5215886535325376,0.7682508165605624,Upregulated
Feature1252,NA,C14 H31 N O,229.24056,NA,NA,Feature1252,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,21672227.111466985,39528659.8829927,1.8239316005542274,0.8670516278625843,0.24792069606120487,0.7429210442740862,Upregulated
Feature1251,11-Aminoundecanoic acid,C11 H23 N O2,201.1728,NA,NA,11-Aminoundecanoic acid,11,23,2,1,0,0,2.090909090909091,0.18181818181818185,-1.454545454545454,101.75454545454544,1,-1,-0.25,-0.1111111111111111,-2,Lipid,8299173.351962993,3668094.2431035233,0.44198308524738955,-1.1779369363490555,0.4639656039911927,0.749905170284088,Downregulated
Feature1250,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak1,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,1680913.6079415467,1545818.2198970965,0.9196297850132295,-0.12087490199894768,0.3950737126742415,0.7429210442740862,Downregulated
Feature1249,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak3,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,35961240.843602434,36385478.50710043,1.0117970807888146,0.016919981836813258,0.9624947897247705,0.9839835417860984,Upregulated
Feature1248,NA,C12 H19 N O7,289.11624,NA,NA,Feature1248,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,32431041.532226235,27388776.7212295,0.8445235005485003,-0.24379052543909047,0.49038583216444914,0.7626394464118028,Downregulated
Feature1247,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,6068377.670349633,5519822.114767534,0.9096042492110591,-0.13668910109980953,0.7530348055340941,0.8797523866032796,Downregulated
Feature1246,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak4,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1454994.9868854634,1223724.5708132633,0.8410507127813179,-0.2497353016931283,0.23305452121114167,0.7429210442740862,Downregulated
Feature1245,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature1245,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,3039721.84248683,3048400.1411058,1.0028549647200187,0.004112975033872958,0.9664280340558453,0.9854176648651762,Upregulated
Feature1244,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak3,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,240422.079187978,374613.073268263,1.558147548401183,0.6398318555225918,0.338056995461529,0.7429210442740862,Upregulated
Feature1243,Etilevodopa,C11 H15 N O4,225.1001,NA,NA,Etilevodopa-peak2,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,41884301.982042834,38610654.05792107,0.9218406952197679,-0.11741063715441906,0.025019204467109195,0.5904389566427806,Downregulated
Feature1242,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature1242,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,1596669.0355795333,2122383.53094291,1.329257024247709,0.41062009013379547,0.22766086100846783,0.7429210442740862,Upregulated
Feature1241,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak2,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,704998.8937833459,621967.85731714,0.882225295389297,-0.18078096854302292,0.7174108204581051,0.8647172118229359,Downregulated
Feature1240,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,2918839.1545069767,4094906.26819613,1.4029228920933137,0.48843571726028817,0.3061605406331754,0.7429210442740862,Upregulated
Feature1239,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,24998732.866806533,26161646.851731468,1.046518917223563,0.06559839046409746,0.730003093428965,0.8678071861534502,Upregulated
Feature1238,Leucylasparagine,C10 H19 N3 O4,245.13753,NA,NA,Leucylasparagine-peak4,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,24398148.715204302,18027625.093733132,0.7388931555490839,-0.43656233011486245,0.03094067668676329,0.6051275072806717,Downregulated
Feature1237,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,22903326.1019664,20066311.461640935,0.8761308891252311,-0.19078167827339856,0.3176912059828154,0.7429210442740862,Downregulated
Feature1236,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature1236,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,473157.99649729766,431884.494129512,0.9127701472376545,-0.131676486802043,0.4294827285653409,0.7437859477801351,Downregulated
Feature1235,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak2,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,8019465.9737781705,4716159.685011443,0.5880889950069259,-0.765893601492576,0.10138878368948717,0.7043924180722835,Downregulated
Feature1234,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe-peak2,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,22065990.536063034,19174907.077535734,0.8689801188030818,-0.20260492455920417,0.14643716762441453,0.7419901680471508,Downregulated
Feature1233,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,4307706.0795840565,4287034.829218987,0.9952013322211006,-0.006939678161321912,0.9638230922472386,0.9841569127587837,Downregulated
Feature1232,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1361946.0075504833,2283599.67175298,1.6767182098944797,0.7456402492199014,0.4278992786859303,0.7437859477801351,Upregulated
Feature1231,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,274662.08259187965,265820.5693661063,0.9678094874169036,-0.04720501289291442,0.6439601809921707,0.8330255361150196,Downregulated
Feature1230,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,725664.4291167804,582332.266866282,0.8024814824877793,-0.3174599929094658,0.5122327932431704,0.7678958865079032,Downregulated
Feature1229,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,1481454.9131309967,1688312.1462175334,1.1396311364274678,0.18856694389957498,0.6042353254774839,0.8123608264752841,Upregulated
Feature1228,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,C14 H16 N2 O4,276.11103,NA,NA,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,14,16,4,2,0,0,1.1428571428571428,0.2857142857142857,-0.14285714285714324,64.37142857142858,8,4,0.25,0.4,2,Lignin,29342307.670613,29940671.333518032,1.0203925222795038,0.029124231620833673,0.21154611686995792,0.7429210442740862,Upregulated
Feature1227,NA,C21 H35 N O16,557.19585,NA,NA,Feature1227,21,35,16,1,0,0,1.6666666666666667,0.7619047619047619,0,60.3,5,-11,-3,-0.3333333333333333,-12,Carbohydrate,49422100.0375069,47963044.9686804,0.9704776796672093,-0.04323306258080962,0.818739226519976,0.9125694928365151,Downregulated
Feature1226,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,532060.8926048774,535593.6124888257,1.00663969093209,0.009547388286202704,0.9810942846955801,0.9910397843019159,Upregulated
Feature1225,NA,C12 H19 N O8,305.11113,NA,NA,Feature1225,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,264740.78661210334,284077.504742353,1.0730401929287219,0.10170411621832788,0.7083104857314613,0.8570556877350681,Upregulated
Feature1224,NA,C18 H33 N O15,503.18519,NA,NA,Feature1224,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,41864925.9428269,44690115.5576402,1.0674834494792023,0.09421370212737862,0.46505203212405494,0.749905170284088,Upregulated
Feature1223,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak1",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,22955992.5996386,11531631.636620384,0.5023364416314513,-0.993274156819779,0.42062194186377544,0.7429771053580235,Downregulated
Feature1222,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577-peak2,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,886877.9849580481,896250.3242049674,1.010567788811854,0.015166100839326084,0.9407116082679414,0.9722791119010938,Upregulated
Feature1221,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,6284872.8186866,6353203.01098793,1.0108721678660173,0.015600569500005212,0.9199156356085361,0.9606848135346713,Upregulated
Feature1220,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,6196868.546305667,8076044.464727963,1.3032460515146136,0.3821094889621891,0.5321059260662586,0.7697066387459335,Upregulated
Feature1219,NA,C7 H17 N O6,211.10558,NA,NA,Feature1219,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,812980.6289884374,728258.6227394294,0.8957884072165108,-0.15877009911066564,0.7661590526595886,0.8909967115762668,Downregulated
Feature1218,NA,C20 H42 O5,362.30324,NA,NA,Feature1218,20,42,5,0,0,0,2.1,0.25,-1.5999999999999996,105.89999999999998,0,-5,-0.3333333333333333,-0.14285714285714285,-5,Lipid,19568834.65214194,1251911.9774827047,0.06397478438225111,-3.96635280989658,0.42812121977608886,0.7437859477801351,Downregulated
Feature1217,leu-phe,C15 H22 N2 O3,278.16307,NA,NA,leu-phe-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,8525633.798821347,9510021.840460943,1.1154621538841707,0.1576415657291874,0.13324937015445265,0.7376791370005154,Upregulated
Feature1216,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak2,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,686037.861947479,4797432.684403115,6.992956147907756,2.8059024582274925,0.3035120469347432,0.7429210442740862,Upregulated
Feature1215,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,5339612.44903314,4970450.83869015,0.9308635947146622,-0.10335831877518449,0.8177848431734003,0.9125694928365151,Downregulated
Feature1214,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak1,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,43884515.921054766,32668748.530668564,0.7444254048384037,-0.42580080412090665,0.30598404183841976,0.7429210442740862,Downregulated
Feature1213,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1604963.3687103444,1368280.1799321414,0.852530473036037,-0.23017669182123235,0.6960763953880055,0.8526055052691839,Downregulated
Feature1212,NA,C32 H36 O10,580.23105,NA,NA,Feature1212,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,259481.18024393497,352792.06743424997,1.3596056064744064,0.44318821610677545,0.2891205567130287,0.7429210442740862,Upregulated
Feature1211,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1516591.1232113766,2334861.31090678,1.5395456792353623,0.6225046736371344,0.3170845007986172,0.7429210442740862,Upregulated
Feature1210,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,687668.0356161377,502672.10038431303,0.7309807557565595,-0.45209466947577065,0.12135022833254586,0.713775301372683,Downregulated
Feature1209,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,917349.8470262226,1072754.8673484758,1.169406492872954,0.22577650669948474,0.4182944166886556,0.7429771053580235,Upregulated
Feature1208,NA,C12 H22 N4 O7,334.14893,NA,NA,Feature1208,12,22,7,4,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,4,-3,-7,-0.7777777777777778,-7,Amino Sugar,8409405.694112603,10568591.403905524,1.2567584188861955,0.329707353520793,0.10108821094557689,0.7043924180722835,Upregulated
Feature1207,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature1207,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,405871.561104656,482809.1232227967,1.1895613526326916,0.25042968189866793,0.41033041318154934,0.7429210442740862,Upregulated
Feature1206,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,290056.08400706365,242451.17447820868,0.8358768798392257,-0.25863763813901736,0.64931200564877,0.8331143341897993,Downregulated
Feature1205,NA,C9 H19 N O3,189.13649,NA,NA,Feature1205,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,742267.3355918099,854577.1907247377,1.15130647645081,0.20327192834445068,0.4403678690978505,0.7437859477801351,Upregulated
Feature1204,NA,C16 H5 O13 P3,497.89406,NA,NA,Feature1204,16,5,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,24262538.048775665,42139947.4782976,1.7368317936723054,0.7964580406428134,0.013912653519835338,0.49964037324760396,Upregulated
Feature1203,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,2158840.1508133067,2304911.8374768635,1.0676621131993154,0.09445514446096097,0.5418430711775116,0.7721846506499914,Upregulated
Feature1202,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,516892.48782238597,331709.49660044303,0.6417378940790965,-0.6399439192277447,0.41154267872305345,0.7429210442740862,Downregulated
Feature1201,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Nicotinamide,6,6,1,2,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Lignin,11295803.149405567,6956537.114687837,0.6158514824201694,-0.6993456196323976,0.06207148859108847,0.6384005117332444,Downregulated
Feature1200,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak2,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,1562661.9800966068,1594832.9007834147,1.020587255015201,0.02939953072577047,0.9696466381547205,0.9855864682789036,Upregulated
Feature1199,NA,C11 H17 N O5,243.11065,NA,NA,Feature1199,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,561600.022939859,688960.3188259314,1.2267811443798877,0.2948778976723451,0.5319582406007456,0.7697066387459335,Upregulated
Feature1198,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,27978664.7939538,41272485.514847934,1.4751413557006814,0.5608532076250518,0.03342852803321803,0.6051275072806717,Upregulated
Feature1197,Fluoranthene,C16 H10,202.07833,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak4,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,18850227.601067867,20550988.418830268,1.0902249486720283,0.12462584036965847,0.6438145586591661,0.8330255361150196,Upregulated
Feature1196,Nicotinic acid,C6 H5 N O2,123.03199,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Aminobenzoate degradation;Other,Other,Nicotinic acid,6,5,2,1,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Lignin,38208535.5272865,31362427.952464502,0.8208225601859859,-0.2848577111388402,0.05937229559456433,0.6384005117332444,Downregulated
Feature1195,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",C11 H15 N O2,193.11027,NA,NA,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,15558722.537534034,15112491.581644066,0.9713195633630283,-0.041982075626918504,0.6433186196276501,0.8330255361150196,Downregulated
Feature1194,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,215103.74482090166,245576.21968816902,1.1416640834990537,0.19113822306530354,0.514011898335119,0.7682508165605624,Upregulated
Feature1193,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,23102714.957913168,30938107.207082998,1.3391546086009274,0.4213225328693457,0.3405082102789887,0.7429210442740862,Upregulated
Feature1192,"2,5-Furandicarboxylic acid",C6 H4 O5,156.00587,Microbial metabolism in diverse environments;Other,NA,"2,5-Furandicarboxylic acid",6,4,5,0,0,0,0.6666666666666666,0.8333333333333334,1,31.799999999999997,5,0,0,0.7142857142857143,0,Condensed HC,36008545.8311526,30569445.271662533,0.848949730294733,-0.23624896631713677,0.09890903232565405,0.7043924180722835,Downregulated
Feature1191,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak5",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3309802.15728067,2726183.6945952266,0.8236696832764941,-0.27986220631499836,0.6665898615028387,0.8393995881059486,Downregulated
Feature1190,MFCD00025555,C9 H18 N2 O3,202.13171,NA,NA,MFCD00025555-peak1,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,21476742.297879834,17987571.928426333,0.8375372614217218,-0.2557747185519602,0.33403156437857023,0.7429210442740862,Downregulated
Feature1189,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,311599.651092246,711508.3201289783,2.2834053813440995,1.1911870092503873,0.15035262998741944,0.7429210442740862,Upregulated
Feature1188,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1518666.7393314287,1390680.600781908,0.9157246713614965,-0.12701420286455103,0.852212034505742,0.9295860827126381,Downregulated
Feature1187,Meglutol,C6 H10 O5,162.05283,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak1,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,28464182.753424868,27849084.087306466,0.9783904329364808,-0.03151779815879325,0.9285857969141801,0.9637324434075984,Downregulated
Feature1186,NA,C7 H17 N O6,211.10569,NA,NA,Feature1186,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,23596160.93498653,21573007.930297133,0.9142592301237602,-0.12932480817272135,0.5411522230325634,0.7721846506499914,Downregulated
Feature1185,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,12530533.173844889,10696422.176322663,0.8536286547366887,-0.22831948930532375,0.6175667334547676,0.8163437773269296,Downregulated
Feature1184,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak2,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,35570714.903108634,34866144.26916383,0.9801923960239768,-0.02886313999956961,0.9260027751777479,0.9629519344082903,Downregulated
Feature1183,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,12807972.5222814,12570622.556975866,0.9814685763189585,-0.026986017226012134,0.7371068013385063,0.8689345312925746,Downregulated
Feature1182,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Other,Thymine,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,34845179.201177396,30961564.766415734,0.8885465787867024,-0.17048068866917074,0.16310952665454453,0.7429210442740862,Downregulated
Feature1181,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak2,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,3247261.0698543666,4917303.201562594,1.5142925363198856,0.5986439371134106,0.18131098477909774,0.7429210442740862,Upregulated
Feature1180,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak1,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,822165.7471837297,530075.3764339864,0.6447305525068661,-0.6332317433134267,0.18196082938654395,0.7429210442740862,Downregulated
Feature1179,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Other,NA,pyroglutamine,5,8,2,2,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,40461062.17800146,37180569.9875355,0.9189222424257177,-0.12198530651008302,0.35588080154653445,0.7429210442740862,Downregulated
Feature1178,pyr-gln-OH,C10 H15 N3 O5,257.10118,NA,NA,pyr-gln-OH,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,40278289.283337265,32109215.09837337,0.7971841820912845,-0.32701501070746053,0.05506024179797455,0.6384005117332444,Downregulated
Feature1177,NA,C9 H17 N5 O2,227.1382,NA,NA,Feature1177,9,17,2,5,0,0,1.8888888888888888,0.2222222222222222,0.22222222222222232,53.96666666666666,4,2,-1.5,-0.6666666666666666,-3,Lipid,40507319.91008996,35475702.692889296,0.8757849882843682,-0.1913513739313597,0.0330452341139272,0.6051275072806717,Downregulated
Feature1176,NA,C5 H10 N6 O,170.09157,NA,NA,Feature1176,5,10,1,6,0,0,2,0.2,2,3.299999999999997,4,3,1.5,1.6666666666666667,-3,Lipid,30501795.0156007,44875746.74730016,1.4712493715319916,0.5570417989932878,0.23722856347647162,0.7429210442740862,Upregulated
Feature1175,NA,C15 H27 N O5,301.18898,NA,NA,Feature1175,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,880458.1248866813,6933882.337503663,7.8753118876563075,2.977337059990716,0.10153031539824692,0.7043924180722835,Upregulated
Feature1174,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak4",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,966503.5297250473,799632.2625111816,0.8273454135637378,-0.2734383200297666,0.03326567777418974,0.6051275072806717,Downregulated
Feature1173,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,5145896.208944201,5571969.454844774,1.0827986474270517,0.11476499053076761,0.7286000084648583,0.8678071861534502,Upregulated
Feature1172,NA,C31 H40 O6,508.28264,NA,NA,Feature1172,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,148904.37609226,180539.96486969735,1.2124557357389965,0.2779320784374811,0.43529507614262053,0.7437859477801351,Upregulated
Feature1171,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,C14 H20 N2 O3,264.14741,Metabolic pathways;Other,NA,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,21502225.4955432,19949136.6039089,0.9277707839146133,-0.10815967935833083,0.379985245956104,0.7429210442740862,Downregulated
Feature1170,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak4,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,9412011.56405564,8170856.09827037,0.8681306905183555,-0.2040158490265018,0.22295842991842754,0.7429210442740862,Downregulated
Feature1169,N6-Acetyl-L-lysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,N6-Acetyl-L-lysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,14160974.889988232,21433966.0478292,1.513593959055951,0.5979782358238956,0.541910251318339,0.7721846506499914,Upregulated
Feature1168,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1306640.566610242,1107095.8127013694,0.8472841277027374,-0.23908225178724146,0.6524680155902118,0.8331143341897993,Downregulated
Feature1167,NA,C6 H9 O7 P,224.00856,NA,NA,Feature1167,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,4580804.011135973,4808794.402766113,1.049770824308548,0.07007440720478264,0.6795798680233018,0.8451333690948524,Upregulated
Feature1166,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,158610.59001857534,192697.11450433565,1.2149069900173017,0.2808458692408651,0.3492406678280959,0.7429210442740862,Upregulated
Feature1165,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,5713860.577957316,5524412.09217444,0.966844048223066,-0.04864489287885273,0.3676521955279025,0.7429210442740862,Downregulated
Feature1164,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,32738356.700356334,37149351.5568998,1.134734766833775,0.18235512104876758,0.14126731177278007,0.7397744129866796,Upregulated
Feature1163,arg-val,C11 H23 N5 O3,273.18012,NA,NA,arg-val,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,3811198.015863513,4659496.934682007,1.2225806466333113,0.289929634633899,0.44350723655816376,0.7437859477801351,Upregulated
Feature1162,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature1162,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,168000.19715572367,209710.17745874234,1.2482734009196228,0.3199339525916933,0.3871604019975551,0.7429210442740862,Upregulated
Feature1161,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,6740573.020004377,6269731.3283728,0.9301481209039301,-0.1044676192280743,0.28527339861020296,0.7429210442740862,Downregulated
Feature1160,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature1160,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,11746163.296634434,14188715.478494173,1.2079446811845014,0.27255438677540883,0.3997395504967532,0.7429210442740862,Upregulated
Feature1159,NA,C12 H22 N4 O6,318.1539,NA,NA,Feature1159,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,11149006.036122704,9166541.577437386,0.8221846456749465,-0.2824656651108471,0.19480740489346351,0.7429210442740862,Downregulated
Feature1158,AC-LYS-OH,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,23082771.019442268,18654111.71027813,0.8081400493279622,-0.30732276359025845,0.2053184064369912,0.7429210442740862,Downregulated
Feature1157,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak2,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,41866076.9735957,22497127.40799024,0.5373593380191518,-0.8960409381391394,0.21680131408331085,0.7429210442740862,Downregulated
Feature1156,Trachelogenin,C21 H24 O7,388.1523,NA,NA,Trachelogenin,21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,1108243.8027952334,1223803.0798046393,1.1042724323997481,0.14309613985658495,0.7297721361837535,0.8678071861534502,Upregulated
Feature1155,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,177406.56710611633,175341.79387953965,0.9883613483973137,-0.01688950223548528,0.835698100795657,0.9174806109836959,Downregulated
Feature1154,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,8425473.182090716,6457185.64099735,0.7663884866102024,-0.383852207136771,0.17815478866830126,0.7429210442740862,Downregulated
Feature1153,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13724,NA,NA,L-gamma-Glutamyl-L-leucine-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,32861212.9352573,27801840.911669932,0.8460381838748535,-0.24120531754243277,0.20603872773287382,0.7429210442740862,Downregulated
Feature1152,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak1,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,504617.11357243,672548.223556104,1.3327891691877194,0.41444858190954376,0.3058801173689935,0.7429210442740862,Upregulated
Feature1151,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak1,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,282204.30752631166,508496.620156486,1.8018740557639281,0.8494981757048894,0.1317601052806516,0.7353513019132542,Upregulated
Feature1150,NA,C11 H14 N O P S,239.05347,NA,NA,Feature1150,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,270215.63411482703,277398.91806162766,1.0265835245630093,0.037851012318071045,0.7317358536820331,0.8680261231817094,Upregulated
Feature1149,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,28952943.9172424,36003294.62466713,1.2435106677779326,0.3144188841405095,0.4005881116141515,0.7429210442740862,Upregulated
Feature1148,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature1148,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,16594845.353103701,16505577.380238933,0.9946207409008442,-0.0077815788052054856,0.967223167844024,0.9854176648651762,Downregulated
Feature1147,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak5",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,28900057.594418667,23699940.507951133,0.8200655113063924,-0.28618893020340513,0.059985888749549944,0.6384005117332444,Downregulated
Feature1146,NA,C4 H11 O6 P,186.02935,NA,NA,Feature1146,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,382354.55294079334,765529.3994744273,2.0021453741992388,1.0015467309281234,0.08745501808970602,0.6687811081011467,Upregulated
Feature1145,NA,C13 H19 N O6,285.1213,NA,NA,Feature1145,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,292294.567762253,344811.35515557934,1.1796707608881822,0.2383842681367824,0.2989016358294223,0.7429210442740862,Upregulated
Feature1144,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,24243884.6853557,25905523.936991468,1.0685384901471449,0.09563887668679626,0.8095451462861558,0.9118080082836999,Upregulated
Feature1143,asn-leu,C10 H19 N3 O4,245.13755,NA,NA,asn-leu-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,14082462.7999286,13919389.503960034,0.9884201152678073,-0.01680372373724158,0.8529119188975963,0.9297508305099924,Downregulated
Feature1142,NA,C15 H29 N O12,415.16907,NA,NA,Feature1142,15,29,12,1,0,0,1.9333333333333331,0.8,-0.13333333333333375,64.10000000000001,2,-10,-5.5,-0.625,-11,Carbohydrate,37365491.968573764,32981279.6968361,0.8826668125920835,-0.18005914006485738,0.04442450424903924,0.6354049378804609,Downregulated
Feature1141,mebutamate,C10 H20 N2 O4,232.14229,Other,NA,mebutamate-peak3,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,8132734.481838973,6939967.429187504,0.8533375145450757,-0.22881162151306783,0.17684915701590004,0.7429210442740862,Downregulated
Feature1140,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak4",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,15047143.526827067,13206224.804381566,0.8776565984657895,-0.18827152938669536,0.28781605846290426,0.7429210442740862,Downregulated
Feature1139,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,17460841.7551087,18092435.668452032,1.0361720197801199,0.05126353148244703,0.47431193417694295,0.7573100988277449,Upregulated
Feature1138,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,993506.6545025134,1146791.6279207491,1.1542868109876843,0.20700174164226204,0.6404169137961347,0.8313876949993997,Upregulated
Feature1137,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06316,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of chorismate metabolism;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,Adenosine 5'-monophosphate,10,14,7,5,0,1,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,23548936.1761885,5268974.076076517,0.2237457368203426,-2.1600679008981523,0.050067111979169715,0.6384005117332444,Downregulated
Feature1136,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1069673.7285508993,1426990.4819510533,1.3340427495440272,0.4158048985816988,0.1741819356297959,0.7429210442740862,Upregulated
Feature1135,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak2,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,34025363.295770235,35957242.43291107,1.0567776196935121,0.07967181880271852,0.8101226597125768,0.9118080082836999,Upregulated
Feature1134,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,11542193.0308732,9406075.72273543,0.8149296842962115,-0.295252512222847,0.18761533337669423,0.7429210442740862,Downregulated
Feature1133,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,600667.3756467937,1846196.6518023591,3.0735757037152043,1.619918019812288,0.25249941384872593,0.7429210442740862,Upregulated
Feature1132,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,8893503.694597423,7817392.222508737,0.8790002782882526,-0.1860644727666712,0.5887126616164717,0.801558357602538,Downregulated
Feature1131,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1816870.53639388,2344677.8131172634,1.2905035147804058,0.3679340707223563,0.36272546186056653,0.7429210442740862,Upregulated
Feature1130,Lys-phe,C15 H23 N3 O3,293.17394,NA,NA,Lys-phe-peak2,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,12138400.391381167,7229879.520663327,0.5956204514226504,-0.7475348032583478,0.10489458135040958,0.7055599272098991,Downregulated
Feature1129,2805789,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,2805789,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,28800954.031549733,24813660.418733533,0.8615568911901892,-0.2149820298033454,0.11620497030198457,0.7055599272098991,Downregulated
Feature1128,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,12475172.503566977,9920231.40291081,0.7951979341427429,-0.3306140859824996,0.3171615917772357,0.7429210442740862,Downregulated
Feature1127,val-arg,C11 H23 N5 O3,273.18012,NA,NA,val-arg,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,13090609.0827419,8721880.26212305,0.6662700113489451,-0.5858211351726632,0.07491472094572636,0.6384005117332444,Downregulated
Feature1126,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,325190.6245602113,1756198.529894012,5.400520178800049,2.433098374541268,0.32760038497215016,0.7429210442740862,Upregulated
Feature1125,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,28302733.452573467,29091876.346820865,1.027882214824577,0.039674955364336205,0.7151759674898417,0.8635125366555892,Upregulated
Feature1124,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak2",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,2563952.1425563134,3399559.66043818,1.3259060510578597,0.4069785548813179,0.568666858271531,0.788874618409681,Upregulated
Feature1123,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,16777036.533401767,16705986.5271652,0.9957650443154779,-0.0061227234659907235,0.8345309769421021,0.9174806109836959,Downregulated
Feature1122,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak1,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,398593.1182090233,429855.47050854965,1.0784317412202091,0.1089348647509877,0.7863379063905721,0.9029702269064507,Upregulated
Feature1121,L-Theanine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,L-Theanine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,18766666.625152066,12649636.746175453,0.6740481407189143,-0.5690764620911652,0.15602654932239843,0.7429210442740862,Downregulated
Feature1120,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,224173.11733534466,777392.1261644453,3.4678204746625805,1.7940292137218075,0.42067954434076676,0.7429771053580235,Upregulated
Feature1119,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak3,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,35712456.5188339,32089233.304479733,0.8985445537065375,-0.15433805434872483,0.46613212628777245,0.7503420241957679,Downregulated
Feature1118,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,616727.688130699,734179.3727833957,1.1904433462500972,0.251498963717123,0.44920593560664934,0.7437859477801351,Upregulated
Feature1117,NA,C5 H13 N O5,167.07939,NA,NA,Feature1117,5,13,5,1,0,0,2.6,1,0,60.3,0,-5,6,-2.3333333333333335,-6,Other,11338300.530738667,17628026.934145734,1.5547327296851343,0.6366665914820417,0.19254281615383526,0.7429210442740862,Upregulated
Feature1116,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak3,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,464754.061431501,666491.6695227947,1.434073900225673,0.5201193704428962,0.37872158631193753,0.7429210442740862,Upregulated
Feature1115,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,12769768.680995867,10791957.388065962,0.8451176883201252,-0.24277583451836124,0.13458743077439597,0.7397744129866796,Downregulated
Feature1114,NA,C42 H55 N10 O17 P3,1064.29584,NA,NA,Feature1114,42,55,17,10,0,3,1.3095238095238095,0.4047619047619048,-0.14285714285714324,64.37142857142858,22,5,-0.6666666666666666,0.02439024390243902,-8,Lignin,28141552.232998,36785292.98883737,1.3071522382373764,0.38642717522648906,0.47838429504887287,0.7587862788690932,Upregulated
Feature1113,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature1113,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,114475.21827924467,139738.92767749168,1.2206915154039724,0.2876986586160626,0.38162260268026543,0.7429210442740862,Upregulated
Feature1112,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,3036053.374607983,2602726.2371188332,0.8572728855450042,-0.22217358138223947,0.35631614104497694,0.7429210442740862,Downregulated
Feature1111,Pro-tyr,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,Pro-tyr,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,20168335.469288066,18113636.883030098,0.8981225501040072,-0.15501577869121722,0.4181653270425402,0.7429771053580235,Downregulated
Feature1110,NA,C18 H28 O,260.21405,NA,NA,Feature1110,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1600786.8073528833,1537685.25880242,0.9605809166713397,-0.05802094725009145,0.8773007889118538,0.9403980032751831,Downregulated
Feature1109,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,126436.83428757667,159508.677660049,1.2615681067848585,0.33521809348699794,0.037354580311368416,0.6051284343194661,Upregulated
Feature1108,NA,C13 H18 O9,318.09513,NA,NA,Feature1108,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,162474.21151436336,180174.86418760868,1.1089443826701109,0.1491870112542574,0.46933750159129983,0.7528955754693768,Upregulated
Feature1107,D-lysopine,C9 H18 N2 O4,218.12664,Lysine degradation,NA,D-lysopine-peak5,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,8241823.1378734065,7316209.705585403,0.8876931211937127,-0.17186707715241717,0.04605184894243649,0.6384005117332444,Downregulated
Feature1106,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,5376172.87298732,6053302.794703237,1.1259501764011661,0.1711429891860876,0.6072654881923675,0.8132671428028913,Upregulated
Feature1105,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak2,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,7999561.434553033,6063218.974896546,0.7579439228639817,-0.39983698158173,0.1573600747829833,0.7429210442740862,Downregulated
Feature1104,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,7307780.377035793,6445224.2847612165,0.8819674309062296,-0.18120271363702192,0.11476456690325443,0.7055599272098991,Downregulated
Feature1103,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature1103,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,642715.5955123333,652982.491975172,1.015974245116387,0.02286383034450788,0.9257591708008768,0.9629519344082903,Upregulated
Feature1102,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature1102,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,5177727.48423383,5524972.839878917,1.0670652050928613,0.09364833753989699,0.13196387000096177,0.7353513019132542,Upregulated
Feature1101,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,228383.03870261466,298699.30042040534,1.3078874075642364,0.38723834852684,0.28679041958553453,0.7429210442740862,Upregulated
Feature1100,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,1862188.0441827567,1010611.2814974393,0.5427009826716818,-0.8817705739087685,0.03647447931861094,0.6051284343194661,Downregulated
Feature1099,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,30003464.949271865,26724691.688891366,0.890720179621785,-0.16695581563843812,0.48596609376913125,0.7608913376127011,Downregulated
Feature1098,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,3973952.3701233133,4118039.3397544697,1.0362578501731476,0.0513830309012161,0.3108952947263423,0.7429210442740862,Upregulated
Feature1097,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,4226497.753903257,4034176.61774214,0.9544963354154147,-0.06718843616664294,0.7324155205871183,0.8680261231817094,Downregulated
Feature1096,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,3305607.824086847,5664744.723907667,1.713677188997009,0.7770953698385081,0.44262784390908455,0.7437859477801351,Upregulated
Feature1095,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,27436119.1228611,22914419.108833935,0.8351917050010377,-0.25982071153954445,0.3046087129936158,0.7429210442740862,Downregulated
Feature1094,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak3,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1011246.8654252177,1423413.9693628675,1.407583071977522,0.49322006901484045,0.29240147036395303,0.7429210442740862,Upregulated
Feature1093,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,9022626.63354521,17248993.923287667,1.9117486097848333,0.9348928249601746,0.056122474057318794,0.6384005117332444,Upregulated
Feature1092,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,7210379.5776828835,7806964.9136016695,1.0827397960802645,0.11468657627177815,0.615206964221229,0.8153208901224099,Upregulated
Feature1091,Hydrocotarnine,C12 H15 N O3,221.10517,NA,NA,Hydrocotarnine,12,15,3,1,0,0,1.25,0.25,-0.5,74.55,6,3,0.25,0.3684210526315789,2,Lignin,21684845.4806517,20642382.563783098,0.9519266615112043,-0.07107766541896815,0.3627790185672166,0.7429210442740862,Downregulated
Feature1090,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,5332095.542536886,5818290.173423297,1.0911826554884068,0.12589261780341438,0.20771206578970663,0.7429210442740862,Upregulated
Feature1089,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine-peak1,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,6283691.06474652,4776337.024735123,0.7601164626841498,-0.3957076141410705,0.13101710208237513,0.7353513019132542,Downregulated
Feature1088,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature1088,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,673533.1079890253,1097033.858359046,1.6287749560440634,0.7037872838955944,0.03289580981540139,0.6051275072806717,Upregulated
Feature1087,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,1096595.8234408023,1056546.2278267127,0.9634782526451491,-0.05367599209764228,0.8791461531391189,0.9403980032751831,Downregulated
Feature1086,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak4,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,14363970.550289499,13709490.995492201,0.9544360278026255,-0.0672795923496531,0.8356281519540019,0.9174806109836959,Downregulated
Feature1085,NP-016455,C11 H18 N2 O4,242.12664,NA,NA,NP-016455-peak2,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,27445290.329669565,30696388.980132934,1.1184574333669477,0.16151035086373616,0.2233823809758663,0.7429210442740862,Upregulated
Feature1084,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,536647.4606940236,622432.6983870573,1.1598539897721518,0.21394320062009914,0.319744131705871,0.7429210442740862,Upregulated
Feature1083,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,27080314.376523566,23918808.71034473,0.8832544695670298,-0.17909895022699798,0.1869203965631513,0.7429210442740862,Downregulated
Feature1082,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak1,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,23407483.212656666,26073452.3597929,1.1138938826919553,0.15561179802239522,0.6636947923266416,0.8393995881059486,Upregulated
Feature1081,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1264970.0024581933,900074.745179344,0.7115384107372072,-0.4909864555153168,0.29880172280159023,0.7429210442740862,Downregulated
Feature1080,NA,C23 H26 N4 O5,438.1904,NA,NA,Feature1080,23,26,5,4,0,0,1.1304347826086956,0.21739130434782608,-0.17391304347826075,65.25652173913043,13,8,0.2857142857142857,0.3939393939393939,4,Lignin,6812452.883879313,5522852.66022157,0.8106995753747676,-0.3027607074663701,0.2452091542134283,0.7429210442740862,Downregulated
Feature1079,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1440911.31262412,903535.8428620147,0.6270586086360428,-0.6733278026782771,0.058045202978300355,0.6384005117332444,Downregulated
Feature1078,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",C11 H11 N O5,237.06372,NA,NA,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",11,11,5,1,0,0,1,0.4545454545454546,0.18181818181818168,55.11818181818182,7,2,0.2,0.4666666666666667,1,Lignin,22064998.619965598,19246362.604055334,0.8722575938273656,-0.1971738423881571,0.17550251841481396,0.7429210442740862,Downregulated
Feature1077,NA,C29 H30 O10,538.18408,NA,NA,Feature1077,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,398244.36128583533,533689.0365354994,1.3401044394259487,0.4223454397654575,0.30911527501217195,0.7429210442740862,Upregulated
Feature1076,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,5385688.85025563,4643567.263723217,0.862204890188339,-0.21389734977937883,0.521756939181002,0.7682508165605624,Downregulated
Feature1075,Kanosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,20651120.282760367,18575807.533222333,0.8995060451383592,-0.1527951177331991,0.38843056575020063,0.7429210442740862,Downregulated
Feature1074,NA,C4 H N4 O7 P3,309.90566,NA,NA,Feature1074,4,1,7,4,0,3,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,27086224.547641467,26757887.531420633,0.9878780811388709,-0.01759509213583516,0.8793331978677037,0.9403980032751831,Downregulated
Feature1073,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak1,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,864851.7366201057,917458.678684246,1.0608277000977433,0.0851903523880743,0.794099194922149,0.9072202635501583,Upregulated
Feature1072,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,6195802.095954677,5924216.782857424,0.9561662382220738,-0.06466662918241048,0.7455878383217279,0.8739323144892864,Downregulated
Feature1071,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,3529775.87226368,3225832.211733613,0.9138915127959257,-0.12990518041447954,0.2502286310315638,0.7429210442740862,Downregulated
Feature1070,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,948418.227701576,1068927.740897627,1.1270636831686558,0.17256903529355302,0.5787431426884642,0.7959606458897521,Upregulated
Feature1069,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1703088.1085226734,3211240.3967924765,1.8855397913488074,0.914977596608376,0.2810977362994566,0.7429210442740862,Upregulated
Feature1068,Dicyclomine,C19 H35 N O2,309.26682,NA,NA,Dicyclomine,19,35,2,1,0,0,1.8421052631578947,0.10526315789473684,-1.473684210526316,102.3,3,1,0,0.0588235294117647,0,Lipid,6386582.898177312,11643693.726691455,1.8231492352529375,0.8664326590990918,0.6211329711201533,0.8194698232691119,Upregulated
Feature1067,Maltol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Maltol,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,26726337.564608466,26547882.205116868,0.993322865167732,-0.009665373842623646,0.9135084824086152,0.9576010948021002,Downregulated
Feature1066,Proacaciberin,C16 H25 N O10,391.14794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,Proacaciberin,16,25,10,1,0,0,1.5625,0.625,-0.125,63.8625,5,-5,-1.2,-0.1,-6,Amino Sugar,31236496.523027066,25222137.285125267,0.8074573045197913,-0.30854211766413187,0.03131020137104841,0.6051275072806717,Downregulated
Feature1065,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,5540083.003718033,3348629.59498577,0.6044367192221586,-0.7263367887350675,0.21837596111879745,0.7429210442740862,Downregulated
Feature1064,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak2,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,13396691.961839233,12191712.952244433,0.9100539884751244,-0.1359759599112787,0.16484470379786142,0.7429210442740862,Downregulated
Feature1063,N6-Me-Adenosine,C11 H15 N5 O4,281.11242,NA,NA,N6-Me-Adenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,20776313.64028027,20876952.275966767,1.0048439120350678,0.006971417004361358,0.9862211617677619,0.9930757365148142,Upregulated
Feature1062,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,23888517.1137921,21478914.216668066,0.8991313321942096,-0.15339623558042656,0.6529125237695985,0.8331143341897993,Downregulated
Feature1061,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature1061,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,270810.52459145035,271257.024124273,1.0016487525124669,0.0023766883259175794,0.9821478414876113,0.9915127791895193,Upregulated
Feature1060,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,169875.95343554165,172248.50604930133,1.013966382915166,0.020009821961033878,0.9214424209276639,0.9611597666573046,Upregulated
Feature1059,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,169312.95796248666,5977247.254340136,35.302952155997815,5.141716926619916,0.13437966430345258,0.7397744129866796,Upregulated
Feature1058,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature1058,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,287294.750269483,411713.2463250603,1.433069159596103,0.5191082354191097,0.3038791498894814,0.7429210442740862,Upregulated
Feature1057,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,1643472.9022793896,2248321.254043775,1.3680306203561376,0.45210052214015356,0.7390352357053374,0.8699970043675063,Upregulated
Feature1056,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,237432.26607840532,263124.4125613843,1.1082083193970567,0.14822910260697428,0.7598002322615136,0.8864336043050993,Upregulated
Feature1055,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,14817643.161579667,11799300.6210458,0.7963007674283816,-0.32861464688121306,0.1763330774023098,0.7429210442740862,Downregulated
Feature1054,NA,C23 H32 N2 O12,528.19573,NA,NA,Feature1054,23,32,12,2,0,0,1.391304347826087,0.5217391304347826,-0.08695652173913082,62.77826086956522,9,-3,-0.5555555555555556,0.06666666666666667,-5,Lignin,29858320.1806354,26895476.238782,0.9007699052080314,-0.15076946721657158,0.11606468866753938,0.7055599272098991,Downregulated
Feature1053,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3395804.94750044,3111932.49482605,0.9164049593356826,-0.12594282874844595,0.4068865708047963,0.7429210442740862,Downregulated
Feature1052,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak3,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,670249.1437742483,1003866.7012924696,1.4977515609189493,0.5827983370442562,0.11307998272351585,0.7055599272098991,Upregulated
Feature1051,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature1051,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,753826.0656575377,1270998.3380436536,1.6860631330584246,0.7536585576590276,0.30468431019591363,0.7429210442740862,Upregulated
Feature1050,ascopyrone M,C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,ascopyrone M,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,16943867.2403523,18471518.650323465,1.0901595478942978,0.12453929290256814,0.668366848567546,0.8393995881059486,Upregulated
Feature1049,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,780780.3182022887,851307.342796175,1.0903288965534783,0.1247633880789441,0.5442722474946647,0.7729780816985922,Upregulated
Feature1048,Xanthine,C5 H4 N4 O2,152.03344,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Other,Other,Xanthine,5,4,2,4,0,0,0.8,0.4,2.4,-8.099999999999994,6,4,-0,Inf,0,Condensed HC,30827697.612410802,31638376.1198806,1.026297082502309,0.037448408735832606,0.8809015989610379,0.9410752829536629,Upregulated
Feature1047,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,9884521.758390054,10302633.38569387,1.0422996314362827,0.059770070944287754,0.340474258745349,0.7429210442740862,Upregulated
Feature1046,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,340505.71873916965,406825.24364239635,1.19476772709955,0.25673017340892723,0.3878203256457802,0.7429210442740862,Upregulated
Feature1045,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak2,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,403360.064041357,487762.47923151235,1.2092483185978011,0.2741105317864215,0.3678974843416425,0.7429210442740862,Upregulated
Feature1044,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak3",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,2907137.3518552333,3088625.8664534367,1.0624285999016811,0.08736588875244641,0.5311596341358895,0.7697066387459335,Upregulated
Feature1043,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak4,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1350999.8119240196,1478251.839423058,1.0941910031192479,0.12986459846006623,0.8091001285228111,0.9118080082836999,Upregulated
Feature1042,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,732756.434528654,755824.1281947896,1.031480711160147,0.044716842868806846,0.8469103329009418,0.926990104955748,Upregulated
Feature1041,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature1041,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,5709532.0566983735,32608948.179756965,5.711317119500262,2.513823492111103,0.05100315533265242,0.6384005117332444,Upregulated
Feature1040,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak2,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,17712468.268960033,16196806.9811308,0.9144296963690073,-0.12905583863524955,0.4912864400572203,0.7628223918028699,Downregulated
Feature1039,4-Oxo-4-(3-pyridyl)butyric acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Oxo-4-(3-pyridyl)butyric acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,19749668.523102432,19116386.308230866,0.9679345395528651,-0.047018612114566066,0.2292790027473841,0.7429210442740862,Downregulated
Feature1038,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,212364.01554264067,261699.91220036402,1.2323175917146716,0.3013741139425751,0.37924218376605556,0.7429210442740862,Upregulated
Feature1037,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak4,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,16679390.859867,13912964.906852067,0.8341410680847254,-0.26163670520301613,0.05786866670766036,0.6384005117332444,Downregulated
Feature1036,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,808421.8846229947,855279.8196297503,1.0579622297441982,0.0812881227889743,0.748681684313552,0.8756841695291173,Upregulated
Feature1035,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak2,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,3043214.0321453065,2633361.9715968934,0.8653226305415368,-0.20868996132879508,0.8298839633700426,0.9146541535125908,Downregulated
Feature1034,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,1148541.9253138728,1627356.5218458734,1.4168890886600858,0.5027268312957377,0.06674346731042256,0.6384005117332444,Upregulated
Feature1033,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,12498824.24503443,5766521.898559853,0.4613651480738914,-1.1160190691933816,0.31794107035860386,0.7429210442740862,Downregulated
Feature1032,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature1032,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,118795.565119912,145012.7384526758,1.2206915157674467,0.28769865904564096,0.3816226023346467,0.7429210442740862,Upregulated
Feature1031,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak5,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,141135.012142653,152445.200914044,1.0801373705906452,0.11121480430259446,0.6994471278754988,0.8535652471997965,Upregulated
Feature1030,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,455340.543839056,880511.0529476176,1.9337418221620999,0.9513951904972555,0.12489801440858585,0.7192763118557381,Upregulated
Feature1029,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature1029,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,665738.2488947103,791936.4918813431,1.1895613526729956,0.2504296819475484,0.4103304131996656,0.7429210442740862,Upregulated
Feature1028,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,2711387.88293172,671904.9045948687,0.24780847802136063,-2.01270254909511,0.002784515122717228,0.2774687422284108,Downregulated
Feature1027,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak1,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,1002015.9596513857,1209241.874705615,1.2068089964618187,0.2711973565711285,0.3702748238447231,0.7429210442740862,Upregulated
Feature1026,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3183932.5532109933,760429.4459844163,0.2388334028048188,-2.065923471472167,1.6158210014922906e-4,0.10448726305784786,Downregulated
Feature1025,(DL)-3-O-Methyldopa,C10 H13 N O4,211.08446,NA,NA,(DL)-3-O-Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,8782006.70549583,7837431.229991034,0.8924419546487392,-0.16416975707747533,0.5390637080530444,0.7721846506499914,Downregulated
Feature1024,NA,C18 H29 N3 O12,479.17524,NA,NA,Feature1024,18,29,12,3,0,0,1.6111111111111112,0.6666666666666666,0.22222222222222232,53.96666666666666,6,-6,-3,-0.3333333333333333,-9,Amino Sugar,24798191.506790467,24294899.118543133,0.9797044720737189,-0.029581469100828768,0.6402252036591259,0.8313876949993997,Downregulated
Feature1023,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,241973.37789871,348922.3733651213,1.441986620161083,0.5280577782286611,0.48050687220211036,0.7593501989503708,Upregulated
Feature1022,NA,C12 H23 N5 O2,269.18519,NA,NA,Feature1022,12,23,2,5,0,0,1.9166666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,2,-0.6,-0.3333333333333333,-3,Lipid,20119450.306749,18438929.8498563,0.9164728443734381,-0.12583596138700254,0.13053635956160986,0.7353513019132542,Downregulated
Feature1021,NA,C10 H23 N O7,269.14745,NA,NA,Feature1021,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,3264480.9134997334,2741116.2830010597,0.8396790655646403,-0.25209007531845357,0.308754906843221,0.7429210442740862,Downregulated
Feature1020,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,6543500.31731272,9430269.007714657,1.4411658211071154,0.5272363421229826,0.39351638082967694,0.7429210442740862,Upregulated
Feature1019,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature1019,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,1631832.4679314734,1944963.12312523,1.1918889722734123,0.25324985105940234,0.3547932153493257,0.7429210442740862,Upregulated
Feature1018,MFCD03548046,C12 H16 N2 O4,252.111,NA,NA,MFCD03548046,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,14827026.236474667,12353949.880799223,0.8332048304068117,-0.26325689163007926,0.38380427637432496,0.7429210442740862,Downregulated
Feature1017,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,301243.64260903734,324787.91132302064,1.0781568982172338,0.10856714080743056,0.7923550299128888,0.9069252842381308,Upregulated
Feature1016,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak3",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,6965270.143838263,6357518.42151126,0.9127454198076376,-0.13171557070941198,0.10288360693854848,0.7055599272098991,Downregulated
Feature1015,Guanine,C5 H5 N5 O,151.04939,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,24562144.953612067,19979206.4544797,0.8134145650639357,-0.2979372708473613,0.2236515069971463,0.7429210442740862,Downregulated
Feature1014,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,4861724.707128193,4211061.599884677,0.8661661968869765,-0.20728422418485754,0.04591522718486367,0.6384005117332444,Downregulated
Feature1013,3-Hydroxy-2-methylpyridine,C6 H7 N O,109.05272,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,3-Hydroxy-2-methylpyridine,6,7,1,1,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,3,0.5,0.5555555555555556,2,Lignin,18619135.2507336,17049106.18857713,0.9156765853508364,-0.12708996283127283,0.12772692602939875,0.7309777455871671,Downregulated
Feature1012,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,569797.4608252316,394584.4472223677,0.6924994833267513,-0.530115100118622,0.6680490561821564,0.8393995881059486,Downregulated
Feature1011,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,C15 H13 N O3,255.08951,NA,NA,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,15,13,3,1,0,0,0.8666666666666667,0.2,-0.2666666666666666,67.89999999999999,10,7,0.5454545454545454,0.6,6,Lignin,18909556.930832166,17933547.8781861,0.9483854087001543,-0.07645462835367543,0.034554411027111556,0.6051275072806717,Downregulated
Feature1010,NA,C10 H15 N O5,229.09503,NA,NA,Feature1010,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,8991415.111738974,7385621.198221587,0.8214080994413324,-0.2838289218993024,0.30959133791818366,0.7429210442740862,Downregulated
Feature1009,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,790602.6510133423,557173.18188992,0.7047448945127773,-0.5048269735819491,0.7281890920433806,0.8678071861534502,Downregulated
Feature1008,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak3,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,12386095.862274867,2405418.8928036266,0.19420315485608072,-2.3643614571670626,0.3881407800236791,0.7429210442740862,Downregulated
Feature1007,NA,C17 H29 N O12,439.16903,NA,NA,Feature1007,17,29,12,1,0,0,1.7058823529411764,0.7058823529411765,-0.117647058823529,63.65294117647058,4,-8,-2.25,-0.3,-9,Carbohydrate,22362191.193994068,20023390.699308336,0.8954127314986076,-0.15937526342352126,0.5200934406077193,0.7682508165605624,Downregulated
Feature1006,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature1006,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,9551111.402641397,8305122.954955743,0.8695451874489631,-0.20166709321565038,0.02322297085949999,0.5785251858234263,Downregulated
Feature1005,Pyridoxine,C8 H11 N O3,169.07393,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak1,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,17748379.551233165,15063656.089039134,0.8487341644658768,-0.23661534283152452,0.028162734365030778,0.5904389566427806,Downregulated
Feature1004,Perillartine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Perillartine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,177147.46512677634,339044.0360541493,1.9139084819052365,0.9365218455720338,0.31668115653271767,0.7429210442740862,Upregulated
Feature1003,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature1003,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,5343100.7329886835,4706606.827452524,0.8808755557224663,-0.182989875768049,0.22895554118479894,0.7429210442740862,Downregulated
Feature1002,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,17535076.52628724,10096155.047162581,0.5757690895746707,-0.79643775564622,0.5441737422749251,0.7729780816985922,Downregulated
Feature1001,2-Mercaptoethanol,C2 H6 O S,78.01397,Metabolic pathways;Other,Other,2-Mercaptoethanol,2,6,1,0,1,0,3,0.5,-1,88.8,0,-1,-Inf,-3,-2,Other,15485856.273706,15111394.936143022,0.9758191390295421,-0.03531431534116455,0.949127453207179,0.9777641602032469,Downregulated
Feature1000,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,5175878.089641213,7135737.3248215,1.3786525109821786,0.46325887174939673,0.437013356928381,0.7437859477801351,Upregulated
Feature0999,metharbital,C9 H14 N2 O3,198.10045,NA,NA,metharbital-peak2,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,17245175.681028932,16517059.045737134,0.9577785318770173,-0.06223599623313096,0.5788804697380016,0.7959606458897521,Downregulated
Feature0998,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak1,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,11679667.598735891,14542330.689111333,1.2450979932584103,0.31625929154997573,0.5820079583539575,0.7983169890296388,Upregulated
Feature0997,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,259954.100004668,341003.278769085,1.3117826522565392,0.39152870129178924,0.33194505651770484,0.7429210442740862,Upregulated
Feature0996,Benserazide,C10 H15 N3 O5,257.1012,NA,NA,Benserazide,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,27540319.132390633,24839167.1385591,0.9019200910183113,-0.1489284767043506,0.405500940404275,0.7429210442740862,Downregulated
Feature0995,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,10796495.82385653,10833035.700644083,1.0033844200362503,0.004874442067803379,0.9846508025497192,0.9928562259043001,Upregulated
Feature0994,NA,C11 H18 N2 O4,242.12664,NA,NA,Feature0994,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,11063174.00136977,11368172.430788286,1.0275687998200835,0.039234991314591794,0.9084645983750121,0.9551748813293666,Upregulated
Feature0993,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,1919593.5616457167,1138002.7670295066,0.5928352698025657,-0.7542968138164804,0.14477564778571328,0.7409363968247682,Downregulated
Feature0992,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak1,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,28641625.466080166,16134844.877772346,0.5633355165851391,-0.8279336629229576,0.24018126409703272,0.7429210442740862,Downregulated
Feature0991,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,3034197.7134117265,2247205.8397630267,0.7406260408904644,-0.43318281839557643,0.2800043141880385,0.7429210442740862,Downregulated
Feature0990,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,813306.8354809444,1246135.2677128587,1.5321834433814439,0.6155890368275203,0.42790371516987014,0.7437859477801351,Upregulated
Feature0989,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,1015801.60822147,1158266.9249518926,1.140249154537036,0.18934910047790587,0.783762968816323,0.9029702269064507,Upregulated
Feature0988,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0988,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,136000.50295317933,161532.08278811435,1.1877315104027575,0.24820874827022643,0.38023607042166685,0.7429210442740862,Upregulated
Feature0987,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,536681.9356093573,792011.2668841047,1.4757554043343053,0.561453625059764,0.4898158780645077,0.7626394464118028,Upregulated
Feature0986,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,1721061.4946849532,1101634.0415661833,0.6400898776530013,-0.6436536008053899,0.20471562287184328,0.7429210442740862,Downregulated
Feature0985,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak1,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,7389767.05469357,7221530.07572258,0.977233791305487,-0.03322434414958918,0.8708356742927013,0.9391342199196943,Downregulated
Feature0984,Valylglutamine,C10 H19 N3 O4,245.13752,NA,NA,Valylglutamine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,17425379.3332002,13667720.479169467,0.7843571274875293,-0.3504174140889394,0.06541993037446085,0.6384005117332444,Downregulated
Feature0983,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1278402.7217220434,1588295.3156545667,1.2424060811722066,0.31313679637641756,0.3975022330625409,0.7429210442740862,Upregulated
Feature0982,NA,C16 H25 N O9,375.15303,NA,NA,Feature0982,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,16771701.054344734,15872857.244633634,0.9464071171553434,-0.07946717183718537,0.2316390107799372,0.7429210442740862,Downregulated
Feature0981,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak2,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,414109.260446414,571396.4868051213,1.379820596596053,0.4644807008972441,0.18238700778454298,0.7429210442740862,Upregulated
Feature0980,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0980,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,3345943.505875087,3614847.1160385767,1.0803670503376182,0.11152154547839492,0.4783847377994047,0.7587862788690932,Upregulated
Feature0979,D-lysopine,C9 H18 N2 O4,218.12662,Lysine degradation,NA,D-lysopine-peak4,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,11176585.352608766,9923266.634828856,0.8878621083059712,-0.17159246235529327,0.10709954617438308,0.7055599272098991,Downregulated
Feature0978,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12236,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,8383500.3518983405,7598143.696736293,0.9063211520013579,-0.1419057396475591,0.441795901731948,0.7437859477801351,Downregulated
Feature0977,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,25329995.8192811,19292673.4012667,0.7616532406444848,-0.3927937662820195,0.1290665829904155,0.7353513019132542,Downregulated
Feature0976,gamma-Glu-gln,C10 H17 N3 O6,275.11175,NA,NA,gamma-Glu-gln,10,17,6,3,0,0,1.7,0.6,0.3999999999999999,48.9,4,-2,-5,-0.5,-5,Amino Sugar,8903282.301883351,11389397.194398638,1.2792357703842983,0.35528218557763297,0.23298940032777304,0.7429210442740862,Upregulated
Feature0975,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,631066.3854703,824859.774488725,1.3070887524360868,0.3863571046774983,0.5035190658433477,0.7643022379378415,Upregulated
Feature0974,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,14856222.617020834,13476886.717880467,0.9071543329217444,-0.14058007952524199,0.36675775599587446,0.7429210442740862,Downregulated
Feature0973,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",C11 H12 O6,240.06344000000001,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",11,12,6,0,0,0,1.0909090909090908,0.5454545454545454,0,60.3,6,0,0,0.375,0,Lignin,10888850.466151264,11117214.280263662,1.020972261013436,0.02994366989642868,0.9124415383663763,0.957332225189993,Upregulated
Feature0972,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,3209000.4647091967,3547354.743353443,1.1054391491572777,0.1446196116532426,0.3153179412023923,0.7429210442740862,Upregulated
Feature0971,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,10172072.567705307,9544674.102108182,0.9383214717137377,-0.09184581586637663,0.05116437783301225,0.6384005117332444,Downregulated
Feature0970,Nojirimycin,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,25873125.805080768,23421603.0090315,0.9052482945231204,-0.14361454120342315,0.46525993740766025,0.749905170284088,Downregulated
Feature0969,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,13226204.159972934,10635404.702703174,0.8041161752885674,-0.31452414397489886,0.19994750056625613,0.7429210442740862,Downregulated
Feature0968,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0968,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,250286.7183304043,304205.71620236133,1.2154289218047054,0.2814655271320092,0.3393426551532435,0.7429210442740862,Upregulated
Feature0967,Methoxyphenamine,C11 H17 N O,179.13104,NA,NA,Methoxyphenamine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,21355892.103646334,17778843.3295252,0.8325029571810589,-0.2644726980153287,0.10077602392967007,0.7043924180722835,Downregulated
Feature0966,Vorinostat,C14 H20 N2 O3,264.14742,Metabolic pathways;Other,NA,Vorinostat,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,4891062.33940594,4494101.8177582,0.9188396110903068,-0.12211504238165061,0.6736676631642038,0.8434538221730681,Downregulated
Feature0965,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0965,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,17124378.7595972,18863761.804719266,1.1015734976165044,0.13956575569192636,0.27939678501186216,0.7429210442740862,Upregulated
Feature0964,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0964,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,14741578.554150466,13891761.928229967,0.9423523998601063,-0.0856614273447682,0.4682329766634237,0.7518356990216489,Downregulated
Feature0963,pyroglutamylglycine,C7 H10 N2 O4,186.06407,NA,NA,pyroglutamylglycine,7,10,4,2,0,0,1.4285714285714286,0.5714285714285714,0.5714285714285716,44.014285714285705,4,0,-2,0,-2,Lignin,13882545.6025644,12882125.164298967,0.9279368159913961,-0.10790152052505955,0.03570643637955551,0.6051284343194661,Downregulated
Feature0962,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0962,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,2466732.8711740933,2555551.92994069,1.036006760117613,0.05103341688193482,0.786755145516283,0.9029702269064507,Upregulated
Feature0961,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak3,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1107736.80975087,1146149.0795251783,1.034676350407591,0.04917955933574481,0.7915709499541541,0.9069252842381308,Upregulated
Feature0960,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak2",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,2815643.34536487,3201498.6617519734,1.1370398410090898,0.18528280605006062,0.2620659941325207,0.7429210442740862,Upregulated
Feature0959,NA,C9 H19 N O9,285.106,NA,NA,Feature0959,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,4823984.67005331,4531729.7051040735,0.9394162741097586,-0.09016350834502006,0.6133589331866971,0.8152864262097903,Downregulated
Feature0958,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0958,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,14408843.539988067,11619440.310647419,0.8064103325433876,-0.3104139706655985,0.18831655527710814,0.7429210442740862,Downregulated
Feature0957,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak1,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,1556997.832457379,1918389.3691152835,1.2321079253447176,0.3011286330945561,0.6611454857007657,0.8390728999405301,Upregulated
Feature0956,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0956,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,112033.77578869433,127327.72200000197,1.136511923334204,0.18461281978699134,0.48241315859135475,0.7594868872246793,Upregulated
Feature0955,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,357049.34185452433,762192.7952516144,2.1346987822264665,1.0940325119785763,0.2527467629571997,0.7429210442740862,Upregulated
Feature0954,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,250730.7668783,333437.988513077,1.3298646698389494,0.41127944115056836,0.11524993970228874,0.7055599272098991,Upregulated
Feature0953,NA,C7 H9 O5 P S,235.99087,NA,NA,Feature0953,7,9,5,0,1,1,1.2857142857142858,0.7142857142857143,-0.2857142857142856,68.44285714285714,4,-1,-Inf,-0.2,-3,Tannin,19667308.2164029,25987259.217135802,1.3213429581309935,0.40200497058019863,0.3957532671248423,0.7429210442740862,Upregulated
Feature0952,NA,C19 H41 N O2,315.3138,NA,NA,Feature0952,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,147055.912422191,176547.10544904566,1.200544082458832,0.2636883784763862,0.39417809557768246,0.7429210442740862,Upregulated
Feature0951,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,2046074.0187300767,3044602.605663037,1.488021732250288,0.5733955968631249,0.22385047758459514,0.7429210442740862,Upregulated
Feature0950,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0950,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,2525884.8998959768,2699013.0532832034,1.0685415845331498,0.09564305458859497,0.6704163953184097,0.8400540732655443,Upregulated
Feature0949,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1290210.41712388,1365491.4215461,1.0583478504150008,0.08181388037129082,0.6558017633197342,0.8352843511756614,Upregulated
Feature0948,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak3,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,264897.6649327687,288375.88856601,1.08863129706787,0.12251541782047717,0.7848845988492729,0.9029702269064507,Upregulated
Feature0947,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak2,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,10763679.201193867,10152660.22197485,0.9432332599478396,-0.08431350388541836,0.3613903501434703,0.7429210442740862,Downregulated
Feature0946,NA,C5 H11 N3,113.09524,NA,NA,Feature0946,5,11,0,3,0,0,2.2,0,-0.4000000000000003,71.7,2,2,-0.5,-0.5,-1,Lipid,13763856.617469367,11375124.157695966,0.8264488997406749,-0.2750024760592216,0.02858087039238961,0.5904389566427806,Downregulated
Feature0945,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10593,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak2,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,13431730.8138679,11416190.920882907,0.8499419083872644,-0.2345638552200889,0.18188577707404943,0.7429210442740862,Downregulated
Feature0944,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak3,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1205644.8090418866,1327247.8117957483,1.1008613829229674,0.1386328206192132,0.7262190520162495,0.8676401028009545,Upregulated
Feature0943,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,9954758.694290094,3909122.1762195597,0.3926887929952311,-1.3485416695871926,0.0010673387103074233,0.19965892031945995,Downregulated
Feature0942,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak1,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,3545295.11242051,4016110.998667093,1.1328001961239098,0.17989342031017905,0.7942193924704161,0.9072202635501583,Upregulated
Feature0941,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,14808281.4751121,15989722.404320933,1.0797824468149428,0.1107406693170438,0.2756196654251434,0.7429210442740862,Upregulated
Feature0940,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,512805.7421632997,730475.8076886357,1.4244688536580785,0.5104240771448937,0.27678462414447313,0.7429210442740862,Upregulated
Feature0939,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,575429.7638842181,663988.8713595934,1.153900811243393,0.20651921594400333,0.8736754960917746,0.9391342199196943,Upregulated
Feature0938,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,323988.162545721,412407.9465038853,1.272910538654901,0.3481310288431676,0.23274721276946037,0.7429210442740862,Upregulated
Feature0937,NA,C19 H41 N O2,315.31381,NA,NA,Feature0937,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,214139.01378166635,254262.49351841235,1.1873711801888442,0.2477710016256349,0.34141787333247525,0.7429210442740862,Upregulated
Feature0936,NA,C12 H21 N O8,307.12685,NA,NA,Feature0936,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1596772.5914955167,1612791.5403772732,1.010032079061899,0.014401114332088858,0.9000568432600318,0.9498388119903466,Upregulated
Feature0935,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,5754641.063631733,5510551.219164637,0.9575838281192378,-0.06252930694302615,0.7768983142603153,0.899566469143523,Downregulated
Feature0934,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0934,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,113786.53469149966,138898.2574265469,1.2206915150648592,0.2876986582152759,0.38162260306638657,0.7429210442740862,Upregulated
Feature0933,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,2140918.830544267,1390158.9516956334,0.6493281911777223,-0.6229802482368978,0.020589327083144975,0.5785251858234263,Downregulated
Feature0932,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,506839.28878853965,697346.6955599303,1.375873400080618,0.46034772768638904,0.35248948014992715,0.7429210442740862,Upregulated
Feature0931,NA,C9 H19 N O9,285.10601,NA,NA,Feature0931,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,9151134.786823682,3524507.7046029535,0.3851443331025719,-1.3765288967953377,0.3499766531165877,0.7429210442740862,Downregulated
Feature0930,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak2,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,478505.1495784367,745959.1961082839,1.5589366107459333,0.6405622665720969,0.18350547699563263,0.7429210442740862,Upregulated
Feature0929,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0929,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,439547.6021558013,661732.2980934284,1.5054849459942494,0.5902282819928282,0.33747335764101566,0.7429210442740862,Upregulated
Feature0928,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak1,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,15934005.864434833,14175468.299397733,0.8896361919282202,-0.16871261432001436,0.2674792671553507,0.7429210442740862,Downregulated
Feature0927,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak3,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,568060.2553100274,734502.7953675697,1.2930015583764152,0.37072401394211246,0.3919962043969015,0.7429210442740862,Upregulated
Feature0926,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0926,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,86391.73120647836,13167709.52096793,152.41863239777868,7.251895465471996,0.40489405829127695,0.7429210442740862,Upregulated
Feature0925,NA,C4 H5 N O,83.03712,NA,NA,Feature0925,4,5,1,1,0,0,1.25,0.25,0,60.3,3,2,0.5,0.6,1,Lignin,17671552.2609948,16016822.754662,0.9063619606306362,-0.1418407813471424,0.3154822261393932,0.7429210442740862,Downregulated
Feature0924,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197-peak2,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,1714329.614753599,2317305.5757548967,1.3517269700132688,0.43480377677820037,0.46450139558335873,0.749905170284088,Upregulated
Feature0923,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak2,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,12093788.003141133,10246998.883328253,0.8472944027683293,-0.23906475624376808,0.06399465194299404,0.6384005117332444,Downregulated
Feature0922,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,7485541.54993139,8059942.538501077,1.076734727172138,0.10666285997235475,0.3437303185226343,0.7429210442740862,Upregulated
Feature0921,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,370063.9180030633,468606.521028773,1.2662853583712368,0.3406025538316557,0.2893119016474974,0.7429210442740862,Upregulated
Feature0920,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0920,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,883918.586303331,867839.2299940977,0.981809007573334,-0.026485692166119252,0.7341131798528718,0.8680261231817094,Downregulated
Feature0919,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0919,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,1170047.43072994,1302043.5805513316,1.1128126487479615,0.15421072343118641,0.540893978367877,0.7721846506499914,Upregulated
Feature0918,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,2263739.5275016935,2742546.067738427,1.21151132204912,0.2768078874040286,0.2577290504886346,0.7429210442740862,Upregulated
Feature0917,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0917,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,237581.67634360766,293605.01001912635,1.2358066267471475,0.30545301471604985,0.3847680479229446,0.7429210442740862,Upregulated
Feature0916,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,624721.432153185,486797.484397195,0.779223281518265,-0.35989131219353215,0.36404796906805115,0.7429210442740862,Downregulated
Feature0915,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,3886891.38657365,3217791.6242023367,0.8278573554479652,-0.2725458903468578,0.1927509476118594,0.7429210442740862,Downregulated
Feature0914,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,2713184.2989063165,2996530.35635864,1.1044330300623293,0.14330594008185737,0.5005406686493313,0.7643022379378415,Upregulated
Feature0913,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,10876077.262005767,9278238.687671864,0.8530868680093185,-0.22923543931648208,0.07463717041191226,0.6384005117332444,Downregulated
Feature0912,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0912,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,202229.43843829635,233016.37970927067,1.1522376836365886,0.20443834667097674,0.5612078903341384,0.786340914992581,Upregulated
Feature0911,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak2,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,3725660.45768465,3531358.3451825767,0.9478476058919163,-0.0772729723644105,0.691676025271374,0.8507102856872568,Downregulated
Feature0910,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak2,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,4349072.62406298,4187022.45337627,0.9627391435612958,-0.05478314548996791,0.7357650435656,0.8680261231817094,Downregulated
Feature0909,Methylone,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak2,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,222002.932817098,251731.25132619464,1.1339095755711885,0.18130559612097794,0.8054592631166331,0.9118080082836999,Upregulated
Feature0908,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,4638386.76462051,5969415.395336223,1.286959388740109,0.36396652862647305,0.6144952027172026,0.8152864262097903,Upregulated
Feature0907,NA,C12 H18 N4 O4,282.13282,NA,NA,Feature0907,12,18,4,4,0,0,1.5,0.3333333333333333,0.16666666666666652,55.55,6,2,-0.5,0,-2,Protein,17072338.856674865,14689764.886902299,0.8604424390955058,-0.2168494111739505,0.2009134380675901,0.7429210442740862,Downregulated
Feature0906,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,689462.2982408187,808483.6925662193,1.1726293005855242,0.22974701103796852,0.4779086194971141,0.7587862788690932,Upregulated
Feature0905,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07429,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak1",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,15855541.567555433,14295280.688992767,0.9015952326878972,-0.1494482078108049,0.008599626757258486,0.3553114079706311,Downregulated
Feature0904,NA,C15 H27 N O13,429.14831,NA,NA,Feature0904,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,20727004.825483333,20340660.914340433,0.9813603598592354,-0.027145097161166493,0.9005995730001988,0.9498388119903466,Downregulated
Feature0903,NA,C6 H2 O4,137.99529,NA,NA,Feature0903,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,18432927.726660866,15397280.654912533,0.8353138949621303,-0.25960965824977045,0.1081778361692312,0.7055599272098991,Downregulated
Feature0902,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0902,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,459624.2387822783,528876.4960212976,1.1506714646348835,0.20247597943057966,0.5026143891155823,0.7643022379378415,Upregulated
Feature0901,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak1,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,365055.6673471457,417428.3175853147,1.1434648326891081,0.19341199628285488,0.5610759222604194,0.786340914992581,Upregulated
Feature0900,Methyldopa,C10 H13 N O4,211.08447,NA,NA,Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,19537627.094921164,14155657.5621889,0.7245331018662283,-0.46487649094736716,0.001236379524899805,0.19965892031945995,Downregulated
Feature0899,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,429313.17472057504,581473.6911582687,1.3544277823216808,0.43768347152887915,0.3819198387168416,0.7429210442740862,Upregulated
Feature0898,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,1595477.4508836267,1712168.2088035434,1.073138456363197,0.10183622467049584,0.7026961097522653,0.8535652471997965,Upregulated
Feature0897,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0897,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,7005513.1675087195,5738964.940403273,0.81920693076709294,-0.2877001738109032,0.2713681424733709,0.7429210442740862,Downregulated
Feature0896,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0896,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,134543.14918958032,163528.68735195766,1.2154367452893107,0.28147481345547437,0.3995672137957755,0.7429210442740862,Upregulated
Feature0895,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2347158.630337043,1697493.1396157034,0.7232119370525671,-0.46750960437926337,0.0054561460327705626,0.32409559267895377,Downregulated
Feature0894,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak3,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,8559544.922250176,9324858.09288204,1.0894104975887755,0.12354767420608481,0.5276712819022511,0.7697066387459335,Upregulated
Feature0893,NA,C10 H17 N3 O3,227.12699,NA,NA,Feature0893,10,17,3,3,0,0,1.7,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,18606005.547092702,17201283.1201087,0.9245016656891464,-0.11325217592927428,0.14272385671241583,0.7397744129866796,Downregulated
Feature0892,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0892,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,542339.7710608484,596391.8027704237,1.0996645176949615,0.13706345786021013,0.4939914942354144,0.7638837682405117,Upregulated
Feature0891,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1168023.0778489849,1834911.8956642048,1.570955172429772,0.6516420135818375,0.4814068291518205,0.7593501989503708,Upregulated
Feature0890,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0890,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,392320.72828323004,670882.535307701,1.7100359143485466,0.7740266250576325,0.03988364840010435,0.614208185361607,Upregulated
Feature0889,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,2163115.2893808736,2614318.68216096,1.208589618405975,0.27332445468080013,0.10000913896495182,0.7043924180722835,Upregulated
Feature0888,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,124764.89483464233,158362.64558955532,1.2692884949684118,0.3440200147713866,0.34490043768050715,0.7429210442740862,Upregulated
Feature0887,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,875877.7028090716,1007418.0985281677,1.150181235687615,0.20186120658421072,0.5061999300003418,0.7663907778152678,Upregulated
Feature0886,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,12272763.3618751,13259963.7024097,1.0804383097291115,0.11161670034302214,0.6369065105779765,0.8313876949993997,Upregulated
Feature0885,NA,C13 H27 N O11,373.15852,NA,NA,Feature0885,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,117632.32954138423,116764.33200560666,0.9926210971153794,-0.010684976963710818,0.9758033762150999,0.987461720016953,Downregulated
Feature0884,leu-phe,C15 H22 N2 O3,278.16308,NA,NA,leu-phe-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,5816629.453276383,5593226.563350776,0.9615923806527218,-0.05650263024226048,0.8121104347451112,0.9118080082836999,Downregulated
Feature0883,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",C12 H12 N2 O2,216.0899,NA,NA,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",12,12,2,2,0,0,1,0.16666666666666666,-0.16666666666666696,65.05000000000001,8,6,0.5,0.5555555555555556,4,Lignin,16913550.032075666,13099872.972054001,0.7745194206544915,-0.3686266806231271,0.005265586154609804,0.32409559267895377,Downregulated
Feature0882,NA,C11 H17 N5 O,235.1433,NA,NA,Feature0882,11,17,1,5,0,0,1.5454545454545454,0.09090909090909093,0,60.3,6,5,0,0.09090909090909093,0,Lipid,15316223.210478533,14567767.4079489,0.951133135614165,-0.07228079728540077,0.18135700170872276,0.7429210442740862,Downregulated
Feature0881,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,2267621.6952990834,3060031.3768379036,1.3494452726314683,0.43236646883574936,0.4325612090712891,0.7437859477801351,Upregulated
Feature0880,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,6856646.0167852165,6086470.104249854,0.8876745407813156,-0.1718972746933526,0.5691603834732935,0.788874618409681,Downregulated
Feature0879,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,128838.19780637167,140173.89232475634,1.0879839574861243,0.12165728395420317,0.5654611862152477,0.7872059339187256,Upregulated
Feature0878,NA,C12 H21 N O8,307.12682,NA,NA,Feature0878,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,17595499.255708102,16881899.572946668,0.959444192381757,-0.059729202709158755,0.6909754067920866,0.8507102856872568,Downregulated
Feature0877,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak3,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,137827.80174374167,206914.209016937,1.501251608159907,0.5861657913651009,0.38344430460100054,0.7429210442740862,Upregulated
Feature0876,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak2,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,146228.19937160332,233659.693080704,1.597911306333704,0.6761873322560814,0.19319627490066987,0.7429210442740862,Upregulated
Feature0875,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,517747.7673565927,660885.7067651,1.2764626878823848,0.35215136712710005,0.20243142044442183,0.7429210442740862,Upregulated
Feature0874,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak1,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,1549074.56735281,1640963.4179374434,1.0593185457441605,0.08313648476092865,0.35917140640129436,0.7429210442740862,Upregulated
Feature0873,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,376437.879210815,426698.113342351,1.1335153471720336,0.18080392450533622,0.5283407499857042,0.7697066387459335,Upregulated
Feature0872,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,10207196.29629436,12496821.525998967,1.2243148033251636,0.2919745603199394,0.017602241183273602,0.5626074823484053,Upregulated
Feature0871,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak6,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,15645292.307191866,11945076.694931766,0.7634933538084696,-0.3893124964366764,0.019861746776310817,0.5702677803232292,Downregulated
Feature0870,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,227341.27938906968,272628.160279305,1.1992021906973251,0.262074923909818,0.44885964780998505,0.7437859477801351,Upregulated
Feature0869,NA,C12 H21 N O8,307.12679,NA,NA,Feature0869,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,4026566.4613919966,5083115.5751577765,1.262394554739456,0.3361628875019321,0.41978026017579273,0.7429771053580235,Upregulated
Feature0868,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0868,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,675053.1314580938,863591.9425018156,1.2792947728965924,0.3553487258283448,0.372031519113298,0.7429210442740862,Upregulated
Feature0867,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,734595.183627009,689172.396946499,0.9381662340117201,-0.09208451784421261,0.28186442555070584,0.7429210442740862,Downregulated
Feature0866,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0866,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,3710369.37561167,3392108.81549721,0.914224022490485,-0.12938036665580976,0.20197909317817267,0.7429210442740862,Downregulated
Feature0865,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak2",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,8931162.464151204,8816384.126842264,0.9871485556589471,-0.01866088316907488,0.9718800955903978,0.9858529643366621,Downregulated
Feature0864,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1258448.22611067,1638903.4152985567,1.3023208911531565,0.38108497157233734,0.08191763239457091,0.6481296779476766,Upregulated
Feature0863,Pro-Hyp,C10 H16 N2 O4,228.111,NA,NA,Pro-Hyp-peak2,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,15168800.595524266,14663867.986443799,0.9667124235762283,-0.04884131251108422,0.5108739393979539,0.7678958865079032,Downregulated
Feature0862,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,628124.7945336823,927182.593373666,1.4761120742925031,0.561802262650141,0.3099101914103094,0.7429210442740862,Upregulated
Feature0861,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,14169730.6454902,11699191.254859226,0.8256466934735085,-0.2764035319050489,0.17374507569782316,0.7429210442740862,Downregulated
Feature0860,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,145720.64831899633,180344.25204771198,1.2376025918641351,0.30754812328421693,0.3843689056942538,0.7429210442740862,Upregulated
Feature0859,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,19749157.585796632,16486016.717302933,0.834770629870283,-0.26054825251836816,0.21232209693664392,0.7429210442740862,Downregulated
Feature0858,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,11807986.6804454,10077623.60837912,0.8534582466177876,-0.2286075202763158,0.20250778647096518,0.7429210442740862,Downregulated
Feature0857,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,422150.8133932457,596413.109125541,1.4127963045518641,0.4985534744497583,0.0666809305664565,0.6384005117332444,Upregulated
Feature0856,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0856,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1108358.039248195,1293768.4230405968,1.1672838353914647,0.2231554077653596,0.44172932084569183,0.7437859477801351,Upregulated
Feature0855,NA,C11 H24 N4 O5,292.17471,NA,NA,Feature0855,11,24,5,4,0,0,2.1818181818181817,0.4545454545454546,-0.18181818181818168,65.48181818181817,2,-3,-3.5,-1,-7,Protein,19847123.348844767,14670558.502408901,0.7391780785835054,-0.43600612274894657,0.004011295258848652,0.319665224680575,Downregulated
Feature0854,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,7123493.190462747,7948698.218154376,1.1158427481613167,0.1581337274960987,0.7061021503226312,0.854994312113322,Upregulated
Feature0853,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10734,NA,NA,N(6)-OH-Me-Adenosine-peak2,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,7754373.693738086,6046279.066819937,0.7797250049610722,-0.3589626939011816,0.07459898970181889,0.6384005117332444,Downregulated
Feature0852,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2594045.2875865432,1985686.1626349867,0.7654786029130726,-0.38556604361904123,0.2723092198190881,0.7429210442740862,Downregulated
Feature0851,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0851,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,397537.19742485665,385870.0190628837,0.9706513542945165,-0.042974904035108445,0.8460101714826086,0.926990104955748,Downregulated
Feature0850,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak1,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,1019256.4658856824,1173242.2149468174,1.1510765486558177,0.20298377846922697,0.606378357247814,0.8132671428028913,Upregulated
Feature0849,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,270734.54832788033,203968.84216120065,0.7533905200535349,-0.40853021498379266,0.5226191562629552,0.7682508165605624,Downregulated
Feature0848,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3610060.3989241733,2737549.7094947933,0.7583113319407634,-0.39913781267630305,0.09941478707696332,0.7043924180722835,Downregulated
Feature0847,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,460376.4036594423,557026.5394215747,1.209937205716625,0.2749321753081225,0.41288918642171935,0.7429210442740862,Upregulated
Feature0846,Leucylasparagine,C10 H19 N3 O4,245.13754,NA,NA,Leucylasparagine-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,14887717.4503827,10885501.436164284,0.7311732958691034,-0.4517147140711592,0.15668929401238524,0.7429210442740862,Downregulated
Feature0845,NA,C17 H29 N O14,471.15895,NA,NA,Feature0845,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,11547284.7248684,16454886.319511866,1.425000483799831,0.5109624090847465,0.034361630224443086,0.6051275072806717,Upregulated
Feature0844,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,7544227.736011737,2497814.4620888764,0.3310894831774191,-1.594706909609272,0.07838683969333815,0.6384005117332444,Downregulated
Feature0843,NA,C13 H19 N O6,285.1213,NA,NA,Feature0843,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,427210.7672003027,502447.89726434665,1.176112438731602,0.23402599133601812,0.36265663599882,0.7429210442740862,Upregulated
Feature0842,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,771351.1667775727,953546.7553090301,1.2362031670900362,0.3059158662731361,0.3931664180410284,0.7429210442740862,Upregulated
Feature0841,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,593619.51275139,795362.3352350217,1.3398520738453594,0.42207372895904677,0.1975291775345107,0.7429210442740862,Upregulated
Feature0840,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,1551960.8938368899,1480411.6504511333,0.9538975217288713,-0.06809381066374791,0.7029064461887344,0.8535652471997965,Downregulated
Feature0839,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,1312578.4772315514,1312305.7919815683,0.9997922522312279,-2.997478128110659e-4,0.9994933828021753,0.9994933828021753,Downregulated
Feature0838,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,7143062.24373595,8534533.816545133,1.1948004266698673,0.2567696579558437,0.5906217521489023,0.8023362054051648,Upregulated
Feature0837,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12237,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,9691861.007821437,8840743.828191813,0.9121822755255401,-0.13260595720631577,0.17616803418691762,0.7429210442740862,Downregulated
Feature0836,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak1,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,288358.3943698392,594227.508708099,2.0607255426244393,1.0431523725815337,0.08360200634554404,0.6481296779476766,Upregulated
Feature0835,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak3,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,13319707.184519736,13370791.257281724,1.0038352249080489,0.0055224767415630064,0.9887736878726765,0.9934991365181108,Upregulated
Feature0834,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,620056.3685812376,721730.6990054863,1.1639759473108737,0.21906124634426213,0.6182816211986132,0.8163437773269296,Upregulated
Feature0833,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0833,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,751855.1463916617,688828.3849256013,0.9161716698109451,-0.12631014287533718,0.8350982242235423,0.9174806109836959,Downregulated
Feature0832,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,394681.38511184836,545407.812756494,1.3818939360464935,0.46664688937895504,0.24075985341202655,0.7429210442740862,Upregulated
Feature0831,NA,C6 H11 N O7,209.05351,NA,NA,Feature0831,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,3640533.85436921,3896548.84735366,1.070323475409298,0.09804687685238697,0.3725743491472858,0.7429210442740862,Upregulated
Feature0830,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0830,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,141274.94417517,195055.684652871,1.3806813783696634,0.465380425402125,0.00415475381446026,0.319665224680575,Upregulated
Feature0829,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0829,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,6961672.7481123265,16464062.6408766,2.3649578537487086,1.2418144733196275,0.013089664730119724,0.49964037324760396,Upregulated
Feature0828,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0828,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,527939.2123716873,500222.06820799864,0.9474993644833208,-0.07780311926280863,0.7931266325315363,0.9071954865012981,Downregulated
Feature0827,N-glycoloyl-beta-D-glucosamine,C8 H15 N O7,237.08484,NA,NA,N-glycoloyl-beta-D-glucosamine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,13239622.955455134,13337677.5912521,1.0074061501695986,0.010645443724476745,0.9421736036467792,0.9726033422167238,Upregulated
Feature0826,Pro-Hyp,C10 H16 N2 O4,228.11102,NA,NA,Pro-Hyp-peak1,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,16747549.226308366,16862242.8206126,1.0068483807842201,0.009846447237739843,0.7804400867615137,0.9027817218351678,Upregulated
Feature0825,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak3,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,8493905.011731606,7347707.518487924,0.8650564738291071,-0.20913377502393268,0.38428603549809764,0.7429210442740862,Downregulated
Feature0824,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,1888861.050030939,1892557.537448722,1.0019569927696494,0.0028205847311809965,0.9982593570430658,0.9992803341529211,Upregulated
Feature0823,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,413270.2945693733,498365.7606541844,1.2059075312283947,0.27011928588409406,0.4316357790210426,0.7437859477801351,Upregulated
Feature0822,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,5888740.00562857,4170642.493658067,0.708240216017635,-0.4976893282526939,0.4966233215390818,0.7638837682405117,Downregulated
Feature0821,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak3,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,11882340.416742066,9375557.550983563,0.7890329027919047,-0.3418426327918823,0.07548194829737352,0.6384005117332444,Downregulated
Feature0820,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9195411.71929739,8403786.29764492,0.9139108235913816,-0.12987469616759323,0.6475288223817517,0.8331143341897993,Downregulated
Feature0819,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1688874.4089673066,2117090.803534043,1.2535513548509372,0.32602110097530157,0.3369160972233629,0.7429210442740862,Upregulated
Feature0818,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1319856.6973631165,1320042.4253714134,1.000140718313335,2.0299933028402673e-4,0.9986904402130432,0.9992803341529211,Upregulated
Feature0817,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,1527223.7629298833,2186993.22593649,1.432005760400742,0.5180372960133907,0.07475270931593452,0.6384005117332444,Upregulated
Feature0816,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,144123.58338597734,140583.15316392967,0.9754347613425206,-0.03588270860865426,0.7615569730556376,0.8878716533766347,Downregulated
Feature0815,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0815,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,848426.334597362,999914.903647867,1.1785524127117024,0.23701591970631206,0.5087798339979526,0.7678958865079032,Upregulated
Feature0814,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0814,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,188198.571901023,301664.215780648,1.6029038516790584,0.6806878897058177,0.41071552066152367,0.7429210442740862,Upregulated
Feature0813,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,135587.25413649884,104333.64538529016,0.7694944930461904,-0.3780170930686142,0.45768031664227676,0.7483691664015606,Downregulated
Feature0812,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,316172.05434452265,341536.4022067627,1.0802232440018287,0.11132949732531212,0.8157153028164892,0.9125694928365151,Upregulated
Feature0811,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,3940584.516266763,3580860.3554803133,0.9087129944043819,-0.13810338565026245,0.5414207720084853,0.7721846506499914,Downregulated
Feature0810,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak1",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,244292.00085744567,322859.08344667696,1.3216113598213082,0.4022979925112129,0.49639962259655646,0.7638837682405117,Upregulated
Feature0809,MFCD02728197,C14 H20 N2 O4,280.14233,NA,NA,MFCD02728197-peak1,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,16568748.438265067,12933519.925812814,0.7805972777004211,-0.35734966343889996,0.18847682212783332,0.7429210442740862,Downregulated
Feature0808,NA,C11 H23 N O11,345.1272,NA,NA,Feature0808,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,4708244.24116994,4524071.600414487,0.9608829467373408,-0.05756740004547757,0.8246671067832204,0.9143744565996981,Downregulated
Feature0807,NA,C11 H19 N3 O5,273.13241,Biosynthesis of secondary metabolites;Other,NA,Feature0807,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,16272716.9633987,14245423.761380333,0.8754176572616458,-0.191956611313757,0.35575560216297863,0.7429210442740862,Downregulated
Feature0806,NA,C10 H15 N O5,229.09493,NA,NA,Feature0806,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,4214569.928083474,3869830.53563598,0.9182029487397163,-0.12311502972301812,0.48097054724641886,0.7593501989503708,Downregulated
Feature0805,Methohexital,C14 H18 N2 O3,262.13173,NA,NA,Methohexital,14,18,3,2,0,0,1.2857142857142858,0.21428571428571427,-0.4285714285714288,72.51428571428572,7,4,0.2222222222222222,0.3333333333333333,2,Lignin,12715553.53281416,11666231.240265746,0.9174772620129749,-0.12425569103245011,0.7401925817645726,0.8707543288258236,Downregulated
Feature0804,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0804,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,13738415.9066844,13685251.6470585,0.9961302482042319,-0.005593701838095742,0.9784431327272389,0.989541890650712,Downregulated
Feature0803,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,5263766.23761183,1381008.2331315496,0.262361239232788,-1.9303735003017581,0.04926215384261105,0.6384005117332444,Downregulated
Feature0802,2-Aminooctanedioic acid,C8 H15 N O4,189.10014,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,9879475.642745785,9274615.620438144,0.9387761006575512,-0.09114698065912567,0.3919214214858676,0.7429210442740862,Downregulated
Feature0801,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1130920.519700094,2121272.79321968,1.8757045754039507,0.9074326204109168,0.14402710993696688,0.7409363968247682,Upregulated
Feature0800,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,266889.14890418865,309425.7318122083,1.159379214489121,0.21335252612072172,0.47528685340034976,0.7581317605086558,Upregulated
Feature0799,NA,C12 H23 N3 O2,241.17901,NA,NA,Feature0799,12,23,2,3,0,0,1.9166666666666667,0.16666666666666666,-0.833333333333333,84.04999999999998,3,1,-0.2857142857142857,-0.125,-2,Lipid,15712001.882195566,13299462.083745934,0.8464524242971573,-0.24049911260157097,0.03680230799164664,0.6051284343194661,Downregulated
Feature0798,b-Ala-Lys,C9 H19 N3 O3,217.14263,Metabolic pathways;Other,Other,b-Ala-Lys,9,19,3,3,0,0,2.111111111111111,0.3333333333333333,-0.44444444444444464,72.96666666666667,2,-1,-1.3333333333333333,-0.5555555555555556,-4,Protein,8776998.24469664,4765625.275828494,0.5429675548480423,-0.8810621028583289,0.10624176719346223,0.7055599272098991,Downregulated
Feature0797,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,118007.574410157,675943.395250693,5.727966180385401,2.5180229745270464,0.4250083904317098,0.7437646832554922,Upregulated
Feature0796,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8065329.797491977,8265856.322326854,1.0248627805520405,0.035430759419140895,0.8182635952353117,0.9125694928365151,Upregulated
Feature0795,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,5990097.28471414,6087183.85685679,1.016207845637232,0.02319550762479713,0.8829609315804638,0.9413063675879836,Upregulated
Feature0794,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,249020.179590991,202357.744346704,0.8126158477560783,-0.29935459438905,0.62388886011771,0.8195540183230478,Downregulated
Feature0793,Aspartame,C14 H18 N2 O5,294.1216,Other,NA,Aspartame-peak2,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,5568562.7047457965,5259886.700526333,0.9445681012164244,-0.08227327948562459,0.5229003491702057,0.7682508165605624,Downregulated
Feature0792,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate-peak1,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,6224045.16225621,5508061.009718883,0.8849648204869736,-0.17630798920331456,0.32841033067703157,0.7429210442740862,Downregulated
Feature0791,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,2907172.658277257,3261463.4941522432,1.121867834325648,0.1659027240803196,0.24727538895957504,0.7429210442740862,Upregulated
Feature0790,delta-guanidinovaleric acid,C6 H13 N3 O2,159.1008,NA,NA,delta-guanidinovaleric acid-peak2,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,8179933.2220895495,7260925.605930693,0.8876509634972183,-0.17193559423617988,0.11052900958786754,0.7055599272098991,Downregulated
Feature0789,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,237878.66807195733,290405.1559080427,1.2208120982928838,0.28784116451694614,0.35967700728882923,0.7429210442740862,Upregulated
Feature0788,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,667815.2949709613,822366.9110301437,1.231428685780404,0.300333081227036,0.4997519381497376,0.7643022379378415,Upregulated
Feature0787,Fluoranthene,C16 H10,202.0783,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,12596037.8957585,9690774.933451694,0.7693510462297748,-0.3782860609487446,0.06568442617271898,0.6384005117332444,Downregulated
Feature0786,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0786,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,1362350.3149196834,1312007.5428947967,0.9630471168292315,-0.054321711613007057,0.6924435372712492,0.8507102856872568,Downregulated
Feature0785,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0785,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,7432170.12945503,6504676.36911286,0.8752055262208888,-0.1923062472661472,0.3622964722247608,0.7429210442740862,Downregulated
Feature0784,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,5048996.16381467,5449587.852669913,1.0793408582336066,0.11015054307108071,0.7298122823122863,0.8678071861534502,Upregulated
Feature0783,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0783,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,363090.301643829,442307.43446454237,1.2181747418261282,0.2847210963672883,0.4126401142775687,0.7429210442740862,Upregulated
Feature0782,NA,C13 H24 N2 O8,336.15338,NA,NA,Feature0782,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,14290716.1047891,12251408.586086467,0.85729843740866,-0.22213058107482642,0.15331021257263494,0.7429210442740862,Downregulated
Feature0781,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,186672.52233405167,198147.08324836133,1.0614689337822085,0.0860621482247274,0.5901659977147251,0.8023362054051648,Upregulated
Feature0780,NA,C11 H19 N O5,245.12631,NA,NA,Feature0780,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,238279.76759707602,293459.68920109,1.2315761936503211,0.300505885491009,0.5629886474608324,0.786883472606147,Upregulated
Feature0779,7-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,7-Methylguanine-peak2,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,5698850.99509457,5459091.62318222,0.957928471525448,-0.062010160875969236,0.6654510696347598,0.8393995881059486,Downregulated
Feature0778,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak5,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,6493456.854518686,5289909.895346221,0.8146523514151114,-0.2957435666985755,0.4051405943028945,0.7429210442740862,Downregulated
Feature0777,Alanyltyrosine,C12 H16 N2 O4,252.11102,NA,NA,Alanyltyrosine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,15513321.667950934,11795613.182552114,0.7603538065558676,-0.3952572076629944,0.17003141081072481,0.7429210442740862,Downregulated
Feature0776,asn-leu,C10 H19 N3 O4,245.13754,NA,NA,asn-leu-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,5075547.370320253,3927034.566003707,0.7737164643497203,-0.37012312078967496,0.1892786593414123,0.7429210442740862,Downregulated
Feature0775,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,251834.62656277834,323301.27929583297,1.283784059835152,0.36040255292393897,0.3141473586792164,0.7429210442740862,Upregulated
Feature0774,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0774,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,5607009.455736933,4919169.467874804,0.8773249816516091,-0.1888167452959762,0.28853374326217385,0.7429210442740862,Downregulated
Feature0773,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak2,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,7121378.687131736,6134534.7020784365,0.8614251497625709,-0.2152026504484333,0.26091937510000496,0.7429210442740862,Downregulated
Feature0772,Betaine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak1,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,5949593.332679656,6204233.994418413,1.0427996751206638,0.060462038521319705,0.7013790881695704,0.8535652471997965,Upregulated
Feature0771,"3-(2,6-Dioxocyclohexyl)propanenitrile",C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,"3-(2,6-Dioxocyclohexyl)propanenitrile",9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,6346389.206189097,5089545.188345783,0.8019591964801623,-0.31839926036834704,0.08298091195725092,0.6481296779476766,Downregulated
Feature0770,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0770,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,390874.02097544464,9380232.123201638,23.998095600707423,4.584848018370041,0.42173319838754025,0.7429771053580235,Upregulated
Feature0769,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0769,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,1034710.68418197,1523871.3123271833,1.4727511135462354,0.5585136438218069,0.019319897517079247,0.5702677803232292,Upregulated
Feature0768,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,3458676.4284156733,2973561.1446475135,0.8597396160616337,-0.2180283089062819,0.5289764740266977,0.7697066387459335,Downregulated
Feature0767,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,395964.64210420265,367044.0426660997,0.9269616618180464,-0.10941842318731583,0.81381973380798045,0.9118080082836999,Downregulated
Feature0766,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak1,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,10187573.99145065,9692023.521245627,0.9513573623493791,-0.07194072641432712,0.45180386084165225,0.7437859477801351,Downregulated
Feature0765,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0765,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,11658090.194225667,13434218.40573992,1.1523515586106876,0.2045809203301226,0.6080142384329438,0.8132671428028913,Upregulated
Feature0764,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,1283262.8926286334,1463841.3201560967,1.1407181868693848,0.18994241947651663,0.5685792146514632,0.788874618409681,Upregulated
Feature0763,Prolylleucine,C11 H20 N2 O3,228.14738,NA,NA,Prolylleucine-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,13971797.2592745,12801007.6224803,0.9162033620250947,-0.12626023802573103,0.15185559598016252,0.7429210442740862,Downregulated
Feature0762,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak2,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,12937481.5956168,10742020.963490054,0.8303023184303068,-0.2682913682019939,0.2107202841675406,0.7429210442740862,Downregulated
Feature0761,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak1,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,12937481.5956168,10742020.963490054,0.8303023184303068,-0.2682913682019939,0.2107202841675406,0.7429210442740862,Downregulated
Feature0760,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0760,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5307036.59383723,6355374.5198489195,1.1975373464032766,0.26007064855490086,0.17180137974293178,0.7429210442740862,Upregulated
Feature0759,MFCD15144952,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,MFCD15144952,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,13360555.872013234,11662220.4182822,0.8728843717282311,-0.19613753769083675,0.0637350145481772,0.6384005117332444,Downregulated
Feature0758,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,2015074.9530758767,1801006.0441669,0.8937662797196626,-0.16203047955577438,0.08358351525512034,0.6481296779476766,Downregulated
Feature0757,NA,C6 H14 O4,150.08923,NA,NA,Feature0757,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,7737107.940510483,10612703.467878336,1.3716628421727983,0.45592590738428923,0.20130581624411323,0.7429210442740862,Upregulated
Feature0756,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0756,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,3998649.657269203,3334371.3350172234,0.8338743377919147,-0.2620981043874807,0.40878669423959574,0.7429210442740862,Downregulated
Feature0755,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,344847.619075978,374449.58331169136,1.0858407093400617,0.11881247818785066,0.8470960345168227,0.926990104955748,Upregulated
Feature0754,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0754,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,4323384.254987639,3850227.154043887,0.8905586288339051,-0.16721750237726707,0.29992721434650377,0.7429210442740862,Downregulated
Feature0753,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak1,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,13292327.655794067,15237939.469797166,1.1463710393232005,0.19707406848750844,0.19911491733952785,0.7429210442740862,Upregulated
Feature0752,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak5,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,219420.280883486,520898.0428454773,2.3739740043541304,1.2473041371724405,0.06980353082682644,0.6384005117332444,Upregulated
Feature0751,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,230129.282056429,261120.211714234,1.1346674763892317,0.18226956584059745,0.8087562658733743,0.9118080082836999,Upregulated
Feature0750,NA,C12 H19 N O9,321.10608,NA,NA,Feature0750,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,592829.8503034323,4691284.80491465,7.913374811530621,2.9842930910962413,0.23510623541103726,0.7429210442740862,Upregulated
Feature0749,NA,C6 H15 N O4,165.10013,NA,NA,Feature0749,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,221334.98254172134,264433.9764419653,1.19472291910349,0.2566760662511376,0.3204478780765958,0.7429210442740862,Upregulated
Feature0748,NA,C18 H29 N O12,451.16875,NA,NA,Feature0748,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,14809626.084511533,13578952.640534334,0.9169004377994199,-0.12516300849479642,0.16964988627068747,0.7429210442740862,Downregulated
Feature0747,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,4763978.793027233,4164657.1556881103,0.8741972491111177,-0.1939692565715966,0.5585675436709667,0.7845882412758023,Downregulated
Feature0746,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0746,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,13526355.025617467,13438274.6627517,0.9934882410894176,-0.00942520302628608,0.9554750956381433,0.9821449102008585,Downregulated
Feature0745,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0745,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,2559678.2454905766,2471525.87479279,0.9655611517372991,-0.05056046283275475,0.8104426301451613,0.9118080082836999,Downregulated
Feature0744,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,4215608.657805187,3394116.0101878536,0.8051307143758845,-0.3127050685882975,0.008064206108737669,0.35027602944106695,Downregulated
Feature0743,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0743,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,1409256.72205047,1500959.9464588165,1.0650720503748374,0.09095102970226893,0.7258348733343083,0.8676401028009545,Upregulated
Feature0742,Gly-Phe,C11 H14 N2 O3,222.1005,NA,NA,Gly-Phe-peak1,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,4722551.59566875,4554669.2569578905,0.9644509254563082,-0.0522202639764359,0.7710535740324523,0.8949169636962143,Downregulated
Feature0741,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0741,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,2900026.3732146933,3181209.2967861234,1.0969587470543372,0.13350927183116632,0.5396553247019598,0.7721846506499914,Upregulated
Feature0740,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0740,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,88806.42815643956,102676.23781541856,1.1561802444587257,0.20936632648582956,0.4320591072377546,0.7437859477801351,Upregulated
Feature0739,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,532876.38375788,303357.2481859633,0.5692825905450485,-0.8127831141085377,0.05495044337693514,0.6384005117332444,Downregulated
Feature0738,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1088613.9920393624,1206225.99167873,1.108038295024151,0.14800774337871295,0.6082700530881129,0.8132671428028913,Upregulated
Feature0737,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak1,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,367642.741042706,475959.197488338,1.2946242217061747,0.3725334012683267,0.3359260017372482,0.7429210442740862,Upregulated
Feature0736,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15866,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak2",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,16316784.775333434,3988285.4177812003,0.2444283890911161,-2.0325162384442375,0.0012964864955809087,0.19965892031945995,Downregulated
Feature0735,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,327513.6054420683,362123.1763616517,1.1056736891063452,0.14492567438945725,0.7637116654556204,0.8891598359325231,Upregulated
Feature0734,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,12135220.135474399,9753862.912676742,0.803764810509178,-0.31515467849494677,0.036867554942187915,0.6051284343194661,Downregulated
Feature0733,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,788118.382282803,765228.7188228937,0.9709565669644593,-0.04252133274077183,0.9468809324078318,0.9762728542293773,Downregulated
Feature0732,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,575408.490229344,708485.9057099951,1.231274681796248,0.3001526447299461,0.3860499037254246,0.7429210442740862,Upregulated
Feature0731,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0731,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,1519001.2896522866,2146146.4061606866,1.4128667439459248,0.49862540274607065,0.21181327565780225,0.7429210442740862,Upregulated
Feature0730,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0730,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1363773.5848972367,1425832.6769170468,1.0455054216528812,0.06420054329664043,0.5706069185535784,0.7897125163641844,Upregulated
Feature0729,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak3,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1879737.2936603334,2139575.6607526634,1.1382312134619395,0.18679364783155608,0.3310181693345724,0.7429210442740862,Upregulated
Feature0728,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0728,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,1497159.8180558432,1356086.414615058,0.9057726491591406,-0.14277911866805013,0.5965618018343887,0.8052395954641071,Downregulated
Feature0727,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,2760096.522342183,2251298.5619347235,0.8156593596314885,-0.2939613235424733,0.18998101660539266,0.7429210442740862,Downregulated
Feature0726,NA,C16 H23 N5 O10,445.14456,NA,NA,Feature0726,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,14753642.788381567,13775425.134428333,0.9336965339350919,-0.09897436735779881,0.2053363828434168,0.7429210442740862,Downregulated
Feature0725,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1108413.449350507,1340240.5177731,1.2091521611889822,0.2739958065222806,0.35047780621201324,0.7429210442740862,Upregulated
Feature0724,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,249556.22412008425,384041.0367548747,1.538895846452932,0.6218955923609619,0.2855933404095611,0.7429210442740862,Upregulated
Feature0723,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine-peak1,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,1945356.30693147,2270241.58538938,1.167005538934084,0.22281140849493644,0.5727498864781995,0.7920312715869958,Upregulated
Feature0722,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak1,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,6529655.869783464,6085736.910452686,0.9320149532864281,-0.10157499316326321,0.1823479879478571,0.7429210442740862,Downregulated
Feature0721,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0721,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,6395077.580498217,5428384.29466211,0.848837911085858,-0.23643900306192311,0.8206229642805316,0.9125694928365151,Downregulated
Feature0720,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,1722831.98244956,2384754.72893941,1.3842062100267687,0.4690588822970576,0.38401926064265807,0.7429210442740862,Upregulated
Feature0719,N2-Dimethylguanosine,C12 H17 N5 O5,311.12308,NA,NA,N2-Dimethylguanosine,12,17,5,5,0,0,1.4166666666666667,0.4166666666666667,0.6666666666666665,41.3,7,2,-1.5,-0.1111111111111111,-3,Lignin,10265384.668629413,12743445.7664364,1.2413997310183453,0.31196773843421244,0.11942873116492633,0.7127267469124424,Upregulated
Feature0718,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1749717.6912681235,2249559.735927757,1.285670109614865,0.36252050870233027,0.1478445289593413,0.7419901680471508,Upregulated
Feature0717,NA,C33 H47 N O8,585.33043,NA,NA,Feature0717,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,160910.53577488667,195096.90202843898,1.2124557356603358,0.27793207834388317,0.43529507643751636,0.7437859477801351,Upregulated
Feature0716,perlolyrine,C16 H12 N2 O2,264.0899,Other,NA,perlolyrine,16,12,2,2,0,0,0.75,0.125,-0.125,63.8625,12,10,0.6666666666666666,0.6923076923076923,8,Condensed HC,11788197.846923899,7506598.202777637,0.6367892955526248,-0.6511120105493681,2.854608106565204e-4,0.12089265331303639,Downregulated
Feature0715,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",C16 H13 N S,251.07697,NA,NA,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",16,13,0,1,1,0,0.8125,0,-0.5,74.55,11,11,0.6428571428571429,0.6428571428571429,9,Unsaturated HC,12587189.6006615,12272139.3335118,0.974970563156279,-0.036569434004153724,0.500263978763007,0.7643022379378415,Downregulated
Feature0714,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,807633.724879137,866702.8089518656,1.0731384565219442,0.10183622488391085,0.702696108996149,0.8535652471997965,Upregulated
Feature0713,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak1,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,1308886.5539313667,1437372.6316304433,1.098164411050871,0.135094062768536,0.6841022641235996,0.8477463316937658,Upregulated
Feature0712,threonylphenylalanine,C13 H18 N2 O4,266.12668,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,13115434.201613734,10754349.160444617,0.8199766012414132,-0.286345353150078,0.2242793572991634,0.7429210442740862,Downregulated
Feature0711,NA,C29 H28 O9,520.17351,NA,NA,Feature0711,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,526833.6310843267,846911.5889629143,1.6075503517491938,0.6848639264062236,0.006247709420723181,0.3282861036703624,Upregulated
Feature0710,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,3925952.1162421033,2951711.92189749,0.7518461342628014,-0.4114906511344135,0.21741553925981993,0.7429210442740862,Downregulated
Feature0709,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak4,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,7884226.36529532,8179367.790800597,1.0374344180177812,0.05302013858870097,0.9378954993988886,0.9699603027971413,Upregulated
Feature0708,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,277308.69920341665,304627.2291975957,1.098513065304669,0.13555202873994263,0.6264624891211119,0.8220197184904443,Upregulated
Feature0707,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak2,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6793164.989146307,5518521.27525177,0.8123637927341553,-0.2998021551141385,0.1836840642338345,0.7429210442740862,Downregulated
Feature0706,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0706,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,7207177.2490772065,9595172.826710079,1.3313357636567946,0.4128744656704478,0.38394609669581775,0.7429210442740862,Upregulated
Feature0705,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,244953.25526139865,247139.10517609667,1.0089235389518112,0.012816844261072815,0.9718970624497643,0.9858529643366621,Upregulated
Feature0704,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12667,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak1,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,8042503.879078797,6592679.61836978,0.8197297405748863,-0.28677975369241554,0.15283726208551215,0.7429210442740862,Downregulated
Feature0703,NA,C12 H17 N3 O5,283.11687,NA,NA,Feature0703,12,17,5,3,0,0,1.4166666666666667,0.4166666666666667,0.16666666666666652,55.55,6,1,-0.5,0.07692307692307693,-2,Lignin,10324160.128191989,9470436.28794709,0.9173081558553464,-0.12452162797887363,0.29363271166667176,0.7429210442740862,Downregulated
Feature0702,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3182077.0966020334,2522013.0584357833,0.7925681816851338,-0.3353930446221979,0.3102922449596584,0.7429210442740862,Downregulated
Feature0701,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0701,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,101693.58828773876,103781.03255593144,1.0205268031479655,0.029314073856028237,0.8393635113114493,0.9209078938870433,Upregulated
Feature0700,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0700,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,194803.06564472066,227777.0309909713,1.1692682054931731,0.22560589167773823,0.49669825590398714,0.7638837682405117,Upregulated
Feature0699,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12154,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak2",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,8334770.71329554,7735217.15333594,0.9280659803870551,-0.10770071820542822,0.5975051162732081,0.8058707539544703,Downregulated
Feature0698,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak1",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,14423693.4333083,11716880.4351542,0.8123356537859214,-0.29985212856758403,0.003288114891996577,0.28281512298137695,Downregulated
Feature0697,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,10083088.128052266,9397621.99226666,0.9320182341877422,-0.10156991456263821,0.28741179285369156,0.7429210442740862,Downregulated
Feature0696,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak3",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,732344.4725159816,470446.56580717635,0.6423842651408965,-0.6384915396429925,0.48966269846608546,0.7626394464118028,Downregulated
Feature0695,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak1,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,148061.38991758766,277723.719563517,1.8757335705014022,0.9074549217693171,0.27266638496132345,0.7429210442740862,Upregulated
Feature0694,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,747792.9017263303,493880.22597054497,0.6604505402904858,-0.5984775696747512,0.3829531911898928,0.7429210442740862,Downregulated
Feature0693,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,393497.82285316003,1527969.5668640267,3.8830445255963024,1.9571882502514601,0.04243007192976106,0.6234855173864765,Upregulated
Feature0692,NA,C10 H23 N O6,253.1525,NA,NA,Feature0692,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,974068.9823968967,777998.09032855,0.7987094388470578,-0.32425733187628347,0.1947215228408359,0.7429210442740862,Downregulated
Feature0691,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,174624.43293507467,205322.19992379466,1.1757930804570367,0.2336341927726363,0.647580332386259,0.8331143341897993,Upregulated
Feature0690,1581740,C12 H13 N O4,235.08444,NA,NA,1581740-peak2,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,8613070.441496722,5850188.17670675,0.6792221445817112,-0.5580445992510994,0.02279396526149649,0.5785251858234263,Downregulated
Feature0689,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak2,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,738025.250083993,867436.2890513957,1.175347711955214,0.23308762326160876,0.3421293787143366,0.7429210442740862,Upregulated
Feature0688,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0688,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,1716487.8607485523,1816353.8328255066,1.0581804126674121,0.0815856182565616,0.8190170092420821,0.9125694928365151,Upregulated
Feature0687,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0687,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,2953972.7421137,2561037.2086313,0.8669806502001649,-0.20592830002362403,0.5415173312498425,0.7721846506499914,Downregulated
Feature0686,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,478228.04789553967,517438.561871585,1.0819912469554906,0.11368882816196962,0.6684474878128245,0.8393995881059486,Upregulated
Feature0685,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,3567817.1782902167,3414112.076618537,0.9569190084607029,-0.06353127157288249,0.41484144883790636,0.7429771053580235,Downregulated
Feature0684,dihydroxyphenylalanine,C9 H11 N O4,197.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,dihydroxyphenylalanine,9,11,4,1,0,0,1.2222222222222223,0.4444444444444444,0,60.3,5,1,0,0.3333333333333333,0,Lignin,11514257.6636492,10100986.176848324,0.8772590011371199,-0.18892524937674698,0.19055884750111463,0.7429210442740862,Downregulated
Feature0683,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,240138.205588643,298951.127145998,1.2449128051622973,0.31604469814455277,0.48992594610203,0.7626394464118028,Upregulated
Feature0682,NA,C18 H29 N O12,451.16881,NA,NA,Feature0682,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,179519.619457253,248026.30139356368,1.3816111138349612,0.4663515932270823,0.5173946608375295,0.7682508165605624,Upregulated
Feature0681,leu-lys,C12 H25 N3 O3,259.18959,NA,NA,leu-lys,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,4028501.1033459166,4277014.527126033,1.0616888061849383,0.08636095675902453,0.8283590399443616,0.9146541535125908,Upregulated
Feature0680,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,4273536.30311751,4583953.362189027,1.0726370474131857,0.10116198804366165,0.6144624178638904,0.8152864262097903,Upregulated
Feature0679,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0679,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2205438.322139817,2442863.95613515,1.1076546243038763,0.1475081074894808,0.2366426834057963,0.7429210442740862,Upregulated
Feature0678,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine-peak1,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,5838818.511964747,4634956.01572699,0.7938174488946976,-0.3331208203334679,0.069181562229747,0.6384005117332444,Downregulated
Feature0677,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,293073.31053244334,408868.34928860335,1.3951060522904266,0.4803747961031762,0.11873782600480969,0.7127267469124424,Upregulated
Feature0676,2'-O-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,2'-O-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,10267116.175155634,7948008.1608928405,0.7741227454039558,-0.3693657557198147,0.17548124973970847,0.7429210442740862,Downregulated
Feature0675,NA,C16 H23 N5 O10,445.14457,NA,NA,Feature0675,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,7461489.79811033,8245357.138244873,1.1050550709501825,0.14411826880852896,0.08801065234591342,0.6687811081011467,Upregulated
Feature0674,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,9154735.626583043,9170957.464290816,1.0017719613508738,0.0025541376047009917,0.9700478617162487,0.9855864682789036,Upregulated
Feature0673,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0673,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,96339.016749726,1416543.8309668081,14.70373975942449,3.8781112326831075,0.29393544934077603,0.7429210442740862,Upregulated
Feature0672,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,2952097.74772747,2586147.62975547,0.8760372625690632,-0.1909358581884676,0.2560655149265355,0.7429210442740862,Downregulated
Feature0671,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak5,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,252822.10367370435,446776.133931049,1.7671561443364316,0.8214295207651784,0.0780812094278751,0.6384005117332444,Upregulated
Feature0670,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2078017.2754091632,2346237.39474392,1.1290750190139511,0.17514134613197435,0.6528890926587687,0.8331143341897993,Upregulated
Feature0669,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0669,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,946167.880691186,1084179.1498680282,1.145863405420213,0.19643507544900915,0.10023693928200227,0.7043924180722835,Upregulated
Feature0668,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine-peak1,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,4120435.884663373,5286081.1344833635,1.282893674952843,0.3594016061449123,0.1093971833901876,0.7055599272098991,Upregulated
Feature0667,2762577,C15 H23 N3 O4,309.16893,NA,NA,2762577-peak1,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,7039307.269168324,4540337.287896186,0.6449977411531029,-0.6326339868056146,0.22381149137082537,0.7429210442740862,Downregulated
Feature0666,NA,C19 H35 P S,326.21985,NA,NA,Feature0666,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,2347466.877458115,9447656.774777278,4.024617712607469,2.008851752092236,0.393025266521589,0.7429210442740862,Upregulated
Feature0665,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,143922.6850526473,172781.22660287732,1.2005141964914945,0.2636524640321178,0.4542763589574686,0.7462909455559859,Upregulated
Feature0664,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,7554823.54261269,6793001.03599331,0.8991607808809365,-0.15334898466496455,0.24891379466337624,0.7429210442740862,Downregulated
Feature0663,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,1532165.5762593732,1455489.8884407168,0.9499560040985567,-0.07406739632654893,0.42361153328054657,0.7436248055722755,Downregulated
Feature0662,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,240434.974468565,274053.073704235,1.1398220009795843,0.1888085451318571,0.4408860580570595,0.7437859477801351,Upregulated
Feature0661,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,7214941.337931403,2351365.069254273,0.32590217426888096,-1.6174891177833661,1.8504237849677898e-4,0.10448726305784786,Downregulated
Feature0660,Prolylleucine,C11 H20 N2 O3,228.14739,NA,NA,Prolylleucine-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,5832130.329988373,5328645.38899469,0.9136704921690789,-0.13025413203743336,0.4480075762205272,0.7437859477801351,Downregulated
Feature0659,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,9313393.551725144,8166608.124140747,0.8768670709322731,-0.18956994166120658,0.02248283079776075,0.5785251858234263,Downregulated
Feature0658,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,10197372.82914675,12122809.2063908,1.1888169050503528,0.2495265363482516,0.13934126240025588,0.7397744129866796,Upregulated
Feature0657,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak3,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,6133625.230427447,5833255.886635943,0.9510290680458527,-0.07243865739279055,0.6519126846967587,0.8331143341897993,Downregulated
Feature0656,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0656,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,2686609.748597863,2798718.4842359032,1.0417287012736216,0.05897960363437351,0.624099577117315,0.8195540183230478,Upregulated
Feature0655,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3459365.4632414402,4736749.00169489,1.3692537119962271,0.4533897914647082,0.2482507452647589,0.7429210442740862,Upregulated
Feature0654,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0654,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,244972.37547717235,282010.141962797,1.1511916044144985,0.20312797572304506,0.5622807605281214,0.7866305244448156,Upregulated
Feature0653,NA,C18 H31 N O14,485.17464,NA,NA,Feature0653,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,9318914.352814453,11183473.064109633,1.2000832544117175,0.26313449463425054,0.5937787512899441,0.804045727166399,Upregulated
Feature0652,NA,C29 H28 O9,520.17353,NA,NA,Feature0652,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,171394.205715013,220191.917427481,1.2847103932650255,0.3614431755360047,0.3205240359812735,0.7429210442740862,Upregulated
Feature0651,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11098,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak1,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,8781187.201143773,8434181.334163133,0.9604830350347796,-0.05816796302398711,0.828197797849716,0.9146541535125908,Downregulated
Feature0650,1-(5-Amino-5-carboxypentyl)-5-oxoproline,C11 H18 N2 O5,258.12159,NA,NA,1-(5-Amino-5-carboxypentyl)-5-oxoproline,11,18,5,2,0,0,1.6363636363636365,0.4545454545454546,-0.18181818181818168,65.48181818181817,4,-1,-0.75,-0.07692307692307693,-3,Protein,7676769.801893383,6554934.66131962,0.8538662524051358,-0.2279179876917329,0.16902995887682315,0.7429210442740862,Downregulated
Feature0649,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3124735.32276787,1795449.1497050792,0.5745923939934477,-0.7993891991637418,0.20485029356247925,0.7429210442740862,Downregulated
Feature0648,NA,C14 H29 N O2,243.2198,NA,NA,Feature0648,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,199951.66281107,205871.78120873266,1.0296077477648007,0.042094814945339454,0.8100482240846116,0.9118080082836999,Upregulated
Feature0647,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak1,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,2465172.1231745332,2032904.0363477233,0.8246499371126446,-0.2781462678556696,0.3506222211166904,0.7429210442740862,Downregulated
Feature0646,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak2",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,350320.12824701454,527229.8453092943,1.5049944402210849,0.5897581573635254,0.3897957300757484,0.7429210442740862,Upregulated
Feature0645,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0645,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,316822.80936793133,375974.60980831867,1.1867030993077692,0.24695903292877833,0.4635675026344909,0.749905170284088,Upregulated
Feature0644,N-Acetylserotonin,C12 H14 N2 O2,218.10552,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-Acetylserotonin,12,14,2,2,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,7,5,0.375,0.4444444444444444,3,Lignin,8139507.452037237,7881001.848185274,0.9682406330634588,-0.04656245546127734,0.2623789562224465,0.7429210442740862,Downregulated
Feature0643,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,174606.293865808,184819.90636034566,1.0584950992796813,0.08201458983556584,0.46234767926074777,0.749905170284088,Upregulated
Feature0642,NA,C9 H19 N O3,189.13649,NA,NA,Feature0642,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,266326.8045067103,182641.56103468433,0.6857798687329744,-0.5441825407237413,0.3382573508504499,0.7429210442740862,Downregulated
Feature0641,N-Aceyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Aceyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,7485489.39288993,7508286.221499413,1.0030454693625157,0.004387006684849524,0.9846288256773449,0.9928562259043001,Upregulated
Feature0640,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0640,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7139333.366608887,6628604.026130387,0.9284626008827079,-0.10708429631279351,0.20106497519934077,0.7429210442740862,Downregulated
Feature0639,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak4,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,892563.7180346854,1114141.9990209907,1.2482492582985485,0.31990604942841105,0.32853856512957924,0.7429210442740862,Upregulated
Feature0638,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak2,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,9382499.3844631,9167875.825745283,0.9771251188064854,-0.0333847868141796,0.7262772525216963,0.8676401028009545,Downregulated
Feature0637,Leucylasparagine,C10 H19 N3 O4,245.13752,NA,NA,Leucylasparagine-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,6186889.175560723,5027867.85291463,0.8126649290528063,-0.29926745948359645,0.03703428752455481,0.6051284343194661,Downregulated
Feature0636,Acetophenone,C8 H8 O,120.05748,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak2,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,12759594.088507466,8668477.396579007,0.6793693699383966,-0.5577319205827218,0.005561599798025909,0.32409559267895377,Downregulated
Feature0635,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0635,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,2846949.8987589134,3023136.8707319032,1.0618862214785711,0.08662919316435985,0.32488200791128446,0.7429210442740862,Upregulated
Feature0634,NA,C9 H12 N2 O4,212.0797,NA,NA,Feature0634,9,12,4,2,0,0,1.3333333333333333,0.4444444444444444,0.22222222222222232,53.96666666666666,5,1,-0.3333333333333333,0.2,-1,Lignin,9396013.744220393,9080850.946796153,0.9664578186022662,-0.049221328018700036,0.5485476731397992,0.7763072333323475,Downregulated
Feature0633,HC Blue 1,C11 H17 N3 O4,255.12193,NA,NA,HC Blue 1,11,17,4,3,0,0,1.5454545454545454,0.3636363636363637,0,60.3,5,1,-0.5,0,-2,Protein,10772411.601498934,9097638.14083362,0.844531241228076,-0.24377730213760618,0.14853800205658418,0.7422518450851139,Downregulated
Feature0632,beta-Pyracin,C8 H7 N O3,165.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,beta-Pyracin,8,7,3,1,0,0,0.875,0.375,0.25,53.175,6,3,0.5,0.6363636363636364,2,Lignin,8061876.552004923,7513334.398954484,0.9319585025258144,-0.10166237770424244,0.14323849318750348,0.7397744129866796,Downregulated
Feature0631,ET8750000,C4 H7 N,69.05786,NA,Superpathway of linamarin and lotaustralin biosynthesis;Other,ET8750000,4,7,0,1,0,0,1.75,0,-1,88.8,2,2,0.3333333333333333,0.3333333333333333,1,Lipid,11395646.10231101,10677382.913129233,0.9369703847650978,-0.09392464617872405,0.5662641668498677,0.7872059339187256,Downregulated
Feature0630,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6362786.795821504,7337880.65791508,1.1532494948178884,0.20570466042968044,0.7002175921436177,0.8535652471997965,Upregulated
Feature0629,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NA,NP-021733-peak1,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,259201.690475405,424611.43312282435,1.6381507093724557,0.7120680905944958,0.07338502428136442,0.6384005117332444,Upregulated
Feature0628,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,5012556.049383267,5854310.51176155,1.167929187042577,0.2239528045265518,0.21754605246968214,0.7429210442740862,Upregulated
Feature0627,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,237818.31711236268,236019.86857782365,0.992437720708917,-0.010951524464063304,0.9575625710346326,0.9835341758228962,Downregulated
Feature0626,4-[(Z)-2-Aminovinyl]phenol,C8 H9 N O,135.06839,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,4-[(Z)-2-Aminovinyl]phenol,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,9388613.54097302,8288082.256729723,0.8827802124945873,-0.17987380289542687,0.21781819389652896,0.7429210442740862,Downregulated
Feature0625,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,560158.4816227697,716880.0678295883,1.2797807965931334,0.35589672370190867,0.5238369455700594,0.7689599530291861,Upregulated
Feature0624,NA,C13 H15 N O4,249.1001,NA,NA,Feature0624,13,15,4,1,0,0,1.1538461538461535,0.3076923076923077,-0.3076923076923075,69.06923076923076,7,3,0.25,0.4,2,Lignin,8380856.391052963,7353865.420998493,0.8774599012159615,-0.18859489726355458,0.10187493649805753,0.7043924180722835,Downregulated
Feature0623,NA,C10 H20 N2 O4 S,264.11437,NA,NA,Feature0623,10,20,4,2,1,0,2,0.4,-0.4000000000000003,71.7,2,-2,-1.6666666666666667,-0.6,-5,Protein,10482837.981111897,6913098.150434136,0.6594681862764873,-0.6006250314806075,0.09827505898521505,0.7043924180722835,Downregulated
Feature0622,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1355580.58690176,969558.3309004823,0.7152347416810174,-0.4835112794600965,0.1393808740471498,0.7397744129866796,Downregulated
Feature0621,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,2957334.4964172235,2661816.565415453,0.9000728759767328,-0.15188627838528998,0.5452736344697962,0.7733903838374202,Downregulated
Feature0620,Pyridostigmine,C9 H12 N2 O2,180.08989,Metabolic pathways;Other,NA,Pyridostigmine,9,12,2,2,0,0,1.3333333333333333,0.2222222222222222,-0.22222222222222232,66.63333333333333,5,3,0.2,0.3333333333333333,1,Lignin,5978920.822680013,6220801.680134387,1.0404556047199756,0.05721540792114446,0.6644899582177554,0.8393995881059486,Upregulated
Feature0619,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,1671520.205267223,226555.48563419367,0.1355385863241627,-2.883224465642594,0.17309072888908797,0.7429210442740862,Downregulated
Feature0618,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak6,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1822322.90136328,1876772.88527877,1.029879437872814,0.04247545919163212,0.7358237974550972,0.8680261231817094,Upregulated
Feature0617,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0617,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,115012.753337999,156877.39717015368,1.36400001406038,0.44784365923366937,0.34268462678760503,0.7429210442740862,Upregulated
Feature0616,5-Hydroxyindole-3-acetic acid,C10 H9 N O3,191.05831,Metabolic pathways;Other,NA,5-Hydroxyindole-3-acetic acid,10,9,3,1,0,0,0.9,0.3,0,60.3,7,4,0.5,0.6,3,Lignin,7891236.74981519,7766364.051967453,0.9841757760150003,-0.023012087719370772,0.6625803014927136,0.8390728999405301,Downregulated
Feature0615,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0615,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3510918.890971487,2918071.8553998466,0.8311419164093543,-0.2668332585424325,0.12024213537709129,0.7132695037733578,Downregulated
Feature0614,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0614,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3779010.9724559602,3390757.5676529966,0.8972605775339574,-0.15640106924964725,0.13779611414473142,0.7397744129866796,Downregulated
Feature0613,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0613,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4357712.385212037,3669013.9265351635,0.8419587164554545,-0.24817859915524754,0.2179646766716144,0.7429210442740862,Downregulated
Feature0612,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,127622.85076453934,165363.20527020967,1.2957178458213587,0.3737515926424277,0.02720593944512415,0.5904389566427806,Upregulated
Feature0611,NP-015145,C14 H13 N O2,227.09462,Other,NA,NP-015145,14,13,2,1,0,0,0.9285714285714286,0.14285714285714285,-0.4285714285714288,72.51428571428572,9,7,0.5454545454545454,0.5833333333333334,6,Lignin,8005987.9991050335,8305614.569842983,1.037425308503016,0.053007470501688886,0.20877683592123758,0.7429210442740862,Upregulated
Feature0610,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0610,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2909115.8475770666,2645777.388482127,0.9094781806938805,-0.13688906831607955,0.3082395012361763,0.7429210442740862,Downregulated
Feature0609,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,214147.79168029933,1288671.2163796173,6.017672217248316,2.5892055251775163,0.15233904085311423,0.7429210442740862,Upregulated
Feature0608,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak3,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,4099396.20309088,2954077.3103628405,0.7206127839352324,-0.472703848956178,0.4907184159320337,0.7626394464118028,Downregulated
Feature0607,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,189536.31014536167,201604.28842042,1.0636710626359824,0.08905207031853177,0.6885480684083433,0.8507102856872568,Upregulated
Feature0606,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1043330.2498603266,1421152.4264037535,1.3621309519148006,0.4458654071652985,0.24073266396049037,0.7429210442740862,Upregulated
Feature0605,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,1246629.3778005934,1119595.7868899163,0.8980983496997317,-0.15505465342343056,0.4084778744915361,0.7429210442740862,Downregulated
Feature0604,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,72191.34691357783,65224.83212853263,0.903499310057409,-0.14640459548773047,0.69802530676012,0.8535652471997965,Downregulated
Feature0603,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam-peak2,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,460495.5406000587,587770.0958611016,1.2763860755202865,0.3520647750214589,0.016697437333718618,0.543951131602295,Upregulated
Feature0602,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,485234.772092323,330133.32301224035,0.680357925687625,-0.5556341694631861,0.2700561455275505,0.7429210442740862,Downregulated
Feature0601,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0601,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,418001.4642434157,413268.19763613265,0.9886764353425167,-0.01642964822472174,0.8737992312366478,0.9391342199196943,Downregulated
Feature0600,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0600,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,2800990.0802773535,2887759.5100874803,1.0309781282058432,0.04401372682467383,0.6656321078911209,0.8393995881059486,Upregulated
Feature0599,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0599,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6327994.46439104,5753964.16408535,0.9092871677534045,-0.13719210182528832,0.37131864996487646,0.7429210442740862,Downregulated
Feature0598,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0598,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,143717.996147259,155376.07297837967,1.0811177245971018,0.11252362894211418,0.3746774665210146,0.7429210442740862,Upregulated
Feature0597,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,232271.559495874,222547.351791192,0.9581343160316846,-0.061700180585748256,0.8660407760004091,0.9374268846930945,Downregulated
Feature0596,NA,C7 H15 N O6,209.08992,NA,NA,Feature0596,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2092790.5618358601,2427176.7346328,1.15978004626684,0.21385122237974044,0.2204137926926332,0.7429210442740862,Upregulated
Feature0595,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0595,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,134506.939319579,1987400.6610478282,14.775450776750667,3.8851302404145214,0.42280397258862734,0.7429771053580235,Upregulated
Feature0594,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2118363.56849876,1733060.90193702,0.8181130603398755,-0.2896278625755741,0.4471787629104686,0.7437859477801351,Downregulated
Feature0593,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak1,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,395267.2871914627,354862.6712319987,0.8977790035533791,-0.1555677386914098,0.8023862175606304,0.9118080082836999,Downregulated
Feature0592,7098783,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,7098783,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,871972.8676819834,1558987.9855356673,1.7878858887891964,0.8382546599376305,0.5181801449247068,0.7682508165605624,Upregulated
Feature0591,NA,C18 H27 N O12,449.1534,NA,NA,Feature0591,18,27,12,1,0,0,1.5,0.6666666666666666,0,60.3,6,-6,-1.4,-0.09090909090909093,-7,Amino Sugar,5725213.473213053,2115665.2041129265,0.3695347280955782,-1.4362181427028,0.0015563564117305332,0.1998427578468617,Downregulated
Feature0590,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,1683861.2199602567,2286879.414707593,1.3581163266896599,0.44160705598233635,0.44724104445396673,0.7437859477801351,Upregulated
Feature0589,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0589,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,115179.09155872467,134481.08678451035,1.1675824575847125,0.22352444025423743,0.3818229197415332,0.7429210442740862,Upregulated
Feature0588,NA,C16 H25 N O9,375.15307,NA,NA,Feature0588,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,10623576.383239968,10240376.444811454,0.9639292904192734,-0.05300077426506466,0.5546384820776088,0.7816618873872457,Downregulated
Feature0587,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,2745008.9697742965,2515640.0868867165,0.9164414814621027,-0.12588533316179648,0.5662840287588748,0.7872059339187256,Downregulated
Feature0586,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,875733.3629756824,799274.3245593883,0.9126914176747916,-0.13180092957549527,0.8214923983758289,0.9125694928365151,Downregulated
Feature0585,N6-Dimethyladenosine,C12 H17 N5 O4,295.1281,NA,NA,N6-Dimethyladenosine,12,17,4,5,0,0,1.4166666666666667,0.3333333333333333,0.5,46.05,7,3,-0.6666666666666666,0,-2,Lignin,8809234.421033222,9627402.73484975,1.0928762108842331,0.12812999748061998,0.30001849440121375,0.7429210442740862,Upregulated
Feature0584,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0584,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,114724.39272530266,247237.20605716523,2.1550535172511456,1.1077236967455293,0.41795609331779915,0.7429771053580235,Upregulated
Feature0583,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0583,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3263273.691213963,2567129.754099237,0.7866731377790885,-0.3461637735873421,0.33008363113545297,0.7429210442740862,Downregulated
Feature0582,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,703470.5638668607,1714424.3593963266,2.4370946667226856,1.2851622923245902,0.15553548906340994,0.7429210442740862,Upregulated
Feature0581,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0581,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,204031.23425334867,257753.051107031,1.2633019255619222,0.3371994803406575,0.3366375209604203,0.7429210442740862,Upregulated
Feature0580,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0580,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2297836.064763887,2120374.1837543934,0.9227699992480846,-0.11595699446376485,0.18251112966959174,0.7429210442740862,Downregulated
Feature0579,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,5745444.059198474,6139054.783013136,1.0685083206378958,0.09559814252864596,0.7490356326137491,0.8756841695291173,Upregulated
Feature0578,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4497535.72483012,3746834.94088826,0.8330861987827312,-0.2634623170366195,0.19969855437482775,0.7429210442740862,Downregulated
Feature0577,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0577,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,4992133.7584098,4901331.04304394,0.9818108408628089,-0.02648299828661294,0.6441933012459715,0.8330255361150196,Downregulated
Feature0576,NA,C15 H21 N5 O2,303.16956,NA,NA,Feature0576,15,21,2,5,0,0,1.4,0.13333333333333333,-0.13333333333333375,64.10000000000001,8,6,0.125,0.2222222222222222,1,Lignin,10199600.00421388,8737561.183661267,0.8566572395046291,-0.22321001748265065,0.0920945006068561,0.6854522562238613,Downregulated
Feature0575,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,923245.2349638067,1161469.685984788,1.25802944006564,0.3311656841724701,0.46239870732457367,0.749905170284088,Upregulated
Feature0574,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0574,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,491107.3565354917,7408369.136304503,15.085029856947601,3.9150456468196153,0.02165110030225972,0.5785251858234263,Upregulated
Feature0573,NA,C19 H23 N3 O5,373.16384,NA,NA,Feature0573,19,23,5,3,0,0,1.2105263157894737,0.2631578947368421,-0.21052631578947345,66.29999999999998,10,5,0.18181818181818185,0.3333333333333333,2,Lignin,10007548.932745656,9556609.942484299,0.954940116376964,-0.06651782929371458,0.2291517703513415,0.7429210442740862,Downregulated
Feature0572,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06369,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak1,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,8889124.305567244,7360143.000775963,0.8279941586784109,-0.27230750503162054,0.014157460398987598,0.49964037324760396,Downregulated
Feature0571,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0571,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,382511.33168072335,7049742.041963574,18.430152149970528,4.2039960760622765,0.1916655521198225,0.7429210442740862,Upregulated
Feature0570,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,8871929.780320404,8547080.342965916,0.9633845797477946,-0.05381626303163262,0.5303933300422395,0.7697066387459335,Downregulated
Feature0569,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0569,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,982677.0560368783,833975.1765998827,0.8486767564954574,-0.23671292933016244,0.45106032438079285,0.7437859477801351,Downregulated
Feature0568,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,3334669.3934252067,6320422.988933247,1.8953671993376298,0.9224773762823016,0.21735725185719235,0.7429210442740862,Upregulated
Feature0567,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak3,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,350873.342092981,376294.43080862536,1.072450897990728,0.10091159565308978,0.6181688193127552,0.8163437773269296,Upregulated
Feature0566,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0566,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,222285.16315833066,338460.6820234057,1.5226418048528267,0.6065765937350545,0.0016448185121573666,0.1998427578468617,Upregulated
Feature0565,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0565,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,389959.535388585,447634.86589426966,1.1479008083446725,0.1989979821774201,0.5104160761239784,0.7678958865079032,Upregulated
Feature0564,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,345863.6714412323,408688.0395137977,1.181644888608199,0.2407965377000685,0.45931378863742073,0.7495930230749429,Upregulated
Feature0563,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0563,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,468483.539891767,340705.8127914093,0.7272524726698445,-0.45947179836761365,0.12985644346282013,0.7353513019132542,Downregulated
Feature0562,1774244,C7 H15 N3 O2,173.11643,NA,NA,1774244,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,924280.370009119,896421.3394222646,0.9698586798001784,-0.04415355047912083,0.6960565242792469,0.8526055052691839,Downregulated
Feature0561,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1011654.137511957,1388842.0362884174,1.3728427382347381,0.4571663714695861,0.6223612494047124,0.8195540183230478,Upregulated
Feature0560,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,3852324.7385727265,3998881.89099606,1.0380438209053042,0.05386734819322533,0.6463171120803806,0.8331143341897993,Upregulated
Feature0559,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,767313.7064791053,901524.1993000687,1.1749095470180007,0.23254969203138323,0.8257001567568829,0.9143744565996981,Upregulated
Feature0558,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0558,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,849117.5792233517,1679168.6351592583,1.977545485155443,0.9837108782396679,0.2831540769873309,0.7429210442740862,Upregulated
Feature0557,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0557,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,3551807.413916697,3428106.4808079535,0.965172398530377,-0.05114143614339906,0.5040336716044183,0.7643984240804697,Downregulated
Feature0556,NA,C12 H23 N3 O5,289.16381,NA,NA,Feature0556,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,4084151.34174426,3243956.8534609536,0.794279296240654,-0.3322816965250674,0.16325606969079806,0.7429210442740862,Downregulated
Feature0555,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0555,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,4613867.028267683,4807293.882467504,1.0419229364467497,0.05924857577614324,0.8128888923775556,0.9118080082836999,Upregulated
Feature0554,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak1",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3246451.0865367167,2678189.4033471565,0.8249591113366268,-0.2776054801758833,0.07042539158562161,0.6384005117332444,Downregulated
Feature0553,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,2150021.203168583,2111137.2873934,0.9819146361357376,-0.02633048722799972,0.9596556746847125,0.9835341758228962,Downregulated
Feature0552,4-Acetamidobenzoic acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Acetamidobenzoic acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,198069.27515746967,235549.81847246632,1.1892294667368208,0.2500271159098288,0.5930630979622376,0.804045727166399,Upregulated
Feature0551,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,9454521.050198706,8673586.108923016,0.9174008987732618,-0.124375774065382,0.463714261841673,0.749905170284088,Downregulated
Feature0550,NA,C32 H66 N3 O18 P3 S,905.32735,NA,NA,Feature0550,32,66,18,3,1,3,2.0625,0.5625,-1.0625,90.58125,3,-15,-3.142857142857143,-0.8125,-22,Amino Sugar,10282118.04262142,8755766.768638486,0.8515528349649454,-0.231832049567027,0.16340551168216538,0.7429210442740862,Downregulated
Feature0549,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,9270890.89060516,6797641.94757995,0.7332242421781142,-0.4476736092114521,0.10079104715828703,0.7043924180722835,Downregulated
Feature0548,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,5970634.402694947,9492038.863673657,1.5897873196505323,0.6688337759445532,0.007800521588401023,0.3497215117308036,Upregulated
Feature0547,4-Hydroxyprolylproline,C10 H16 N2 O4,228.111,NA,NA,4-Hydroxyprolylproline,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,5982818.236218557,5310760.541638227,0.887668709286227,-0.17190675237497274,0.28637195702327317,0.7429210442740862,Downregulated
Feature0546,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0546,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4039030.94898945,3040509.3948549633,0.7527819007219262,-0.4096961533945351,0.18564937792388933,0.7429210442740862,Downregulated
Feature0545,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,1468516.60782318,1088281.81011578,0.7410755890115319,-0.4323073913167139,0.033305539351602687,0.6051275072806717,Downregulated
Feature0544,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak1,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,387297.7574760667,391541.52409998135,1.0109573746348812,0.015722169645199326,0.9630137171554651,0.9839835417860984,Upregulated
Feature0543,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0543,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,122537.682388148,413482.13864601834,3.3743264160675106,1.7545995397380811,0.348333967670232,0.7429210442740862,Upregulated
Feature0542,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0542,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4907747.662641143,4472854.896432467,0.9113864860006605,-0.13386511638718865,0.13885485931115463,0.7397744129866796,Downregulated
Feature0541,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0541,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,93654.74085486223,1859358.7259233634,19.85333266582662,4.311309299580075,0.07747763350779428,0.6384005117332444,Upregulated
Feature0540,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0540,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,6177915.20563324,6380144.226544727,1.0327341852680476,0.04646896771274111,0.6756023249335659,0.8435495508777358,Upregulated
Feature0539,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak4,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3037877.4546272634,2709746.1173079233,0.8919866445502816,-0.1649059856221888,0.3093722055839357,0.7429210442740862,Downregulated
Feature0538,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0538,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4009255.66868817,4532935.304753116,1.1306176705453894,0.17711115031840696,0.12525768122635347,0.7192763118557381,Upregulated
Feature0537,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,153674.18695165133,228643.987892759,1.4878490163393188,0.5732281323395828,0.13542797364433495,0.7397744129866796,Upregulated
Feature0536,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak2",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,9339725.495383786,7658993.637844853,0.820044833397979,-0.28622530814105046,0.1083215870606847,0.7055599272098991,Downregulated
Feature0535,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0535,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,2629071.5177795934,2802814.68770783,1.0660853722514834,0.0923229739246062,0.6428358705182673,0.8330255361150196,Upregulated
Feature0534,NA,C10 H21 N O10,315.11663,NA,NA,Feature0534,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4002320.291550275,3836025.9201765303,0.9584505088898491,-0.06122415691422034,0.9730496790855367,0.9858529643366621,Downregulated
Feature0533,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0533,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,8674412.70846283,7358986.332859197,0.8483555694415723,-0.23725902968227527,0.461985252076438,0.749905170284088,Downregulated
Feature0532,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0532,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,2303368.575136923,1524669.54865873,0.6619303419853665,-0.5952486913894273,0.06264216925225073,0.6384005117332444,Downregulated
Feature0531,1-Aminocyclohexanecarboxylic acid,C7 H13 N O2,143.09463,ABC transporters,NA,1-Aminocyclohexanecarboxylic acid,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,268110.299949409,517955.42185196397,1.9318743888231802,0.9500012926658181,0.23352604697714657,0.7429210442740862,Upregulated
Feature0530,ascopyrone P,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,949265.2080105604,990251.3272052837,1.0431766790237902,0.06098352254128721,0.7429995091848048,0.8727605772830022,Upregulated
Feature0529,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,2937042.0483947233,2892878.1669361633,0.9849631429408039,-0.021858354573557184,0.8960876309465665,0.949799513816329,Downregulated
Feature0528,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,7276035.1949870065,5213220.646747197,0.7164919502229685,-0.48097759896747994,0.004717609573208013,0.319665224680575,Downregulated
Feature0527,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,542654.031784424,667304.5301065766,1.2297052837003,0.29831259467762794,0.3647291199273096,0.7429210442740862,Upregulated
Feature0526,NA,C9 H16 N2 O3,200.11609,NA,NA,Feature0526,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,7125945.00897953,6914406.191967097,0.9703142787734301,-0.043475991925878095,0.5844897058674735,0.7997783212758481,Downregulated
Feature0525,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10586,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak1",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,9059570.831481064,8104763.234525477,0.8946078556350892,-0.16067266804940408,0.41154203446349547,0.7429210442740862,Downregulated
Feature0524,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak1",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,178246.26921187033,154439.84605778233,0.8664408334640049,-0.2068268592727877,0.6159271513592408,0.8153208901224099,Downregulated
Feature0523,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1904616.56427401,2494474.2617031634,1.3096989223413542,0.3892351986576784,0.23517022238727953,0.7429210442740862,Upregulated
Feature0522,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak2,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,3715486.11412243,3496130.5929540168,0.9409618245282493,-0.0877919018814675,0.8075199278500353,0.9118080082836999,Downregulated
Feature0521,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,4322571.344644253,4123787.908114083,0.9540126881245196,-0.06791964105427417,0.7055799422634703,0.8549731203106714,Downregulated
Feature0520,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,1692387.6189213968,2144660.84806953,1.2672397411157965,0.34168948469971266,0.11069251189793754,0.7055599272098991,Upregulated
Feature0519,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak2,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,226791.30203543967,375149.274345763,1.654160767978395,0.7260994569358555,0.2150031832658576,0.7429210442740862,Upregulated
Feature0518,NA,C13 H17 N O5,267.11069,NA,NA,Feature0518,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,2157212.49166149,2100408.87909711,0.973668049492598,-0.03849809360367401,0.9192434409955694,0.9606848135346713,Downregulated
Feature0517,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0517,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,266702.431055746,327919.71555566636,1.2295340325830204,0.2981116682070649,0.4292385560744691,0.7437859477801351,Upregulated
Feature0516,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,1726280.3966869267,1589870.8322934867,0.9209806444797514,-0.11875725823036488,0.2770642628787389,0.7429210442740862,Downregulated
Feature0515,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,134932.78836967467,155298.26609857965,1.150930533452772,0.20280075956259705,0.46429627030061765,0.749905170284088,Upregulated
Feature0514,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0514,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,344520.95975164766,350406.58644087566,1.0170835083400172,0.024438137525751313,0.958028891163317,0.9835341758228962,Upregulated
Feature0513,NP-019722,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak1,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1091350.671530287,920354.8341625687,0.8433172381449596,-0.24585265019291688,0.3097482188754106,0.7429210442740862,Downregulated
Feature0512,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1060122.265672951,1100854.3394631308,1.0384220529170036,0.054392927217179844,0.8258517819347921,0.9143744565996981,Upregulated
Feature0511,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,6891117.650282453,6588950.23875337,0.9561511750540643,-0.06468935716432073,0.7206467263274898,0.865798265531041,Downregulated
Feature0510,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak1,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,6381858.736558356,5599226.1620269,0.8773660454048974,-0.18874922061803961,0.3178157549825547,0.7429210442740862,Downregulated
Feature0509,NA,C14 H25 N3 O6,331.17445,NA,NA,Feature0509,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,4718298.265892576,4588881.735233543,0.9725713544659621,-0.04012399496045461,0.5623433087973269,0.7866305244448156,Downregulated
Feature0508,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1809536.5090253532,2490238.5588532803,1.376174808539544,0.46066373994907467,0.4840915209023379,0.7603958548235219,Upregulated
Feature0507,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,566825.3409995233,741208.5879323106,1.30764899576523,0.3869753389807823,0.375293099773319,0.7429210442740862,Upregulated
Feature0506,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1729828.3977418,1348419.3486278434,0.7795104707427245,-0.35935969289163183,0.07753394433800305,0.6384005117332444,Downregulated
Feature0505,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak3,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,6061640.53809573,5021494.098341256,0.8284051267610737,-0.2715916128766321,0.11794407629273361,0.7127267469124424,Downregulated
Feature0504,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0504,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,158104.54730399768,171066.419142942,1.081982916114498,0.1136777200228877,0.6092211599231606,0.8135849757712432,Upregulated
Feature0503,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine-peak2,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,175592.40985495283,251302.56593273298,1.4311698674237692,0.5171949175891439,0.28392606055956493,0.7429210442740862,Upregulated
Feature0502,NA,C20 H31 N O14,509.17464,NA,NA,Feature0502,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,1720210.5608757667,1793348.1641695567,1.0425166575285734,0.060070435508666434,0.7140914140201595,0.862818013801819,Upregulated
Feature0501,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0501,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,153623.90463418266,179540.47694207434,1.1687014294396798,0.2249064086686606,0.5068765491848622,0.7666507806421041,Upregulated
Feature0500,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0500,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,1687528.24674411,1975955.34893747,1.170916903316935,0.2276386954579518,0.4617767820822423,0.749905170284088,Upregulated
Feature0499,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0499,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,85309.83507563481,93073.6557708523,1.0910073344806512,0.1256608004546414,0.6005392104058532,0.8089665062878493,Upregulated
Feature0498,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0498,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,4427936.48373174,3638511.4727824633,0.8217171782274592,-0.2832861678642834,0.26123820280206467,0.7429210442740862,Downregulated
Feature0497,NA,C14 H27 N3 O5,317.19512,NA,NA,Feature0497,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,6738051.705388627,6362294.947445267,0.9442336190975121,-0.08278424439430211,0.288522109576478,0.7429210442740862,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak1",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,364113.15955095633,1324479.8054381022,3.637549950327313,1.8629670590435259,0.18298548763176836,0.7429210442740862,Upregulated
Feature0495,7-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,7-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,9759368.40724236,8667325.090211786,0.8881030747624841,-0.17120096693941544,0.48600025224140647,0.7608913376127011,Downregulated
Feature0494,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,251185.92681627566,281702.47453371034,1.1214898784506957,0.16541660002750153,0.792204465373909,0.9069252842381308,Upregulated
Feature0493,NA,C7 H10 N2 O2,154.07425,NA,NA,Feature0493,7,10,2,2,0,0,1.4285714285714286,0.2857142857142857,0,60.3,4,2,0,0.25,0,Lignin,6316766.64588313,5846164.098236296,0.9254994566003887,-0.11169595185813061,0.2541065513637127,0.7429210442740862,Downregulated
Feature0492,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,572729.6139089267,388806.433640911,0.6788656011468922,-0.5588021106250299,0.22755127464319183,0.7429210442740862,Downregulated
Feature0491,NA,C16 H33 N O2,271.25118,NA,NA,Feature0491,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,179222.05860156767,233799.069049506,1.3045217250253198,0.38352097046836364,0.40810187358713235,0.7429210442740862,Upregulated
Feature0490,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak2,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3488467.6612943434,3012777.9158581966,0.8636393420773035,-0.2114991297494797,0.028258507991775147,0.5904389566427806,Downregulated
Feature0489,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0489,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,203342.873515232,235483.54392556366,1.158061454796566,0.21171181479323825,0.5383626791209332,0.7721846506499914,Upregulated
Feature0488,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,2188257.445555663,2286836.98048713,1.0450493314356961,0.06357104617010183,0.43578801475398615,0.7437859477801351,Upregulated
Feature0487,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,674034.7616439307,1775832.575506313,2.634630551064107,1.3976006698257397,0.3541897731268409,0.7429210442740862,Upregulated
Feature0486,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,316333.58237906866,220225.370037927,0.6961808113500472,-0.5224660449045367,0.3661507897230759,0.7429210442740862,Downregulated
Feature0485,Υ-L-Glutamyl-L-glutamic acid,C10 H16 N2 O7,276.09576,Other,NA,Υ-L-Glutamyl-L-glutamic acid,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,2011475.0901575733,1982778.8391814767,0.9857337278912817,-0.02073010480592207,0.7992833846829626,0.9105487919656615,Downregulated
Feature0484,NA,C13 H17 N5 O7,355.11293,NA,NA,Feature0484,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,5159403.77569113,5118230.9399442095,0.9920198461805007,-0.011559111674623484,0.924339575492111,0.9624039587483934,Downregulated
Feature0483,NA,C25 H34 O2,366.25594,NA,NA,Feature0483,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,420697.5082853797,531546.8576284386,1.2634894363763725,0.33741360242979546,0.3693370451798678,0.7429210442740862,Upregulated
Feature0482,NA,C15 H29 N3 O4,315.21585,NA,NA,Feature0482,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7785512.935589193,6849245.438375933,0.879742349032215,-0.1848470327283122,0.44172681949434983,0.7437859477801351,Downregulated
Feature0481,NA,C16 H29 N3 O4,327.2159,NA,NA,Feature0481,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,5280369.36683627,4971986.327156577,0.9415982068192967,-0.0868165219784769,0.5664722747620582,0.7872059339187256,Downregulated
Feature0480,Gly-Tyr,C11 H14 N2 O4,238.09535,Other,NA,Gly-Tyr-peak2,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,4615091.575360097,3797531.8277615267,0.8228508071294817,-0.28129721870711166,0.16034846107629758,0.7429210442740862,Downregulated
Feature0479,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak1,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,148593.30761179602,282084.136430439,1.8983636676787043,0.924756394518631,0.016148662097487436,0.5430439187793944,Upregulated
Feature0478,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,6222622.235215337,5518844.00866029,0.8869000559647998,-0.1731565573146883,0.12042212401368378,0.7132695037733578,Downregulated
Feature0477,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital-peak1,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,2350490.2527573435,2471008.898935477,1.0512738336339638,0.07213850847162259,0.7177050766369822,0.8647172118229359,Upregulated
Feature0476,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0476,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,190955.110977579,615146.8081133097,3.221421018605452,1.6876972238255974,0.07409962973126474,0.6384005117332444,Upregulated
Feature0475,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe-peak1,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,1498143.84896633,1010094.4098669627,0.6742305891145864,-0.5686860125625377,0.2858081500342542,0.7429210442740862,Downregulated
Feature0474,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0474,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,118250.072536193,129102.72388666234,1.091777122142125,0.12667837127746565,0.5304209738602662,0.7697066387459335,Upregulated
Feature0473,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0473,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,79883.8118213714,86379.46154916887,1.0813137177570147,0.11278514785558408,0.6925203565305356,0.8507102856872568,Upregulated
Feature0472,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0472,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1342226.8022590433,1168279.0892353267,0.8704036361582463,-0.20024351134999185,0.26106940683965163,0.7429210442740862,Downregulated
Feature0471,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0471,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2465260.7502938034,2282151.4841830335,0.9257241790390945,-0.11134569061119282,0.21526653620637257,0.7429210442740862,Downregulated
Feature0470,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0470,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,897342.7260092776,809386.12913082,0.9019810443333909,-0.1488309801800664,0.5544730873611189,0.7816618873872457,Downregulated
Feature0469,NA,C17 H25 N3 O4,335.18461,NA,NA,Feature0469,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,8673782.284497943,7371082.866337903,0.8498118380849534,-0.23478465400446183,0.15717496276591822,0.7429210442740862,Downregulated
Feature0468,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,1167923.20549596,862370.020010872,0.7383790440610909,-0.43756648645697843,0.20263268314901825,0.7429210442740862,Downregulated
Feature0467,NA,C6 H9 O P S,160.01125,NA,NA,Feature0467,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,292748.32149166835,314237.37552836834,1.0734045337209954,0.10219388672369305,0.3323902696792659,0.7429210442740862,Upregulated
Feature0466,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,338962.5250953577,340483.83435335266,1.004488134071951,0.006460521745009089,0.9888072869950029,0.9934991365181108,Upregulated
Feature0465,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0465,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,181387.95058014768,347329.11295459996,1.9148411558965703,0.9372247195105089,0.02280346756652007,0.5785251858234263,Upregulated
Feature0464,NA,C14 H25 N3 O6,331.17446,NA,NA,Feature0464,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,6960964.992202514,5938514.493269663,0.8531165578223462,-0.22918523036088423,0.23213118267156319,0.7429210442740862,Downregulated
Feature0463,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0463,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,117774.440132695,1317384.254149077,11.185654991565203,3.4835778327699445,0.4075495079516667,0.7429210442740862,Upregulated
Feature0462,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,144532.283727806,764749.9571857317,5.291205102840317,2.4035963419780106,0.38682764617896587,0.7429210442740862,Upregulated
Feature0461,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3619392.409589813,3073452.32470466,0.8491625048893152,-0.23588742501535798,0.522870117289605,0.7682508165605624,Downregulated
Feature0460,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1346744.7814773936,1231296.0881067447,0.9142757447747446,-0.12929874839765013,0.8712421848203635,0.9391342199196943,Downregulated
Feature0459,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0459,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2512326.027654833,2410030.79880498,0.959282661675347,-0.05997211331328857,0.6855197473696704,0.848520782027442,Downregulated
Feature0458,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,222387.53324190568,264543.61488443764,1.1895613527790516,0.2504296820761728,0.4103304128622736,0.7429210442740862,Upregulated
Feature0457,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,3124615.5108147534,2867112.69735211,0.9175889601228092,-0.12408006106619619,0.15381360962007576,0.7429210442740862,Downregulated
Feature0456,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,184592.3070513154,110041.1929189127,0.5961309800864127,-0.7462987448035006,0.30952178757617244,0.7429210442740862,Downregulated
Feature0455,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1140806.8450515722,2223225.8879036224,1.9488188535572097,0.9625999955623009,0.3072667852597335,0.7429210442740862,Upregulated
Feature0454,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,681916.6701355187,674750.5626845134,0.9894912270591931,-0.015241178654801043,0.9704594032403845,0.9855864682789036,Downregulated
Feature0453,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak1,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,7112685.206309764,7221765.891911456,1.0153360766627104,0.02195733911686031,0.7459894490858962,0.8739323144892864,Upregulated
Feature0452,NA,C28 H40,376.313,NA,NA,Feature0452,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,185146.03887493233,270639.81130179367,1.4617639834283092,0.5477103923952442,0.388074043866964,0.7429210442740862,Upregulated
Feature0451,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,734208.2902898223,665968.1633985863,0.9070561749387238,-0.14073619375217664,0.6656495629210155,0.8393995881059486,Downregulated
Feature0450,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,2571769.21888576,3239246.53499661,1.2595401294988826,0.3328970876987897,0.11843083076302803,0.7127267469124424,Upregulated
Feature0449,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0449,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,369477.13196283864,654676.9933087523,1.7719012536196654,0.8252982061035709,0.33434352266370604,0.7429210442740862,Upregulated
Feature0448,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,4561188.510143924,5113801.297291123,1.1211554369915229,0.1649863072523839,0.6007555282822399,0.8089665062878493,Upregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak5,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2269096.08722355,2398714.1913970467,1.0571232328605777,0.08014356695120128,0.4957917129137336,0.7638837682405117,Upregulated
Feature0446,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,7782388.767593343,6824732.918796423,0.8769457710999101,-0.18944046337376094,0.03500737645425373,0.6051275072806717,Downregulated
Feature0445,NA,C15 H29 N3 O4,315.21587,NA,NA,Feature0445,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,4591624.085959586,3773455.5324231167,0.8218128186847239,-0.28311826096411224,0.03393897979829378,0.6051275072806717,Downregulated
Feature0444,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak2,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,1338163.5378552633,1786782.12560079,1.3352494482584307,0.41710928809075504,0.11266575963025292,0.7055599272098991,Upregulated
Feature0443,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,108785.22457341776,109130.13874084734,1.0031705975584653,0.00456696918338833,0.9872134240206301,0.9930757365148142,Upregulated
Feature0442,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak4,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2992982.5918521034,3153215.8807172766,1.0535363250362304,0.07524005791047592,0.07403290106266058,0.6384005117332444,Upregulated
Feature0441,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1289632.6861369866,1218719.8759329566,0.9450131723813198,-0.08159365592744972,0.37141370309363464,0.7429210442740862,Downregulated
Feature0440,NA,C11 H21 N O12,359.10644,NA,NA,Feature0440,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1089047.1259758137,1266793.09791917,1.1632123786967359,0.2181145273527522,0.3424790983519305,0.7429210442740862,Upregulated
Feature0439,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak1,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,4382515.48089065,4352800.80555194,0.9932197215347494,-0.009815186697312179,0.933573297555026,0.9677654731174266,Downregulated
Feature0438,NA,C17 H33 N O15,491.18523,NA,NA,Feature0438,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,2215500.64784806,2153329.9908143966,0.971938325951721,-0.04106332392311999,0.8635586095023833,0.9365353934039933,Downregulated
Feature0437,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak1,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,656940.453256052,787295.9630019274,1.198428197106424,0.26114347362478535,0.703939451159507,0.8542073282694876,Upregulated
Feature0436,NA,C8 H19 N O4,193.13145,NA,NA,Feature0436,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,125779.29903838073,105268.2633900285,0.836928367345302,-0.2568239470199624,0.4495776974356222,0.7437859477801351,Downregulated
Feature0435,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0435,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,1349597.1812366766,1396805.7259277166,1.0349797297648335,0.049602512599844745,0.8613555303025422,0.9359437256783235,Upregulated
Feature0434,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak3,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,6141820.279087667,6049384.725661733,0.9849498114198052,-0.021877881648791692,0.9089385529533287,0.9551748813293666,Downregulated
Feature0433,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,4997853.676950917,5423085.592135433,1.0850829061173999,0.11780527647156301,0.35224770221330887,0.7429210442740862,Upregulated
Feature0432,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0432,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,633706.561719557,864035.0467343373,1.363462364015588,0.4472748777394591,0.20339947090785673,0.7429210442740862,Upregulated
Feature0431,Fenspiride,C15 H20 N2 O2,260.15248,NA,NA,Fenspiride,15,20,2,2,0,0,1.3333333333333333,0.13333333333333333,-0.666666666666667,79.30000000000001,7,5,0.2727272727272727,0.3333333333333333,3,Lignin,7153350.48804917,6608568.163934167,0.9238423554074205,-0.11428140393373488,0.42609381827412396,0.7437859477801351,Downregulated
Feature0430,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0430,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,2741651.8279956835,2710389.25773795,0.9885971770964848,-0.016545307967350924,0.8634527150124158,0.9365353934039933,Downregulated
Feature0429,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2029721.93029629,1536553.6766903466,0.7570266910729231,-0.4015839275697539,0.1224960830527196,0.7180220231533114,Downregulated
Feature0428,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,646168.7097163966,1103164.51647213,1.7072391465013972,0.7716651622355745,0.019447838280366454,0.5702677803232292,Upregulated
Feature0427,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,3945291.9777034167,3636999.976413233,0.9218582545899068,-0.11738315672848082,0.30957591745019464,0.7429210442740862,Downregulated
Feature0426,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,283566.082356899,299687.45238252735,1.0568522507756688,0.07977370030399049,0.8645464450217716,0.9367992712394632,Upregulated
Feature0425,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,163230.80517356066,163134.735181765,0.9994114469282099,-8.493525670274933e-4,0.9980199303093837,0.9992803341529211,Downregulated
Feature0424,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0424,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,681460.5074853377,992527.624961317,1.456471232095093,0.5424772059591226,0.6082584103397352,0.8132671428028913,Upregulated
Feature0423,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,4889446.400903443,3516634.72393299,0.7192296296127118,-0.4754756390867102,0.006395183837734332,0.3282861036703624,Downregulated
Feature0422,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0422,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,927991.286919857,635059.3882513323,0.684337662651112,-0.547219746340107,0.3433593550442258,0.7429210442740862,Downregulated
Feature0421,1-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,1-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,3447765.20160715,8008561.173995446,2.3228267314323827,1.215881541995941,0.0281177307618316,0.5904389566427806,Upregulated
Feature0420,NA,C10 H23 N O7,269.14745,NA,NA,Feature0420,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,8107676.508666373,6737746.430579697,0.8310329628195766,-0.2670223924366439,0.24203381726023848,0.7429210442740862,Downregulated
Feature0419,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,727391.245234985,847856.7198912377,1.1656130389874793,0.2210889211366822,0.26530347743051436,0.7429210442740862,Upregulated
Feature0418,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,936787.8703282543,419291.71483104804,0.4475844832236422,-1.1597680727918533,0.018518092621010687,0.5702677803232292,Downregulated
Feature0417,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0417,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,2700686.3755683466,2748568.0410671635,1.017729443126746,0.025354081120646972,0.8566615312832625,0.9320389428348406,Upregulated
Feature0416,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0416,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,400399.6637086737,407977.29975290335,1.018925180840669,0.02704811902770297,0.8649079458196696,0.9367992712394632,Upregulated
Feature0415,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,545690.2807028149,590850.6356028493,1.0827582174303538,0.11471112156367423,0.5639884730009719,0.786982267927221,Upregulated
Feature0414,Levetiracetam,C8 H14 N2 O2,170.10556,NA,NA,Levetiracetam-peak1,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,6074680.677456487,6251567.428755653,1.0291186912845647,0.04140938208875382,0.6700276549528956,0.8400540732655443,Upregulated
Feature0413,NP-003800,C10 H15 N O3,197.10521,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,3792406.2285304265,1587744.93887485,0.41866425778182204,-1.2561343373583773,0.02194202747857227,0.5785251858234263,Downregulated
Feature0412,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,1344014.8545967601,1091994.7709495774,0.8124871293012641,-0.29958313557005994,0.5149375578510422,0.7682508165605624,Downregulated
Feature0411,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,213170.169231809,291214.54164206,1.366113010518759,0.4500768342657313,0.3356385788090909,0.7429210442740862,Upregulated
Feature0410,NA,C7 H16 O6,196.09463,NA,NA,Feature0410,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,1809146.8755970234,1958247.0853291599,1.0824146517584057,0.11425327313747902,0.6679448756622821,0.8393995881059486,Upregulated
Feature0409,NA,C20 H29 N3 O4,375.21585,NA,NA,Feature0409,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,6350049.294248713,5681114.780658587,0.8946567998777607,-0.1605937399646377,0.5470875121410019,0.7748881651896801,Downregulated
Feature0408,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,106197.86244540253,125180.75829264637,1.1787502630479323,0.23725809284981414,0.3352645902870892,0.7429210442740862,Upregulated
Feature0407,NA,C11 H21 N3 O2,227.16337,NA,NA,Feature0407,11,21,2,3,0,0,1.9090909090909092,0.18181818181818185,-0.7272727272727275,81.02727272727273,3,1,-0.3333333333333333,-0.14285714285714285,-2,Lipid,8497627.258864164,6693855.00098385,0.7877322453748794,-0.3442227620498457,0.02802959425363197,0.5904389566427806,Downregulated
Feature0406,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,294280.53757004463,343007.4982981883,1.16557996369891,0.22104798282334376,0.6391302985216354,0.8313876949993997,Upregulated
Feature0405,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0405,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,197601.61022930467,718279.2672386151,3.6349869133409167,1.8619501701717893,0.37957811264099595,0.7429210442740862,Upregulated
Feature0404,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,6703289.270683502,6124395.240505967,0.9136403030211901,-0.13030180179789927,0.8955582496572656,0.949799513816329,Downregulated
Feature0403,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0403,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1805565.4299471767,1748321.42736258,0.9682958027246504,-0.046480254067945016,0.6915652302955244,0.8507102856872568,Downregulated
Feature0402,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0402,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6463934.75283589,5751740.766220444,0.889820362697351,-0.16841398128448476,0.07422427114648657,0.6384005117332444,Downregulated
Feature0401,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0401,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,204720.319153825,186113.337148235,0.9091102335005209,-0.13747285692296726,0.5745071836373911,0.7938133516164277,Downregulated
Feature0400,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,1935263.91325596,1600180.0660447767,0.8268536684242586,-0.2742960623689209,0.29413800422045855,0.7429210442740862,Downregulated
Feature0399,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak1,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,731806.1765846083,761369.6925759474,1.0403980137600288,0.05713555012471081,0.6836421478010584,0.8477463316937658,Upregulated
Feature0398,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0398,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,833029.6875655013,1118490.6904809296,1.3426780667921663,0.42511343200390517,0.30151186669007407,0.7429210442740862,Upregulated
Feature0397,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,160034.67770430702,477950.5951668218,2.9865439292471465,1.5784769426203222,0.3632340103597529,0.7429210442740862,Upregulated
Feature0396,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,7862112.884864886,5834445.224131471,0.7420963435113204,-0.43032159633903927,0.013805867551160304,0.49964037324760396,Downregulated
Feature0395,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1244209.1123914933,1051656.4337870344,0.8452409030871397,-0.24256551070357477,0.3287936259722266,0.7429210442740862,Downregulated
Feature0394,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,134201.58667198202,148654.62527206008,1.1076964807830807,0.14756262357485056,0.6282962089281082,0.8231506403126181,Upregulated
Feature0393,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1090846.8698666226,1186671.960256795,1.0878446764960592,0.12147258191398437,0.7009835802139008,0.8535652471997965,Upregulated
Feature0392,N-Acetyltyramine,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,2292511.9316926533,4003902.9663613224,1.7465134689201294,0.8044777686814462,0.38831398814000495,0.7429210442740862,Upregulated
Feature0391,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,336156.8772461403,225461.632717582,0.6707036148259278,-0.5762527172608264,0.30043900903954884,0.7429210442740862,Downregulated
Feature0390,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,176287.21114613567,415103.736102485,2.3547013615093104,1.2355440995027662,0.18976289573464986,0.7429210442740862,Upregulated
Feature0389,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1217309.86685386,1034775.240079207,0.8500508114286347,-0.23437901457211877,0.441922590970278,0.7437859477801351,Downregulated
Feature0388,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0388,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5247825.031395593,4777334.126025727,0.9103455426667028,-0.13551383741262796,0.0195838985094801,0.5702677803232292,Downregulated
Feature0387,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0387,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,239065.03220363767,304961.46086278,1.2756422721120133,0.35122381138569647,0.42485772153991314,0.7437646832554922,Upregulated
Feature0386,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak1,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,5473823.60209538,5689462.887170357,1.0393946354048438,0.0557435180006919,0.5443700421879696,0.7729780816985922,Upregulated
Feature0385,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,314423.0507861177,527716.680860529,1.6783651184006276,0.7470565996904922,0.2427824192252185,0.7429210442740862,Upregulated
Feature0384,NA,C8 H19 N O7,241.11608,NA,NA,Feature0384,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,956382.4779060454,920305.5815978716,0.9622777527384625,-0.05547471995462763,0.5871602865092753,0.801558357602538,Downregulated
Feature0383,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,773514.500166406,575886.7794811777,0.7445067666569758,-0.42564313368495843,0.40992396832372213,0.7429210442740862,Downregulated
Feature0382,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0382,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,1700574.0180007634,1745174.6598805333,1.0262268160089871,0.03734962974322818,0.8703797101953099,0.9391342199196943,Upregulated
Feature0381,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak2,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,271634.144134656,264477.56047372834,0.9736535932044685,-0.038519513809496336,0.9607920090654749,0.9835341758228962,Downregulated
Feature0380,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,119689.94754773367,117405.12361598533,0.9809104776252231,-0.027806619380186512,0.8787462170058857,0.9403980032751831,Downregulated
Feature0379,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",C7 H10 N4 O,166.08548,Metabolic pathways;ABC transporters;Other,NA,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",7,10,1,4,0,0,1.4285714285714286,0.14285714285714285,0.5714285714285716,44.014285714285705,5,4,0,0.2,0,Lignin,7108849.490596203,7134158.5841237735,1.0035602235721899,0.00512719531730359,0.9602223152471216,0.9835341758228962,Upregulated
Feature0378,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2653002.16855292,2769892.3624247066,1.044059592282785,0.062204059644605736,0.14121832611555302,0.7397744129866796,Upregulated
Feature0377,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,420521.001843381,375638.1201355563,0.8932683944176922,-0.16283437741524534,0.7768123663158849,0.899566469143523,Downregulated
Feature0376,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,6515643.68374806,6121508.843895134,0.9395094546320857,-0.0900204147937183,0.5114017867511466,0.7678958865079032,Downregulated
Feature0375,NA,C31 H37 N O11,599.23689,NA,NA,Feature0375,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,211415.73970630832,251491.99329696866,1.1895613526520443,0.2504296819221388,0.41033041303517126,0.7429210442740862,Upregulated
Feature0374,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0374,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,271972.52726989234,348760.95914381865,1.2823389282908166,0.3587776235324043,0.4514514722883286,0.7437859477801351,Upregulated
Feature0373,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0373,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5044553.671841467,4644173.933878217,0.9206312859355316,-0.11930462419488759,0.5362140079727402,0.7721846506499914,Downregulated
Feature0372,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,381502.2878741333,405573.59064237535,1.063096090202698,0.08827200382441693,0.7021043991469302,0.8535652471997965,Upregulated
Feature0371,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0371,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,6758975.045708933,7127630.17712503,1.0545430525964354,0.07661799555784934,0.5003856489170012,0.7643022379378415,Upregulated
Feature0370,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3228993.91253832,3768230.758518947,1.1669984089739989,0.22280259414989992,0.3636166074171887,0.7429210442740862,Upregulated
Feature0369,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,969531.728832908,829623.431220622,0.8556949778418256,-0.22483147159826247,0.7684140040624989,0.8927937742674027,Downregulated
Feature0368,NA,C11 H21 N5 O2,255.16954,NA,NA,Feature0368,11,21,2,5,0,0,1.9090909090909092,0.18181818181818185,-0.18181818181818168,65.48181818181817,4,2,-0.75,-0.4,-3,Lipid,7286377.743493363,6447850.78024552,0.8849185435113303,-0.1763834332293348,0.06890173153016894,0.6384005117332444,Downregulated
Feature0367,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1948382.77167948,1962203.91260341,1.007093647677872,0.010197842985893912,0.8948618773246267,0.949799513816329,Upregulated
Feature0366,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak2,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,6867873.33707697,5896921.924501156,0.8586241526421249,-0.21990133928433095,0.33404146449580463,0.7429210442740862,Downregulated
Feature0365,NA,C20 H36 N4 O6,428.2636,NA,NA,Feature0365,20,36,6,4,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,5,-1,-0.5,-0.15384615384615383,-5,Lipid,5467544.365502637,4388941.10508479,0.8027261987624147,-0.317020110939425,0.02653217122012053,0.5904389566427806,Downregulated
Feature0364,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0364,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,3911723.45374732,4189518.4575466234,1.0710160130397726,0.09898005035928654,0.10900421109371523,0.7055599272098991,Upregulated
Feature0363,Acetylcarnitine,C9 H17 N O4,203.11573,NA,NA,Acetylcarnitine-peak1,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,5709090.153348533,5350802.487716223,0.9372425980307624,-0.09350556816058528,0.17399235678597005,0.7429210442740862,Downregulated
Feature0362,NA,C8 H12 N6,192.11229,NA,NA,Feature0362,8,12,0,6,0,0,1.5,0,0.75,38.925,6,6,0,0,0,Lipid,6599964.7963775,9122869.383112673,1.3822603096489108,0.46702933213390513,0.30894541235261996,0.7429210442740862,Upregulated
Feature0361,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,101648.07573858343,365821.8503761712,3.598905810248536,1.8475583448673842,0.4114176391312924,0.7429210442740862,Upregulated
Feature0360,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,2475530.5801280597,4067619.217010047,1.6431302645429764,0.7164468592049048,0.5062522316264962,0.7663907778152678,Upregulated
Feature0359,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,712816.6364041073,325052.2334723523,0.45601100882285656,-1.132859441149918,0.0010421337381937544,0.19965892031945995,Downregulated
Feature0358,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0358,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,252121.18468086934,283274.9340717037,1.1235665675229483,0.16808560185672758,0.5809292098785599,0.7974830482449599,Upregulated
Feature0357,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,360473.3337064417,234094.909980795,0.6494097845568645,-0.6227989732363789,0.11317734346595786,0.7055599272098991,Downregulated
Feature0356,MFCD00037215,C8 H14 N2 O5,218.09028,NA,NA,MFCD00037215,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,7139685.77252102,6216172.79471102,0.8706507530955514,-0.19983397287197044,0.0833415531658795,0.6481296779476766,Downregulated
Feature0355,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak1,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2584250.7900783867,2501575.7010331033,0.9680081014726997,-0.04690897310487059,0.7202276605265624,0.865798265531041,Downregulated
Feature0354,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0354,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,852883.6776459027,1695321.0663893376,1.9877518011233357,0.9911376273011222,0.24705619485205443,0.7429210442740862,Upregulated
Feature0353,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1053978.1880325896,1016558.9533793537,0.9644971451230081,-0.052151126932293214,0.8077372881624926,0.9118080082836999,Downregulated
Feature0352,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,652570.2125163167,838355.6039854384,1.2846979342693738,0.36142918435286064,0.07451599664672463,0.6384005117332444,Upregulated
Feature0351,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1072594.347162298,388110.104934955,0.361842392663877,-1.4665666540284352,0.008285327899145382,0.35088363652880694,Downregulated
Feature0350,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,377849.892737958,282473.690497825,0.7475817670635752,-0.41969671158242444,0.3558005540472205,0.7429210442740862,Downregulated
Feature0349,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0349,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,145792.757910726,196735.60955933668,1.349419630842053,0.43233905487932456,0.09237854109141509,0.6854522562238613,Upregulated
Feature0348,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,543757.223958498,328283.6333802553,0.603731994566221,-0.7280198365909131,0.5131440623854298,0.7682508165605624,Downregulated
Feature0347,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,128899.54758224887,140194.53624813532,1.0876262863426986,0.12118292473384024,0.871457007699311,0.9391342199196943,Upregulated
Feature0346,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak1,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,4450878.626071444,4011427.135917553,0.901266350517904,-0.14997456733320974,0.15993574577355227,0.7429210442740862,Downregulated
Feature0345,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2460789.516442973,1992543.2147835866,0.8097170446596228,-0.30451024810480887,0.17431900849202114,0.7429210442740862,Downregulated
Feature0344,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,4898842.170078367,3297791.4244322823,0.6731777244375945,-0.57094065644754,0.5028098779695929,0.7643022379378415,Downregulated
Feature0343,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,475186.2372091793,243741.54051332767,0.5129389730326542,-0.9631409036367544,0.06633983193388167,0.6384005117332444,Downregulated
Feature0342,NA,C13 H21 N3 O5,299.1482,NA,NA,Feature0342,13,21,5,3,0,0,1.6153846153846154,0.38461538461538464,-0.1538461538461542,64.6846153846154,5,0,-0.6,-0.06666666666666667,-3,Protein,7223420.063203284,7000107.67646561,0.969084950787336,-0.045304955864466145,0.4843609595316808,0.7603958548235219,Downregulated
Feature0341,NA,C19 H41 N O2,315.3138,NA,NA,Feature0341,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,149234.41076494067,174065.69871760733,1.1663911682660004,0.2220517009545437,0.47640644847839453,0.7584892140248123,Upregulated
Feature0340,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,3196236.25005972,1957181.5961801957,0.6123394652518651,-0.7075964271665653,0.3136235834713164,0.7429210442740862,Downregulated
Feature0339,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,551921.593137869,368964.026542572,0.6685080473928938,-0.580983167532174,0.08503360201993232,0.6547587355534789,Downregulated
Feature0338,1581740,C12 H13 N O4,235.08445,NA,NA,1581740-peak1,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,4250401.796906574,4231107.326330286,0.9954605537315719,-0.006563946257876577,0.9186448964903953,0.9606848135346713,Downregulated
Feature0337,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1322389.00530226,1265084.5991216467,0.9566659992250048,-0.06391277035166852,0.6535921323082718,0.8331143341897993,Downregulated
Feature0336,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",C9 H15 N O3,185.10525,Other,NA,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,8321224.647056866,4075647.6803151667,0.4897894063894408,-1.0297665245679515,0.005739591369757151,0.32409559267895377,Downregulated
Feature0335,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,2877959.8829588667,2338804.5915466966,0.8126605952346154,-0.29927515317685194,0.05987042973483144,0.6384005117332444,Downregulated
Feature0334,Alanyltryptophan,C14 H17 N3 O3,275.12704,NA,NA,Alanyltryptophan-peak2,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,5363951.613872827,4540622.570072777,0.846506996507823,-0.240406102625363,0.21353528824503584,0.7429210442740862,Downregulated
Feature0333,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak3,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1806337.1305003,2015323.7132485965,1.1156963333253376,0.15794441245354787,0.147498743540198,0.7419901680471508,Upregulated
Feature0332,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,4992536.27611036,4224774.824376097,0.8462181526035061,-0.24089846096553696,0.038998750076739544,0.614208185361607,Downregulated
Feature0331,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr-peak2,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,955091.0381799053,887078.6692046323,0.9287896480477059,-0.1065762023495443,0.738533685482606,0.8699970043675063,Downregulated
Feature0330,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan-peak1,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,733520.2855483469,809539.7850756866,1.1036365333380125,0.14226511968095767,0.5764980605777014,0.7946197840672303,Upregulated
Feature0329,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0329,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,397092.46355741867,514659.53082055267,1.2960697521425866,0.37414336356378836,0.6062280874068836,0.8132671428028913,Upregulated
Feature0328,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,499640.68344882864,336480.7203928137,0.6734454009433657,-0.5703671098252577,0.4220372538242996,0.7429771053580235,Downregulated
Feature0327,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,5288986.582793834,3824310.7613572734,0.7230706112582223,-0.4677915548508889,0.007402320329418902,0.3497215117308036,Downregulated
Feature0326,Brivaracetam,C11 H20 N2 O2,212.15246,NA,NA,Brivaracetam,11,20,2,2,0,0,1.818181818181818,0.18181818181818185,-0.9090909090909092,86.2090909090909,3,1,-0.14285714285714285,0,-1,Lipid,6032308.79808834,5508998.156587313,0.9132486981324852,-0.13092030291013854,0.06647856869458355,0.6384005117332444,Downregulated
Feature0325,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3250847.4326550434,1022807.899463758,0.314628084108028,-1.6682806415684894,0.14964766282783082,0.7429210442740862,Downregulated
Feature0324,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,108865.51637651534,148723.5800629486,1.3661220284721078,0.45008635771916017,0.4664168544735204,0.7503420241957679,Upregulated
Feature0323,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine-peak1,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,937362.6337012086,608042.528259902,0.6486737431158581,-0.6244350520063419,0.350208271460887,0.7429210442740862,Downregulated
Feature0322,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",C9 H14 N2 O4,214.09536,NA,NA,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",9,14,4,2,0,0,1.5555555555555556,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Protein,4050369.097247787,3574221.2149425233,0.8824433351941173,-0.18042445407761015,0.02562329136626008,0.5904389566427806,Downregulated
Feature0321,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0321,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,485919.0259911973,568107.7384224783,1.1691407580998276,0.22544863285312847,0.45458585686935404,0.7462909455559859,Upregulated
Feature0320,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,186348.320528851,1062146.2660547215,5.699789850750369,2.5109087285985523,0.26848842702073183,0.7429210442740862,Upregulated
Feature0319,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,206294.81775981834,768819.809761068,3.726801371502106,1.8979379293470946,0.030262518660160238,0.6051275072806717,Upregulated
Feature0318,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,478547.3034596607,218665.25292986166,0.45693550323869736,-1.1299375526332343,0.3875430918045642,0.7429210442740862,Downregulated
Feature0317,CMPF,C12 H16 O5,240.09978,NA,NA,CMPF,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,180436.69869837567,196524.11617850166,1.0891582344178126,0.12321356601658692,0.5371118944323661,0.7721846506499914,Upregulated
Feature0316,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,2765635.44195629,2567072.3650296065,0.928203452300919,-0.1074870315010489,0.4468053835421518,0.7437859477801351,Downregulated
Feature0315,Aspartame,C14 H18 N2 O5,294.12149,Other,NA,Aspartame-peak1,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,5272997.4034574,5321716.02413111,1.0092392650604693,0.013268241436811755,0.7818068393932651,0.9027817218351678,Upregulated
Feature0314,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,212477.760136303,273724.36810257967,1.2882494992745943,0.3654120317347222,0.5028390660615938,0.7643022379378415,Upregulated
Feature0313,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,4376329.98139087,1974044.9553916666,0.4510731511987774,-1.1485666784491104,0.3969428259037122,0.7429210442740862,Downregulated
Feature0312,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1448271.64008214,536756.6568152427,0.37061877203146787,-1.4319921384255083,0.042142098862737315,0.6234855173864765,Downregulated
Feature0311,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0311,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2796714.6850834,3052107.29339867,1.09131879260957,0.12607259876059448,0.5197351215425785,0.7682508165605624,Upregulated
Feature0310,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0310,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,1795045.14481617,1504821.07967774,0.8383193503647778,-0.25442816430184423,0.19535094222509836,0.7429210442740862,Downregulated
Feature0309,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,311788.9400495753,214560.93144468698,0.6881608161295626,-0.5391823475159728,0.38561831958608417,0.7429210442740862,Downregulated
Feature0308,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,3762863.2694562934,4075323.1317586666,1.0830377932779687,0.11508358756615311,0.7435166508216222,0.8727605772830022,Upregulated
Feature0307,NA,C11 H14 N2 O5 S,286.06233,NA,NA,Feature0307,11,14,5,2,1,0,1.2727272727272727,0.4545454545454546,0.36363636363636376,49.93636363636363,6,1,-0.6666666666666666,0.09090909090909093,-2,Lignin,3841899.96066918,3333067.2448595967,0.8675570105888559,-0.20496952890676698,0.1709550404738435,0.7429210442740862,Downregulated
Feature0306,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,605649.2011707054,522464.64839099505,0.8626522537816997,-0.21314898722153558,0.5961035599641751,0.8052395954641071,Downregulated
Feature0305,tyr-thr,C13 H18 N2 O5,282.12161,NA,NA,tyr-thr-peak1,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,6935126.56673875,5574753.659504646,0.8038431030576245,-0.3150141563309061,0.2197329420528721,0.7429210442740862,Downregulated
Feature0304,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,1059640.1976719378,892598.1119723483,0.8423596178527523,-0.24749181868518055,0.27156971221009824,0.7429210442740862,Downregulated
Feature0303,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,577107.084670695,802634.7324126586,1.390789948230583,0.4759045453085392,0.29993834075992026,0.7429210442740862,Upregulated
Feature0302,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,118210.96601551434,134245.88779699075,1.135646652099704,0.18351402096821384,0.4962777531463755,0.7638837682405117,Upregulated
Feature0301,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0301,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1252434.25562189,1152879.2785951667,0.9205108159730989,-0.11949342159129227,0.5317343003661453,0.7697066387459335,Downregulated
Feature0300,NA,C9 H15 N O5,217.09502,NA,NA,Feature0300,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,1062457.7983900243,1258676.6754871933,1.1846839256999249,0.24450219865920866,0.0523766265194967,0.6384005117332444,Upregulated
Feature0299,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,2277480.4863104266,1937161.94756277,0.8505723580099775,-0.23349412401716568,0.16133931858471492,0.7429210442740862,Downregulated
Feature0298,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,398670.8859262163,428801.8361909733,1.0755785068045662,0.10511283135700536,0.653513827322266,0.8331143341897993,Upregulated
Feature0297,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak2,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,249152.410631798,236549.67569055432,0.9494175677077102,-0.07488534972260248,0.743405531836292,0.8727605772830022,Downregulated
Feature0296,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,84809.4525980296,127833.68219174296,1.5073046491366335,0.5919710369617716,0.5214569907891456,0.7682508165605624,Upregulated
Feature0295,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,4682869.90861447,4348509.645867174,0.9285992843550455,-0.10687192582623467,0.23802298962214954,0.7429210442740862,Downregulated
Feature0294,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0294,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2560635.4665471236,2678636.3907327,1.046082671948887,0.06499687232824186,0.7027083081096672,0.8535652471997965,Upregulated
Feature0293,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,277572.6316399513,226826.73811820566,0.8171797658078559,-0.2912746129528697,0.6227416348910676,0.8195540183230478,Downregulated
Feature0292,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1047881.14241936,1134894.5708685904,1.0830374981730588,0.11508319446219072,0.541987927758465,0.7721846506499914,Upregulated
Feature0291,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0291,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,178399.48407378234,104013.68496913237,0.5830380368483267,-0.7783380883356937,0.0757387534668339,0.6384005117332444,Downregulated
Feature0290,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1940851.84939408,2007186.2877164767,1.0341780019650164,0.04848452264568647,0.6371338777920041,0.8313876949993997,Upregulated
Feature0289,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3605420.5798377567,3340237.0175383133,0.9264486468562354,-0.1102170851530385,0.49693029079164347,0.7638837682405117,Downregulated
Feature0288,NA,C24 H36 N4 O6,476.26356,NA,NA,Feature0288,24,36,6,4,0,0,1.5,0.25,-0.5,74.55,9,3,-0.07142857142857142,0.1176470588235294,-1,Lipid,6149405.65410546,5170767.7646442335,0.8408565080093766,-0.25006846901553287,0.07305540740750428,0.6384005117332444,Downregulated
Feature0287,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,151117.50283111,186329.45328260498,1.2330104044324244,0.3021849735929264,0.3245820629051944,0.7429210442740862,Upregulated
Feature0286,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,1612515.57764259,418634.3521500557,0.2596156948524344,-1.9455504919766116,0.05519702681434102,0.6384005117332444,Downregulated
Feature0285,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak1,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,2103236.0878208,2142149.729938643,1.0185017946122075,0.026448522351764633,0.9166722488517125,0.9597297834084061,Upregulated
Feature0284,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,453101.55835833796,759424.3212605687,1.6760576238406437,0.7450717505885927,0.22249401049601164,0.7429210442740862,Upregulated
Feature0283,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3009544.10170018,2706387.67992918,0.8992683238634921,-0.15317644327604807,0.20157794039927993,0.7429210442740862,Downregulated
Feature0282,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0282,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,547861.0945936803,659439.0197866061,1.2036609759188635,0.26742909871268894,0.31767186048690993,0.7429210442740862,Upregulated
Feature0281,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0281,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,6749536.944478894,4976879.839600947,0.7373661157113931,-0.4395469733001158,0.20090629738966134,0.7429210442740862,Downregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1294881.7616426416,1414430.3868087698,1.0923239701935974,0.12740080577578908,0.8065503711786531,0.9118080082836999,Upregulated
Feature0279,Acetophenone,C8 H8 O,120.05746,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak1,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,7179503.946241637,6058746.584737577,0.8438948749250622,-0.2448648031472573,0.016349019986864884,0.5430439187793944,Downregulated
Feature0278,NA,C19 H41 N O,299.31886,NA,NA,Feature0278,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,196276.23079404468,282338.34991124936,1.4384744845009318,0.5245396309413328,0.007844992589002679,0.3497215117308036,Upregulated
Feature0277,NA,C16 H35 N O,257.27187,NA,NA,Feature0277,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,4804703.49202942,8604068.798918637,1.790759578232461,0.84057165861111,0.24966388861273203,0.7429210442740862,Upregulated
Feature0276,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0276,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,219900.38647877568,216197.63491229733,0.9831616868629937,-0.02449939891818753,0.9464080825058014,0.9762728542293773,Downregulated
Feature0275,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,291373.1558646507,266463.12012147333,0.9145081307533058,-0.12893209807320966,0.5329786819651594,0.7697066387459335,Downregulated
Feature0274,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,195011.01468550868,196296.70241496232,1.0065928980038745,0.009480324077259968,0.9742176308847555,0.9864463040757777,Upregulated
Feature0273,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15865,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak1",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,3989880.1529086335,2612340.044192503,0.6547414819686,-0.611002709309729,0.3797268975024108,0.7429210442740862,Downregulated
Feature0272,N-benzoyl-4-methoxyanthranilic acid,C15 H13 N O4,271.08448,NA,NA,N-benzoyl-4-methoxyanthranilic acid,15,13,4,1,0,0,0.8666666666666667,0.26666666666666666,-0.13333333333333375,64.10000000000001,10,6,0.5,0.5833333333333334,5,Lignin,4901960.206963677,4663712.845328353,0.9513975325020241,-0.07187981128523915,0.2512159283842165,0.7429210442740862,Downregulated
Feature0271,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6384297.538000099,6228418.161078947,0.9755839423220268,-0.03566208267683332,0.4777431216276407,0.7587862788690932,Downregulated
Feature0270,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0270,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,125833.69437581333,1982561.5196341132,15.755410579562417,3.9777754457760066,0.23873842237361342,0.7429210442740862,Upregulated
Feature0269,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0269,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,1475689.38644119,1290299.8884614434,0.8743709213584325,-0.19368267227365904,0.44995879903029773,0.7437859477801351,Downregulated
Feature0268,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,288495.809611078,304280.264810507,1.0547129444296195,0.076850401777007,0.8546700653902829,0.9307799941551471,Upregulated
Feature0267,Methylone,C11 H13 N O3,207.08954,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak1,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,5221715.508410874,4378324.167287613,0.8384838584628426,-0.2541450839537436,0.05505329790606568,0.6384005117332444,Downregulated
Feature0266,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak1,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,2156810.44842337,616039.19244078,0.28562509648963597,-1.8078053473465165,0.07351199369473899,0.6384005117332444,Downregulated
Feature0265,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,613173.993831894,625920.5137658977,1.020787769967782,0.029682949426501817,0.9356506671062976,0.9682298290030961,Upregulated
Feature0264,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,2508382.3197770766,2550297.55935641,1.0167100681777483,0.02390832930681566,0.9122746339696005,0.957332225189993,Upregulated
Feature0263,asn-ile,C10 H19 N3 O4,245.13753,NA,NA,asn-ile,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,227382.21870334234,169343.873634292,0.7447542494746656,-0.42516364455148153,0.25550971677258444,0.7429210442740862,Downregulated
Feature0262,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0262,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,556084.544159425,715519.9323910574,1.2867106987708754,0.36368771761010404,0.02294068368495624,0.5785251858234263,Upregulated
Feature0261,beta-Aspartylleucine,C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,beta-Aspartylleucine,10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2495059.5193485003,2369318.7791226464,0.9496041119457195,-0.07460191278153809,0.382394051438859,0.7429210442740862,Downregulated
Feature0260,.alpha.-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,.alpha.-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,1672793.4018387834,1971423.43981403,1.1785217694229209,0.23697840801397818,0.3069771601495264,0.7429210442740862,Upregulated
Feature0259,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,138976.87362515432,175703.18728323234,1.264262050944789,0.33829553029863507,0.36430137938984,0.7429210442740862,Upregulated
Feature0258,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0258,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,162259.29866107734,171550.80191500566,1.057263302199624,0.08033471207794847,0.881407160896776,0.9410752829536629,Upregulated
Feature0257,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak1,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,176481.84204405334,210873.81808284333,1.1948754367047296,0.25686022806788855,0.5582040611340988,0.7845882412758023,Upregulated
Feature0256,NA,C19 H41 N O2,315.31381,NA,NA,Feature0256,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,4346935.337238385,7616689.07174916,1.7521974634635478,0.8091653682648843,0.2655053941267495,0.7429210442740862,Upregulated
Feature0255,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,462868.04938907,362564.2873274533,0.7832994474472681,-0.3523641542166735,0.28938953993559197,0.7429210442740862,Downregulated
Feature0254,Desthiobiotin,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak1,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,4639153.66303265,4503016.9159391,0.9706548312511476,-0.04296973618665016,0.40325462612848295,0.7429210442740862,Downregulated
Feature0253,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2210009.387980663,1888829.51879149,0.854670359802117,-0.2265600046888143,0.06796747443460512,0.6384005117332444,Downregulated
Feature0252,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,160799.22640829565,271551.7156711917,1.6887625751486968,0.7559665124300815,0.3460555397243758,0.7429210442740862,Upregulated
Feature0251,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0251,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,1332526.67074677,1183213.0505555717,0.887946993130336,-0.17145453884183456,0.7866822714528243,0.9029702269064507,Downregulated
Feature0250,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0250,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,479900.5932320147,555846.0126604964,1.158252397474668,0.2119496686187426,0.7014676524085574,0.8535652471997965,Upregulated
Feature0249,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1815613.653757625,1901167.808334913,1.0471213434643565,0.0664286356503405,0.9271771608668252,0.9635816628885902,Upregulated
Feature0248,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,576346.619080569,509726.78385268303,0.8844101222730119,-0.17721255766910426,0.8516118535135682,0.9295299483582373,Downregulated
Feature0247,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,410290.57013402134,245516.23078570102,0.5983959872767809,-0.7408275940523525,0.49311634478251837,0.7638837682405117,Downregulated
Feature0246,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0246,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,429243.85327767866,762664.4781926183,1.776762724425664,0.8292510313100331,0.0033390215228025614,0.28281512298137695,Upregulated
Feature0245,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak1,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1181858.6064183193,2196558.5785962935,1.8585629166360877,0.8941875275768443,0.16126163871018195,0.7429210442740862,Upregulated
Feature0244,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,1017522.947086107,834930.056386294,0.8205515745637909,-0.2853340798211145,0.3990942941964887,0.7429210442740862,Downregulated
Feature0243,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1165837.967637673,1465446.592435221,1.2569899360926136,0.3299730990763197,0.6603856158197986,0.8390728999405301,Upregulated
Feature0242,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,899468.5129035553,905113.3326574276,1.0062757280248205,0.009025669904831465,0.9862732616106391,0.9930757365148142,Upregulated
Feature0241,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,1601467.1801101167,1305606.1170340013,0.8152562433057341,-0.2946745105827633,0.26444704787198586,0.7429210442740862,Downregulated
Feature0240,ELK,C17 H32 N4 O6,388.23223,NA,NA,ELK,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,6510231.596920193,4374876.819018417,0.6720001821575822,-0.5734664708151648,0.051992691363386453,0.6384005117332444,Downregulated
Feature0239,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine-peak1,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1044711.8907249119,1190167.1493614102,1.1392300211454172,0.18805907001503186,0.5097649432570874,0.7678958865079032,Upregulated
Feature0238,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,1989306.7772881468,1672963.0876056633,0.8409779259317017,-0.24986016190612576,0.2655200702097666,0.7429210442740862,Downregulated
Feature0237,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5048328.12797129,4767532.872252867,0.9443785648237444,-0.08256279873952536,0.3650389832550848,0.7429210442740862,Downregulated
Feature0236,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,C11 H9 N3 O2,215.06947,NA,NA,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,11,9,2,3,0,0,0.8181818181818182,0.18181818181818185,0.36363636363636376,49.93636363636363,9,7,0.6666666666666666,0.7142857142857143,4,Lignin,5922066.65190599,5203791.05106299,0.8787120032477469,-0.1865376935314656,0.04109343085208542,0.6160378041011744,Downregulated
Feature0235,NA,C14 H21 N O10,363.11672,NA,NA,Feature0235,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,90969.77187313806,311378.2769595183,3.4228763087781626,1.7752091591498032,0.18067119360364658,0.7429210442740862,Upregulated
Feature0234,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0234,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,5143740.9489097865,4549726.7064704,0.8845170765130994,-0.17703809898921027,0.04744767244883566,0.6384005117332444,Downregulated
Feature0233,Anhalamine,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,3045699.2947085234,2664105.99870586,0.8747107776970536,-0.1931220248656179,0.048868530322914126,0.6384005117332444,Downregulated
Feature0232,NA,C19 H37 N O2,311.28246,NA,NA,Feature0232,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,167435.67210984332,206449.92582937,1.2330104046999737,0.30218497390597493,0.3245820625933024,0.7429210442740862,Upregulated
Feature0231,NA,C13 H25 N O9,339.15309,NA,NA,Feature0231,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,104287.87118000044,121662.58549566027,1.1666034038193296,0.22231418864722557,0.39084800922831286,0.7429210442740862,Upregulated
Feature0230,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0230,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,1301647.6964709267,1280329.11204535,0.9836218475372588,-0.02382431543973006,0.8880120461157954,0.9460958529057594,Downregulated
Feature0229,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0229,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,1224482.4677915866,1024477.888592217,0.8366619494682618,-0.25728327060638057,0.18317451853575298,0.7429210442740862,Downregulated
Feature0228,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0228,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,177122.75912162167,170207.44858408734,0.9609575270178243,-0.05745542758748731,0.7987835550232149,0.9105487919656615,Downregulated
Feature0227,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0227,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2316192.1594555834,1963188.9718456832,0.84759330689865,-0.23855589951122366,0.308327454828952,0.7429210442740862,Downregulated
Feature0226,NA,C16 H32 N2 O10,412.20583,NA,NA,Feature0226,16,32,10,2,0,0,2,0.625,-0.375,70.9875,2,-8,-2.5,-0.5555555555555556,-10,Amino Sugar,6276406.211571217,5651013.2302756095,0.9003581093679646,-0.15142916027766093,0.6033033490988875,0.8117520836961997,Downregulated
Feature0225,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0225,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,467810.9908721523,342406.2870499533,0.7319329680809685,-0.45021656529242676,0.25830464266024683,0.7429210442740862,Downregulated
Feature0224,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak1",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2566625.18070062,2672451.6735521997,1.0412317675550473,0.058291233561328114,0.6953842620347485,0.8526055052691839,Upregulated
Feature0223,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0223,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,3339175.00341994,2978415.3255642764,0.8919614343404649,-0.1649467610742495,0.0803373518761239,0.6449832894699236,Downregulated
Feature0222,NA,C9 H21 N O7,255.13179,NA,NA,Feature0222,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,279066.6006109537,273177.8725902873,0.9788984851366149,-0.03076883933177517,0.7353521754079488,0.8680261231817094,Downregulated
Feature0221,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0221,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,749535.9939049303,639183.409883827,0.8527721351363144,-0.22976779698426428,0.3910863139204483,0.7429210442740862,Downregulated
Feature0220,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,188490.78351534234,180473.367821711,0.9574652110617453,-0.06270802637770058,0.9350556346300882,0.9682055287673407,Downregulated
Feature0219,NA,C17 H31 N O9,393.19997,NA,NA,Feature0219,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,324938.87805724936,466154.7302983913,1.4345920472349936,0.5206405382209633,0.503210021330675,0.7643022379378415,Upregulated
Feature0218,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1465916.6468582565,1590990.4241423002,1.0853212067357998,0.11812207933767614,0.5936602087332719,0.804045727166399,Upregulated
Feature0217,NA,C10 H23 N O6,253.15257,NA,NA,Feature0217,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,121431.741250988,148823.88338174002,1.225576458416544,0.29346049051854123,0.21291439709580026,0.7429210442740862,Upregulated
Feature0216,NP-008521,C14 H18 N2 O2,246.13679,NA,NA,NP-008521,14,18,2,2,0,0,1.2857142857142858,0.14285714285714285,-0.5714285714285712,76.58571428571427,7,5,0.3,0.3636363636363637,3,Lignin,5080364.950440937,4676833.87530237,0.9205704552576398,-0.11939995336539272,0.2730787756781095,0.7429210442740862,Downregulated
Feature0215,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,190122.12514579433,348945.019612898,1.835373023236044,0.8760733077993221,0.12389723850274847,0.7187737055604655,Upregulated
Feature0214,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,200295.51851664265,353039.54511631,1.7625933307488144,0.8176996514084858,0.2100620460944874,0.7429210442740862,Upregulated
Feature0213,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0213,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2693134.35350304,2737713.71297418,1.0165529652886252,0.02368538563866468,0.9008431142371364,0.9498388119903466,Upregulated
Feature0212,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3300424.39263334,3583125.5731012537,1.0856560086935827,0.11856705602796072,0.652183555738313,0.8331143341897993,Upregulated
Feature0211,N-Acetyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Acetyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,757594.8773672903,1276325.2948913216,1.6847068704142585,0.7524975923635868,0.45079374098907016,0.7437859477801351,Upregulated
Feature0210,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0210,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2145855.7464333833,2098831.4193063667,0.9780859793557066,-0.031966802983946795,0.6941228779231349,0.8520609820302829,Downregulated
Feature0209,NA,C20 H33 N O11,463.2054,NA,NA,Feature0209,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,122845.81887329734,137779.39235176533,1.1215635470171794,0.16551136484617854,0.2312273606343807,0.7429210442740862,Upregulated
Feature0208,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,381787.23522694333,311555.5051511127,0.8160448448883231,-0.2932796587196738,0.39212273444541235,0.7429210442740862,Downregulated
Feature0207,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0207,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4264299.70803717,3685026.9687917936,0.8641575923583449,-0.2106336609922215,0.4984657358874107,0.7643022379378415,Downregulated
Feature0206,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,4383317.128796903,4511002.24716188,1.0291297924866374,0.041424944494658285,0.5924592660149091,0.804045727166399,Upregulated
Feature0205,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2176183.5991415298,1794047.1745279934,0.8244006504027127,-0.2785824518098073,0.1539431924142862,0.7429210442740862,Downregulated
Feature0204,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,70712.04320552693,2088275.8202945204,29.532109745787945,4.884212519800238,0.2248342815959229,0.7429210442740862,Upregulated
Feature0203,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0203,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,97982.36041338921,441309.3967921927,4.50396780533048,2.1711965149723027,0.43466854085621953,0.7437859477801351,Upregulated
Feature0202,NL8513000,C11 H13 N O2,191.09465,NA,Other,NL8513000-peak1,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,6550665.010219797,4984605.6836453,0.7609312452810115,-0.3941619914519565,0.010070646821704742,0.4061827551420913,Downregulated
Feature0201,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0201,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,255668.06999672198,546642.8678522106,2.1380959611390633,1.0963266049539298,0.3804269166512543,0.7429210442740862,Upregulated
Feature0200,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,4497771.51657036,3920199.3306878265,0.8715870328773516,-0.19828336211263942,0.266134909185042,0.7429210442740862,Downregulated
Feature0199,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,965341.8731360381,863233.8221798883,0.8942260210629437,-0.1612885674453362,0.6094683201025429,0.8135849757712432,Downregulated
Feature0198,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0198,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,4825427.504153663,4654445.66542139,0.9645664889618393,-0.05204740613151364,0.3336494723665424,0.7429210442740862,Downregulated
Feature0197,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0197,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,783584.9321966617,896937.6057260594,1.1446590776211465,0.19491797363814112,0.2197036855581983,0.7429210442740862,Upregulated
Feature0196,Crotetamide,C12 H22 N2 O2,226.16812,Microbial metabolism in diverse environments;Other,NA,Crotetamide,12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,4764308.910072603,4761750.94886842,0.9994630992128207,-7.747921149780885e-4,0.9867582543582042,0.9930757365148142,Downregulated
Feature0195,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0195,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1759356.3869953,1493773.7894252934,0.8490455944383279,-0.23608606513278607,0.2072682144543447,0.7429210442740862,Downregulated
Feature0194,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,180170.53054986632,105383.06437486263,0.5849073322548465,-0.773720020424278,0.03953940839386633,0.614208185361607,Downregulated
Feature0193,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0193,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,536290.464569608,515649.852423447,0.9615122522032425,-0.056622853463389175,0.8923319967321574,0.9484653686568222,Downregulated
Feature0192,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,1533546.0671765066,1439747.1916710234,0.9388353062792686,-0.09105599734217616,0.5956802057409927,0.8052395954641071,Downregulated
Feature0191,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,84044.82426373793,90450.43691940796,1.0762166226389958,0.10596849513673422,0.5882035322210449,0.801558357602538,Upregulated
Feature0190,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,634572.7957712794,595438.13599188,0.9383291246643596,-0.09183404929253308,0.8073650663844254,0.9118080082836999,Downregulated
Feature0189,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,396230.1193311323,551428.5974068984,1.3916877352427257,0.4768355377997523,0.6239362688559877,0.8195540183230478,Upregulated
Feature0188,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0188,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1583384.6643884366,1285720.5045887867,0.8120076779229013,-0.30043472603734783,0.19672087115684408,0.7429210442740862,Downregulated
Feature0187,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0187,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,60436.8308136024,67360.72764110213,1.1145641942883178,0.15647971225877047,0.45557497973137284,0.7470900442061429,Upregulated
Feature0186,NA,C9 H9 O P S,196.01126,NA,NA,Feature0186,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,150511.15981705434,179974.21349702365,1.1957532831172222,0.25791975246194176,0.3184008566402473,0.7429210442740862,Upregulated
Feature0185,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,100310.57109240083,108904.16164817949,1.0856698398004603,0.11858543564548005,0.6235951832455582,0.8195540183230478,Upregulated
Feature0184,NA,C8 H11 N O7,233.05354,NA,NA,Feature0184,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,771508.9991850597,824071.7992738993,1.068129859981363,0.09508705616595296,0.7282339301364604,0.8678071861534502,Upregulated
Feature0183,NA,C23 H32,308.25044,NA,NA,Feature0183,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,333301.1430749623,457088.06778378034,1.3713966401878714,0.4556458928332348,0.5695358077420543,0.788874618409681,Upregulated
Feature0182,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0182,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,307684.95786197734,451599.00254388864,1.4677318179020922,0.5535883848514607,0.09531648823760654,0.6957353835318275,Upregulated
Feature0181,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0181,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,2043983.7578481368,1907133.4572312299,0.9330472661089146,-0.09997792822221238,0.7327642138566763,0.8680261231817094,Downregulated
Feature0180,(+)-castanospermine,C8 H15 N O4,189.10012,NA,NA,(+)-castanospermine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,442734.75410004734,129857.0937181591,0.29330675424865005,-1.7695178011234323,0.15550422298791775,0.7429210442740862,Downregulated
Feature0179,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0179,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,166899.80882606196,134618.62449643333,0.8065834553275545,-0.3101042814590812,0.6616711392563932,0.8390728999405301,Downregulated
Feature0178,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,564637.951255784,352430.75418689667,0.6241712116641689,-0.6799862767957666,0.16313870893647478,0.7429210442740862,Downregulated
Feature0177,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0177,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,87184.10573917843,483852.61677849485,5.5497801196240655,2.472430613514645,0.3889829174575512,0.7429210442740862,Upregulated
Feature0176,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0176,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,668637.0445495357,634691.1911539846,0.949231270279946,-0.0751684672434951,0.7867674468204965,0.9029702269064507,Downregulated
Feature0175,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa-peak1,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,276019.276308294,296957.7373070277,1.0758586910261547,0.10548859913652858,0.919353743379317,0.9606848135346713,Upregulated
Feature0174,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1647286.5369904,1581880.0896627,0.9602944321713466,-0.058451282066710505,0.7217521438022985,0.8661346898978831,Downregulated
Feature0173,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,4137796.4071210064,3438485.55304611,0.8309943783431668,-0.26708937765572316,0.22090314475801334,0.7429210442740862,Downregulated
Feature0172,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,3497461.7350133434,2895555.45073738,0.82790196723234,-0.27246814813007947,0.09300781093630547,0.6854522562238613,Downregulated
Feature0171,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,2023985.60854625,3530795.0884945467,1.7444763804573586,0.8027940641257398,0.03382486836310506,0.6051275072806717,Upregulated
Feature0170,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0170,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,102774.69145288407,317443.597685393,3.0887331618107705,1.6270152407419791,0.3208041574213299,0.7429210442740862,Upregulated
Feature0169,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,709149.4541935826,723356.600852003,1.0200340655617879,0.02861733395793919,0.7809106791193721,0.9027817218351678,Upregulated
Feature0168,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,1923530.3583174832,1425253.19321108,0.7409569529527741,-0.43253836553510633,0.07103262077183722,0.6384005117332444,Downregulated
Feature0167,NA,C9 H19 N O8,269.11107,NA,NA,Feature0167,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,269920.61353596166,114190.07750924933,0.4230506000018251,-1.2410978641524588,0.11581717505741966,0.7055599272098991,Downregulated
Feature0166,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,2807760.7394669,2448157.778268377,0.8719253545561009,-0.1977234635793098,0.3050537395976737,0.7429210442740862,Downregulated
Feature0165,NA,C14 H25 N3 O6,331.17443,NA,NA,Feature0165,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5213923.47268945,4649833.303849896,0.8918108077737888,-0.16519041124006736,0.3735952340493079,0.7429210442740862,Downregulated
Feature0164,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3292899.2453856166,2908857.3816736033,0.8833727256458951,-0.1789058053923084,0.2344204457014659,0.7429210442740862,Downregulated
Feature0163,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,764078.167372882,511050.325022749,0.6688456061765059,-0.5802548719281385,0.24547641227632,0.7429210442740862,Downregulated
Feature0162,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,474830.25536146364,625816.8447612093,1.3179801364696262,0.39832862737729136,0.34602569255965915,0.7429210442740862,Upregulated
Feature0161,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,134448.829738619,166748.48150651465,1.2402375076874166,0.3106164257343771,0.32956770418025444,0.7429210442740862,Upregulated
Feature0160,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0160,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,270819.65176018764,157601.5216495616,0.5819427084601624,-0.7810509663051399,0.17267015568162214,0.7429210442740862,Downregulated
Feature0159,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,257461.49325282898,490090.62563511636,1.9035492237817635,0.9286918769596185,0.06951430379653324,0.6384005117332444,Upregulated
Feature0158,DL-Metanephrine,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,DL-Metanephrine,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,3457134.18317374,1481313.7932126066,0.4284802714405264,-1.2226993151707133,0.004599183173541252,0.319665224680575,Downregulated
Feature0157,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,3094804.6873131865,2154300.7720822934,0.6961023359288597,-0.5226286786350677,0.02852137632909571,0.5904389566427806,Downregulated
Feature0156,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,667893.952995538,625927.781458191,0.9371664148939713,-0.09362284142693264,0.580058271608418,0.7969332620475751,Downregulated
Feature0155,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0155,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,125434.35974321634,167124.71594876132,1.3323679117180622,0.41399251418143335,0.01364766044907686,0.49964037324760396,Upregulated
Feature0154,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,154458.531483705,151006.17875922102,0.9776486757233723,-0.03261197822856122,0.6118909794371205,0.8152864262097903,Downregulated
Feature0153,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,493606.5891495907,2602592.030545057,5.272603907149879,2.398515621475151,0.12480161229868944,0.7192763118557381,Upregulated
Feature0152,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,4168115.9410079103,3869503.892244367,0.9283580272262449,-0.10724679762655794,0.5581521683577603,0.7845882412758023,Downregulated
Feature0151,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0151,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,1783549.67100533,1588202.04030743,0.8904725593721263,-0.16735694068311954,0.6300776136541555,0.8248465823262283,Downregulated
Feature0150,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,1544286.4384588134,1148157.391772994,0.7434873240995672,-0.4276199492668117,0.26092597710998094,0.7429210442740862,Downregulated
Feature0149,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1605376.98442561,1313103.7194386632,0.8179410395051107,-0.2899312432598472,0.38447190700228817,0.7429210442740862,Downregulated
Feature0148,NA,C13 H21 N O8,319.12681,NA,NA,Feature0148,13,21,8,1,0,0,1.6153846153846154,0.6153846153846154,-0.1538461538461542,64.6846153846154,4,-4,-1.25,-0.125,-5,Amino Sugar,5471365.05101819,1541026.55491028,0.28165303183773194,-1.8280090934191906,0.006211568009257972,0.3282861036703624,Downregulated
Feature0147,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0147,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2569957.3990971935,2130605.8331991797,0.8290432494903011,-0.27048072875425133,0.26330638598650663,0.7429210442740862,Downregulated
Feature0146,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0146,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3393462.088519247,3406925.5106575433,1.0039674591279053,0.0057125090141716146,0.9162796174572748,0.9597297834084061,Upregulated
Feature0145,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0145,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,1236690.18899002,1050022.671166287,0.8490587865209955,-0.23606364937029548,0.18523748212799632,0.7429210442740862,Downregulated
Feature0144,Kynurenine,C10 H12 N2 O3,208.08476,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Kynurenine,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,3633800.599790153,3316302.0994647667,0.9126263283836429,-0.13190382015199656,0.4124004095644826,0.7429210442740862,Downregulated
Feature0143,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,88610.38681667953,97516.05098763207,1.1005036146538545,0.13816388383431003,0.5315094983115296,0.7697066387459335,Upregulated
Feature0142,NA,C14 H26 N4 O5,330.19042,NA,NA,Feature0142,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,5452134.1442729635,4105320.8164699404,0.7529750200262875,-0.40932609065679765,0.041035269464280155,0.6160378041011744,Downregulated
Feature0141,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,333275.48466037505,398185.692965555,1.1947644255062049,0.25672618669350183,0.7336524859568656,0.8680261231817094,Upregulated
Feature0140,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,3631788.110370957,3373303.006195537,0.9288270415784202,-0.10651811990268495,0.10716993663498287,0.7055599272098991,Downregulated
Feature0139,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0139,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,1005701.9638110696,985326.0550823797,0.9797396152519419,-0.029529718821985174,0.8626703316772432,0.9365353934039933,Downregulated
Feature0138,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,179047.793887086,216168.88977128934,1.2073250671137183,0.27181416786824625,0.19487849049887615,0.7429210442740862,Upregulated
Feature0137,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0137,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1553676.6656558134,1489650.66088567,0.9587906504709474,-0.06071225409489767,0.8007757419420698,0.9116358244958779,Downregulated
Feature0136,NA,C9 H17 N3 O2,199.13218,NA,NA,Feature0136,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,5734987.275217737,6032167.22333456,1.0518187632954321,0.07288613826117657,0.6857290145192255,0.848520782027442,Upregulated
Feature0135,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,154403.63909992768,214076.83606145866,1.3864753273263941,0.47142194348841426,0.044635884065982796,0.6354049378804609,Upregulated
Feature0134,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,178983.52396974768,329204.39017508033,1.8392999694805618,0.8791567865418876,0.06770826858221875,0.6384005117332444,Upregulated
Feature0133,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,466590.97893223935,504292.9565490373,1.080803057322446,0.11210366080666893,0.588168074730472,0.801558357602538,Upregulated
Feature0132,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,534722.4922279386,547334.987674654,1.0235869925616277,0.033633719267968036,0.8046797644317116,0.9118080082836999,Upregulated
Feature0131,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0131,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,192723.30589943565,199755.88314163365,1.0364905386475034,0.051706947215657224,0.8491652296139908,0.9276253512962122,Upregulated
Feature0130,Nipecotic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Nipecotic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,237441.03852185298,887869.9987115216,3.7393283159423434,1.9027791465069686,0.08803907149147326,0.6687811081011467,Upregulated
Feature0129,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,4597049.458606253,5916782.52201062,1.2870826331732543,0.3641046803202979,0.2666188978142255,0.7429210442740862,Upregulated
Feature0128,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,2650391.780372047,2401773.4534261166,0.9061956316092141,-0.1421055586497368,0.30489645248171876,0.7429210442740862,Downregulated
Feature0127,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,168404.43826831967,219243.697656913,1.3018878831898175,0.3806052109223571,0.3692686267297023,0.7429210442740862,Upregulated
Feature0126,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,956625.6981450763,1071800.310455764,1.1203967367111447,0.16400968651014736,0.8783583734673182,0.9403980032751831,Upregulated
Feature0125,Methyl picolinate,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Methyl picolinate,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,217496.66647217167,540265.3484434884,2.4840166849757876,1.3126748640781138,0.18313046342632264,0.7429210442740862,Upregulated
Feature0124,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,73931.13361058243,74551.82617429543,1.0083955504724489,0.012061657456755193,0.8980975899700142,0.9498388119903466,Upregulated
Feature0123,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0123,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1178189.4039819157,934728.016961616,0.7933597211131966,-0.33395294119714264,0.14725862298742767,0.7419901680471508,Downregulated
Feature0122,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0122,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,4895504.4719341,3604716.22007743,0.7363319226329479,-0.4415718460104038,0.04450256732224363,0.6354049378804609,Downregulated
Feature0121,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid-peak1,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4033171.3243103432,3801689.52261309,0.9426055123664165,-0.08527397661447135,0.418689585263645,0.7429771053580235,Downregulated
Feature0120,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0120,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,258000.49391303133,277405.75047265267,1.0752140287226062,0.10462386673795984,0.7123558595784661,0.8613353505538343,Upregulated
Feature0119,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0119,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,114278.253879176,259300.66659335166,2.269028951628057,1.182075017165275,0.11441012475988663,0.7055599272098991,Upregulated
Feature0118,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2174982.843054993,2104895.3627402866,0.9677756169256668,-0.04725550386810863,0.7838403950306844,0.9029702269064507,Downregulated
Feature0117,NA,C9 H19 N O8,269.11113,NA,NA,Feature0117,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5029062.933408231,4592849.104965554,0.9132614098851509,-0.13090022179210736,0.16163096876544747,0.7429210442740862,Downregulated
Feature0116,Val-pro,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Val-pro,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,170304.47234025467,171390.25952294923,1.0063755647034638,0.009168798405845115,0.9909398651820849,0.9950516488550396,Upregulated
Feature0115,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0115,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1205579.5764865468,1135772.021425282,0.9420962693605784,-0.08605360380444069,0.6784711240289214,0.8450956500772007,Downregulated
Feature0114,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,274665.621404943,363636.906075044,1.323925812830174,0.40482228191802544,0.21622245084180344,0.7429210442740862,Upregulated
Feature0113,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,3058974.25564854,2580382.3108878997,0.8435449582889109,-0.2454631332245727,0.05141458352889664,0.6384005117332444,Downregulated
Feature0112,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0112,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,428469.44963277,495886.41232774133,1.1573436863532574,0.21081735274991376,0.7581138298320677,0.88507569106514306,Upregulated
Feature0111,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,121354.66632535098,135877.82745796975,1.1196753414795133,0.1630804723394898,0.813845164418509,0.9118080082836999,Upregulated
Feature0110,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,119259.9881928995,131788.89973945665,1.1050554484903352,0.1441187617027089,0.7489110931441654,0.8756841695291173,Upregulated
Feature0109,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,637560.74856446,643153.0063043423,1.0087713331670338,0.012599183469697704,0.9727740588339394,0.9858529643366621,Upregulated
Feature0108,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak1",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3160163.32541436,3208302.5822819835,1.015233154717189,0.02181108950543602,0.8549549415026028,0.9307799941551471,Upregulated
Feature0107,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0107,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1881485.65029467,1889202.72163071,1.0041015839450231,0.005905232675214342,0.954059271860191,0.9818811704320557,Upregulated
Feature0106,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,113439.48712300333,132941.79737930722,1.171918180793231,0.2288718493810365,0.40266382906921944,0.7429210442740862,Upregulated
Feature0105,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0105,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3707498.6982578402,3357659.82884003,0.9056401908968437,-0.1429901107447931,0.1686697996943984,0.7429210442740862,Downregulated
Feature0104,NA,C14 H27 N O10,369.16362,NA,NA,Feature0104,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1436578.4531367433,1135424.826677498,0.7903674346488478,-0.33940458981508936,0.17775873253956356,0.7429210442740862,Downregulated
Feature0103,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0103,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,993381.8516538707,866858.993704902,0.8726342164009518,-0.1965510513079851,0.38062881518023706,0.7429210442740862,Downregulated
Feature0102,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,142700.54875396035,147772.913904811,1.035545519587288,0.05039097165545186,0.8736311090535139,0.9391342199196943,Upregulated
Feature0101,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1688165.65993351,1969251.3620507668,1.166503625081633,0.22219079071616996,0.39066885622112096,0.7429210442740862,Upregulated
Feature0100,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0100,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,226700.21302804365,401986.5259086993,1.7732075349173673,0.8263613980945108,0.05218130455478598,0.6384005117332444,Upregulated
Feature0099,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0099,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2063966.2829147733,2114284.2322950168,1.024379249698393,0.03474993444354257,0.8130998066571338,0.9118080082836999,Upregulated
Feature0098,NA,C20 H30 N6 O8,482.21265,NA,NA,Feature0098,20,30,8,6,0,0,1.5,0.4,0.20000000000000015,54.599999999999994,9,1,-0.8333333333333334,-0.1,-5,Protein,4867608.9978176365,4372063.492785374,0.8981952935713535,-0.15489893228786553,0.07970177263123125,0.6437290065319814,Downregulated
Feature0097,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,94223.45820913451,100055.2711326026,1.0618934290283004,0.08663898541964296,0.577123217218259,0.7948347398111631,Upregulated
Feature0096,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak1,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,119846.852335225,141283.57514097734,1.178867633050482,0.23740173709432688,0.3789716283408859,0.7429210442740862,Upregulated
Feature0095,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,168012.383482144,207354.211992473,1.2341602904199627,0.3035297811778994,0.11948901778225127,0.7127267469124424,Upregulated
Feature0094,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,129059.15880652033,153130.234276049,1.1865119507373743,0.24672663165930817,0.397143640806769,0.7429210442740862,Upregulated
Feature0093,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0093,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1599157.9213158435,1501422.0627460233,0.9388829225262507,-0.09098282797911865,0.679998100399223,0.8451333690948524,Downregulated
Feature0092,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0092,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,1306995.6414116,1314980.20875356,1.0061091002058251,0.008786756228564613,0.8289752696966604,0.9146541535125908,Upregulated
Feature0091,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,239760.925976345,202260.363791518,0.843591852875448,-0.2453829327488182,0.6536062279446537,0.8331143341897993,Downregulated
Feature0090,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0090,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,350749.48601752997,237291.007832818,0.6765256038634894,-0.5637835592548266,0.23319328008051574,0.7429210442740862,Downregulated
Feature0089,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,3522204.180086387,3407116.07693522,0.9673249768421023,-0.04792744436322382,0.40191294976723674,0.7429210442740862,Downregulated
Feature0088,NA,C10 H15 N O5,229.09499,NA,NA,Feature0088,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,113802.88154040101,109673.41846650597,0.9637138970648205,-0.053323185515881895,0.7624243557936634,0.8882715672038968,Downregulated
Feature0087,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0087,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2297828.8466652134,1992316.9750814734,0.8670432430043158,-0.20582414652431308,0.39903628364290383,0.7429210442740862,Downregulated
Feature0086,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0086,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,1010659.4046284347,665788.778588527,0.6587667175899895,-0.6021604262541802,0.3484760785363178,0.7429210442740862,Downregulated
Feature0085,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0085,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,356505.93644158135,279777.82970864803,0.7847774780448675,-0.34964445595408555,0.23621319189262524,0.7429210442740862,Downregulated
Feature0084,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,283651.522167814,346832.57496911165,1.2227418076886556,0.2901197987206478,0.36811098814806487,0.7429210442740862,Upregulated
Feature0083,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,686694.3875154647,907237.1743722031,1.321165850291403,0.4018115842032466,0.4965941172165085,0.7638837682405117,Upregulated
Feature0082,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0082,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,99058.23219242226,135502.08681399433,1.3679033414484854,0.4519662903556327,0.16790973054397174,0.7429210442740862,Upregulated
Feature0081,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,2376275.68414351,2929268.4634045465,1.2327140672065386,0.30183819985304433,0.07765530223668665,0.6384005117332444,Upregulated
Feature0080,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak1,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,3112574.9549977835,3087358.2443213067,0.991898440666951,-0.011735682588571397,0.8966679217779587,0.949799513816329,Downregulated
Feature0079,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0079,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,269473.2421256677,318286.705838916,1.181144010174058,0.24018487506341055,0.4516282728764795,0.7437859477801351,Upregulated
Feature0078,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0078,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,358336.734747369,556587.4642198903,1.5532525980410299,0.6352924673990242,0.5278841983398279,0.7697066387459335,Upregulated
Feature0077,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,572779.9904927784,827088.4433188334,1.4439897640405812,0.5300605154797705,0.5955335313458296,0.8052395954641071,Upregulated
Feature0076,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,372027.7270070037,145139.92036788905,0.3901319977829413,-1.357965764944214,0.07569925836919085,0.6384005117332444,Downregulated
Feature0075,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0075,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,915001.524507255,868299.2490133157,0.9489593467955266,-0.07558181104746049,0.649591171348487,0.8331143341897993,Downregulated
Feature0074,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0074,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,251202.14218264335,352305.3156778227,1.4024773539616933,0.48797747558206517,0.2927882802320704,0.7429210442740862,Upregulated
Feature0073,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0073,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,1079143.139335297,1008032.7214988776,0.934104739914095,-0.09834376841861757,0.7756777749670919,0.8993827178605432,Downregulated
Feature0072,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455-peak1,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,3542271.8844909165,3221791.017867693,0.909526745243249,-0.13681203297268446,0.05617527387436194,0.6384005117332444,Downregulated
Feature0071,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,478227.76339152,330633.03271931264,0.6913714719833756,-0.5324670198916687,0.3474497987149192,0.7429210442740862,Downregulated
Feature0070,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0070,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,168609.96174475,196327.11356328666,1.1643862054870533,0.2195696530297706,0.640164316225902,0.8313876949993997,Upregulated
Feature0069,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0069,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,465179.5113108767,263171.2047672057,0.5657411781219442,-0.8217859118670517,0.3037114030914339,0.7429210442740862,Downregulated
Feature0068,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0068,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,160135.03957146633,87145.35829776243,0.5441991867049841,-0.8777932943776152,0.003329451659297509,0.28281512298137695,Downregulated
Feature0067,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0067,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,429847.3766498867,251622.234497309,0.5853757593180726,-0.7725650905750958,0.39060786003645154,0.7429210442740862,Downregulated
Feature0066,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,261754.231359648,365300.78336436,1.395586926969062,0.4808719883964013,0.3642152998258357,0.7429210442740862,Upregulated
Feature0065,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,1876221.0543364966,2345355.997828677,1.2500424682943791,0.32197710909290383,0.3543058259181161,0.7429210442740862,Upregulated
Feature0064,Ala-Tyr,C12 H16 N2 O4,252.11102,NA,NA,Ala-Tyr,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,110872.34790734934,130416.7066928653,1.176278027428879,0.2342290987675607,0.413562305047499,0.7429210442740862,Upregulated
Feature0063,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,137309.26323042356,118896.7145664925,0.8659045411012635,-0.20772010650659004,0.6500297436357013,0.8331143341897993,Downregulated
Feature0062,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1706015.2446552666,1456518.8324636966,0.8537548753018408,-0.22810618306155234,0.12125993008589368,0.713775301372683,Downregulated
Feature0061,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,1054456.8847155198,436444.17357488966,0.41390423819238203,-1.2726310736981699,0.09446509861444571,0.6927440565059352,Downregulated
Feature0060,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0060,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,987832.393752196,898136.0223688193,0.9091987953111431,-0.13733232230198333,0.20640879574933813,0.7429210442740862,Downregulated
Feature0059,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,402664.5371320267,764583.1592285914,1.8988092784984885,0.9250950046014125,0.38374339821684056,0.7429210442740862,Upregulated
Feature0058,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,119076.41082380233,139087.42691072435,1.1680518916255578,0.22410436850550708,0.3940492782156545,0.7429210442740862,Upregulated
Feature0057,NA,C12 H22 N4 O3,270.16923,NA,NA,Feature0057,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,4082579.999771807,3594008.8018119233,0.8803278324032372,-0.18388721419839044,0.123196632553019,0.718122968801801,Downregulated
Feature0056,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,271430.53464477963,149468.83560069557,0.550670674529323,-0.8607383137775924,0.028051050367660035,0.5904389566427806,Downregulated
Feature0055,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0055,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,399510.19584317465,278385.945312049,0.696818124314724,-0.5211459458086294,0.30467593013172317,0.7429210442740862,Downregulated
Feature0054,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0054,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1914256.1065374967,1838769.87078651,0.9605662818610379,-0.058042927417215916,0.8748216827942469,0.9391342199196943,Downregulated
Feature0053,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0053,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,141751.075759227,174264.97587287065,1.2293732159667734,0.29792295890522386,0.39319705249845455,0.7429210442740862,Upregulated
Feature0052,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0052,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,4221134.52604589,3874005.5992500465,0.9177640691965785,-0.12380476907705575,0.19833694053709236,0.7429210442740862,Downregulated
Feature0051,NA,C15 H33 N O,243.2562,NA,NA,Feature0051,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1410424.022572247,2641623.00712133,1.8729282576339674,0.9052956383220175,0.1956872072641217,0.7429210442740862,Upregulated
Feature0050,N-feruloylglycine,C12 H13 N O5,251.07936,NA,NA,N-feruloylglycine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,4356417.89954291,3318061.75523587,0.7616490960575688,-0.3928016168246809,0.0773544722882427,0.6384005117332444,Downregulated
Feature0049,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,2400257.675909647,2320244.4328710567,0.9666647277741683,-0.04891249417066788,0.2882371734481077,0.7429210442740862,Downregulated
Feature0048,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0048,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,139876.38881746132,165637.47694772133,1.1841703832079782,0.2438766766798807,0.46050050743862636,0.749905170284088,Upregulated
Feature0047,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0047,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,276464.11939913966,218424.15190257566,0.7900632905900894,-0.3399598651886899,0.4287686927468545,0.7437859477801351,Downregulated
Feature0046,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1448704.0432238167,1058535.557835771,0.7306775754419795,-0.4526931633005948,0.29151034982751234,0.7429210442740862,Downregulated
Feature0045,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0045,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2551402.3186838864,1882781.8302786066,0.7379400012655861,-0.43842457317541617,0.11302402290897592,0.7055599272098991,Downregulated
Feature0044,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,4216242.238473513,3753955.246009147,0.8903556849163067,-0.16754630672512888,0.0643044449531936,0.6384005117332444,Downregulated
Feature0043,NA,C12 H17 N O4,239.11576,NA,NA,Feature0043,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,2999730.60710589,1025001.3928557973,0.3416978146063284,-1.549207074122507,0.0010267235359873615,0.19965892031945995,Downregulated
Feature0042,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1408328.0171104732,1268817.98863491,0.900939250813314,-0.15049826465888835,0.12336114753324919,0.718122968801801,Downregulated
Feature0041,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0041,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,820664.4811655456,749385.3337343417,0.9131445931107314,-0.13108477109943673,0.5557458994425344,0.7825715325483401,Downregulated
Feature0040,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0040,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,391960.79208553967,275714.2705469853,0.7034230874980341,-0.5075354075324747,0.37876609453980775,0.7429210442740862,Downregulated
Feature0039,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0039,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,78077.02427377253,417887.1189186943,5.3522418766037685,2.4201433152117615,0.038255485472449856,0.6113659659465099,Upregulated
Feature0038,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0038,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1049481.3333260287,797297.291084911,0.7597060240777289,-0.3964868337691856,0.2765947938709993,0.7429210442740862,Downregulated
Feature0037,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,345415.63273426134,168833.31858991634,0.4887830850429543,-1.0327337351539856,0.28308709346899946,0.7429210442740862,Downregulated
Feature0036,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak1,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,4054082.9498891034,3404660.0003156066,0.8398101475473605,-0.2518648743164729,0.3479580069495028,0.7429210442740862,Downregulated
Feature0035,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0035,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2453320.70670546,2225182.31871574,0.9070083306409277,-0.14081229328553832,0.3689097051433132,0.7429210442740862,Downregulated
Feature0034,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0034,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,810102.558886183,640534.0030655713,0.790682606837148,-0.33882940579538273,0.06579442099655253,0.6384005117332444,Downregulated
Feature0033,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3083345.070530227,2837657.936921267,0.9203179897192919,-0.11979566532007117,0.34675981215932344,0.7429210442740862,Downregulated
Feature0032,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,145778.17219142467,174847.18622700265,1.199405806771996,0.26231986255939177,0.36431318770109844,0.7429210442740862,Upregulated
Feature0031,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0031,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2392333.4126727,1993427.4373126533,0.8332565296931621,-0.26316737703844817,0.06127029279343715,0.6384005117332444,Downregulated
Feature0030,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0030,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,315032.7541615197,95243.4035787017,0.30232857479279657,-1.7258107521651769,0.06052556658834019,0.6384005117332444,Downregulated
Feature0029,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,320613.06902079366,322471.8372418387,1.0057975435209863,0.008339935011320531,0.9673846379402528,0.9854176648651762,Upregulated
Feature0028,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0028,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,379890.276364156,338482.359345207,0.8910003240534219,-0.16650213843738199,0.4125238185491614,0.7429210442740862,Downregulated
Feature0027,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1793866.41628308,1714077.653229099,0.9555213463334107,-0.06563999153773745,0.8888772908239879,0.9464224579860689,Downregulated
Feature0026,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0026,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2440429.4392175,2067531.3195008435,0.8471997945426266,-0.23922585543007047,0.21915291955716093,0.7429210442740862,Downregulated
Feature0025,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0025,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,405064.26393919764,517480.95491018303,1.2775280393233104,0.3533549559368786,0.37825084965886757,0.7429210442740862,Upregulated
Feature0024,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0024,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,2337103.54806072,1706534.5426246135,0.7301920978386518,-0.4536520389202029,0.10346104435286024,0.7055599272098991,Downregulated
Feature0023,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,315684.776276562,307719.80776998564,0.9747692346760538,-0.03686737694132489,0.958753117957126,0.9835341758228962,Downregulated
Feature0022,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0022,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,3069990.76432419,3158010.785176797,1.0286711028174649,0.04078178283262178,0.47168437940431307,0.7552299987815749,Upregulated
Feature0021,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0021,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,222928.36754777332,964277.3920553733,4.325503311500856,2.1128680131560804,0.20840224792591985,0.7429210442740862,Upregulated
Feature0020,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,151229.80362668133,181176.86118572566,1.1980235167994413,0.26065622802397403,0.44800264381386856,0.7437859477801351,Upregulated
Feature0019,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,195494.16464050434,221241.549450449,1.1317041092110944,0.17849680624919495,0.8295601992004349,0.9146541535125908,Upregulated
Feature0018,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0018,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1250357.7475692967,1176290.8821385843,0.9407634610376919,-0.08809606745481206,0.6920020767630903,0.8507102856872568,Downregulated
Feature0017,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2660037.9560097465,2171983.8217408434,0.8165236202114121,-0.2924334745394836,0.16832410071539874,0.7429210442740862,Downregulated
Feature0016,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0016,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,3785885.06483311,3847902.9099680767,1.0163813333138523,0.023441784456254274,0.8192481401969568,0.9125694928365151,Upregulated
Feature0015,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0015,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2593023.7832551533,2477653.96044981,0.9555076110175459,-0.06566072996978192,0.15812389029496532,0.7429210442740862,Downregulated
Feature0014,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1343605.69764311,1521663.7598818266,1.1325225566928285,0.17953978502188847,0.6626486729084824,0.8390728999405301,Upregulated
Feature0013,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,363217.07768243,362364.561515403,0.9976528742192778,-0.003390166856403459,0.9963912703386496,0.9987495928719955,Downregulated
Feature0012,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,109497.814669978,2386016.7863661097,21.79054251956962,4.445630210595394,0.05837445698175635,0.6384005117332444,Upregulated
Feature0011,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0011,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,319091.01249915,267635.46319849533,0.8387433450486427,-0.25369868049365885,0.41720302676787935,0.7429771053580235,Downregulated
Feature0010,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0010,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,299599.127714759,218341.76145869,0.7287796968039502,-0.45644532747114647,0.3645569393324149,0.7429210442740862,Downregulated
Feature0009,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,174556.31854352696,614175.6125673867,3.5184954500185412,1.8149586473797983,0.44350797233271183,0.7437859477801351,Upregulated
Feature0008,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0008,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,290652.90496821166,225300.914056871,0.7751545235080719,-0.36744416117500084,0.0619192660272782,0.6384005117332444,Downregulated
Feature0007,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,3274965.9642293267,3130124.6379392636,0.955773181195748,-0.06525980846926065,0.6132342333312606,0.8152864262097903,Downregulated
Feature0006,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak1,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1207442.6261671267,939923.8395410826,0.7784418233806698,-0.3613388709413146,0.11420709026762031,0.7055599272098991,Downregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,1150161.2901010439,833699.196933346,0.7248541609847641,-0.46423733753738256,0.22988696731246164,0.7429210442740862,Downregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,2192587.535284707,289281.6766369636,0.13193620413398932,-2.9220875912715276,0.002505775640121551,0.2652989958978692,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,395987.76946469035,302967.73243859067,0.7650936614738195,-0.3862917239806604,0.1774447767776646,0.7429210442740862,Downregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,72182.76700445064,85733.74685750781,1.187731510101596,0.24820874790441627,0.3802360710950841,0.7429210442740862,Upregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,1442229.2885151966,558475.3644690054,0.3872306358748037,-1.368734998482943,0.007045294948640629,0.3497215117308036,Downregulated
